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Measuring performance on the Healthcare Access and 
Quality Index for 195 countries and territories and selected 
subnational locations: a systematic analysis from the Global 
Burden of Disease Study 2016
GBD 2016 Healthcare Access and Quality Collaborators*
Summary
Background A key component of achieving universal health coverage is ensuring that all populations have access to 
quality health care. Examining where gains have occurred or progress has faltered across and within countries is 
crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, 
and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access 
and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 
1990 to 2016.
Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which 
death should not occur in the presence of effective care to approximate personal health-care access and quality by 
location and over time. To better isolate potential effects of personal health-care access and quality from underlying 
risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local 
joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion 
of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised 
death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We 
transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 
100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational 
locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, 
providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared 
HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall 
development. As derived from the broader GBD study and other data sources, we examined relationships between 
national HAQ Index scores and potential correlates of performance, such as total health spending per capita.
Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 
96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in 
the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of 
progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 
2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and 
elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. 
Striking subnational disparities emerged in personal health-care access and quality, with China and India having 
particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged 
from 91·5 (89·1–93·6) in Beijing to 48·0 (43·4–53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point 
disparity, from 64·8 (59·6–68·8) in Goa to 34·0 (30·3–38·1) in Assam. Japan recorded the smallest range in 
subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations 
with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high 
for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point 
to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point 
to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high 
and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. 
Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 
2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was 
positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these 
relationships were quite heterogeneous, particularly among low-to-middle SDI countries.
Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving 
personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-
SDI countries face considerable challenges unless heightened policy action and investments focus on advancing 
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access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or 
minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities 
of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium 
Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health 
coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive 
view—and subsequent provision—of quality health care for all populations.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Providing access to quality health care is among 
the foremost objectives of health systems,1,2 because the 
receipt of effective personal health care can substantially 
improve many health outcomes and avert premature 
mortality. The advancement of population health was 
elevated to global agendas with the Alma Ata Declaration 
of 1978, wherein WHO called for the achievement of 
“health for all” by 2000.3 Such aspirations garnered new 
momentum in the Sustainable Development Goal (SDG) 
Research in context
Evidence before this study
Improving, and subsequently measuring, health-care access and 
quality has emerged as an increasing priority alongside a 
heightened emphasis on universal health coverage in the 
Sustainable Development Goal era. Nevertheless, few studies 
have sought to assess personal health-care access and quality 
across a wide range of key health service dimensions and the 
development spectrum. Primarily focused on high-income 
countries, past analyses have used amenable mortality—deaths 
from causes that should not occur in the presence of high-quality 
health care—to approximate national levels of personal 
health-care access and quality. Drawing from the Global Burden 
of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), 
the GBD collaboration used this amenable mortality framework 
in developing the Healthcare Access and Quality (HAQ) Index, 
and subsequently offered several advances from previous work. 
First, the extensive cause-of-death standardisation processes that 
occur as part of GBD enabled better comparisons across locations 
and over time. Second, risk-standardising death rates for 
environmental and behavioural risk factors helped isolate 
differences in health-care access and quality from variations in 
death rates due to background risk exposure. Third, estimating 
the HAQ Index for 195 countries and territories from 
1990 to 2015, allowed for a broader investigation of trends in 
personal health-care access and quality across the development 
spectrum. Despite these methodological strengths, additional 
areas for improvement were identified, including the 
consideration of health outcomes that more directly reflect the 
progression of disease onset to mortality for amenable causes 
and examining subnational inequalities.
Added value of this study
Based on updated cause of death and risk factor estimates from 
the GBD 2016 study, our analysis offers an improved 
assessment of national levels of personal health-care access and 
quality from 1990 to 2016. For the first time, we report 
subnational levels and trends on the HAQ Index for 
seven countries: Brazil, China, England, India, Japan, Mexico, 
and the USA. Because of major improvements in cancer 
estimation and data availability, we used mortality-to-incidence 
ratios rather than risk-standardised death rates from cancer, 
ultimately providing a more robust approximation of cancer 
detection and treatment effects across countries. To improve 
index stability, we used percentiles (ie, first and 99th percentile) 
for transforming HAQ Index components to a scale of 0–100. 
Finally, we did an exploratory analysis of national HAQ Index 
levels and potential correlates of performance, examining 
relationships between the HAQ Index and some indicators such 
as health financing (eg, total health spending per capita).
Implications of all the available evidence
Globally, personal health-care access and quality improved since 
1990, with many countries in sub-Saharan Africa and southeast 
Asia accelerating their pace of progress from 2000 to 2016. Such 
gains in the more recent time period could reflect the catalytic 
effects of the Millennium Development Goals and their focus on 
a subset of health service areas (ie, vaccine-preventable diseases, 
infectious diseases, and maternal and child health). 
Nonetheless, inequalities increased in some parts of the world, 
which might be related to many low-to-middle income 
countries recording much slower gains for cancers and other 
non-communicable diseases. Large disparities in subnational 
levels of personal health-care access and quality emerged for 
several countries, especially China and India. These results 
emphasise the urgent need to improve both access to and 
quality of health care across service areas and for all populations; 
otherwise, health systems could face widening gaps between 
the health services they provide and the disease burden 
experienced by local communities. Going forward, the HAQ 
Index can provide a robust measure for both informing and 
monitoring the effects of policy action on health-care access and 
quality, a key component of achieving universal health coverage. 
To deliver health systems for the next generation and hasten 
progress in the Sustainable Development Goal era, now is the 
time to align investments for improving access and quality 
across the full range of health-care needs.
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era,4 with a heightened emphasis on attaining universal 
health coverage in this pursuit. Making progress on 
universal health coverage entails all people having access 
to quality health services they need without incurring 
financial hardship.5 To advance toward this ambition, it is 
crucial to monitor where improvements in health-care 
access and quality have occurred, and where progress 
must be accelerated, across the development spectrum.
Measuring health-care access and quality has become 
an increasingly important priority alongside its ascent in 
global health policy. In particular, the use of amenable 
mortality—deaths from causes that should not occur in 
the presence of effective medical care—to approximate 
national levels of personal health-care access and quality 
has gained greater traction.6–15 Amenable mortality 
metrics are thought to provide a strong signal of what 
can or should be addressed by the receipt of effective 
health care, and thus perform ance on overall personal 
health-care access and quality. Combining such measures 
with those capturing avertable or preventable health 
outcomes (ie, burden that can be avoided through public 
health programmes or policies implemented outside the 
immediate health sector) can offer a more complete set 
of potential pathways for improving health.1,16 The Nolte 
and McKee list of causes amenable to health care6–9 
remains the most widely used framework to quantify 
national levels of health-care access and quality on the 
basis of amenable mortality. This is particularly true for 
Europe,11,15,17 the Organisation for Economic Co-operation 
and Development (OECD),12 and the USA,13 but in-
creasingly also for other country-specific analyses (eg, 
Brazil,14 China,18 and Mexico19). As part of the Global 
Burden of Diseases, Injuries, and Risk Factors Study 2015 
(GBD 2015),20 the GBD collaboration applied this 
framework to develop a novel measure, the Healthcare 
Access and Quality (HAQ) Index, to track gains and gaps 
in personal health-care access and quality in 195 countries 
and territories over time.
The HAQ Index offered several strengths and in-
sights into personal health-care access and quality 
across countries, which has prompted calls for further 
improvements. First, 32 causes considered amenable 
to health care comprise the HAQ Index, representing 
a range of health service areas: vaccine-preventable 
diseases; infectious diseases and maternal and child 
health; non-communicable diseases, including cancers, 
cardiovascular diseases, and other non-communicable 
diseases such as diabetes; and gastro intestinal con-
ditions from which surgery can easily avert death 
(eg, appendicitis). Other than in high-income countries, 
past research rarely accounts for this array of services,21 
even though effective preventive interventions, treat ment, 
and medical technologies exist; instead, these studies 
often focus on infectious diseases and maternal and child 
health, and do not shed light on potential challenges 
across service areas. Second, because GBD quantifies risk 
exposure and risk-attributable deaths, we could account 
for local variations in risk exposure and better isolate 
differ ences in mortality related to health care. Nonetheless, 
challenges can still exist in ensuring that these mea-
sures provide a strong signal on health-care access and 
quality. For instance, in the absence of stronger monitor-
ing systems, low rates of cancer mortality could 
actually represent inadequate detection and treatment of 
cancer rather than good access to cancer screening and 
high-quality care.22 Third, although some insights into 
the relationship between the HAQ Index and socio-
demographic development were explored in GBD 2015,20 
further examination of how health financing and system 
measures are related to the HAQ Index has yet to occur. 
Fourth, considerable debate continues about how well the 
current cause list represents the range of causes amenable 
to health care, particularly non-fatal outcomes, as well as 
the ages at which health care can substantially im-
prove outcomes. Finally, GBD 2015 highlighted sizeable 
in equalities across countries20 but did not capture sub-
national differences in personal health-care access and 
quality, a crucial need in light of the magnitude by which 
health outcomes can vary within countries.23–30
In this study, we provide updated estimates from 
1990 to 2016 for the HAQ Index in 195 countries and 
territories, as well as at global and regional levels. For the 
first time, we report subnational estimates of the HAQ 
Index for seven countries, allowing for a more in-depth 
examination of inequalities in personal health-care 
access and quality. With the improved estimation of 
cancers in GBD 2016,31–33 we use mortality-to-incidence 
ratios (MIRs) for cancers to better reflect potential 
differences in cancer diagnostic and treatment capacity 
across locations. Finally, we do an exploratory analysis of 
the associations between the HAQ Index and potential 
correlates of performance.
Methods
Overview
Drawing from methods established in GBD 2015,20 our 
analysis involved four steps: mapping the Nolte and 
McKee cause list to GBD causes; constructing MIRs for 
cancers and risk-standardising non-cancer deaths to 
remove variations in mortality not directly amenable to 
health care; calculating the HAQ Index on the basis of 
principal components analysis (PCA), providing an 
overall score of personal health-care access and quality 
on a scale of 0–100; and examining associations between 
national HAQ Index scores and potential correlates 
of performance.
Our study draws from GBD 2016 results,31–33 which 
entail several improvements since GBD 2015, including 
169 new country-years of vital registration data, 528 new 
cancer-registry years with a total of 92 countries’ cancer 
registries,31 five new risk factors,32 and cause-specific 
mortality modelling updates (eg, cancers, tuberculosis).31 
Further information can be found in the appendix 
(pp 12–89) and the GBD 2016 capstone series.31–33
See Online for appendix
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In addition to national and aggregated HAQ Index 
results, we report estimates at the subnational level 
for Brazil (26 states and the Federal District), China 
(33 provinces and special administrative regions), England 
(nine regions and 150 local government areas), India 
(31 states and union territories), Japan (47 prefectures), 
Mexico (32 states), and the USA (50 states and the 
District of Columbia).
As with all GBD revisions, GBD 2016 HAQ Index 
estimates for the full time series published here 
supersede previous iterations. This analysis complies 
with the Guidelines for Accurate and Transparent Health 
Estimates Reporting (GATHER);34 additional information 
is found in the appendix (pp 5–7).
Mapping the Nolte and McKee amenable cause list to 
GBD causes
We mapped 32 of 33 causes from the Nolte and McKee 
cause list6–9 to GBD causes in accordance with International 
Classification of Diseases codes (table 1; appendix p 156). 
GBD includes thyroid diseases within a larger residual 
category, and only non-fatal outcomes are estimated for 
benign prostatic hyperplasia; consequently, these causes 
were not included in our analyses. GBD provides separate 
estimates for diphtheria and tetanus, so we disaggregated 
these causes from the original Nolte and McKee list.
Mortality-to-incidence ratios for cancers
GBD cancer mortality estimates are informed by MIRs, 
which are derived from incidence and mortality data 
recorded in cancer registries; more detail on MIR 
estimation is in the appendix (pp 41–49).31 MIRs provide a 
good approximation of cancer survival and have been 
used to identify countries with higher or lower cancer 
mortality relative to incidence.22,35 Because of the 
improved quantity and quality of cancer registry data 
from GBD 2016, we used cancer-specific MIRs instead of 
risk-standardised death rates. As detailed in the appendix 
(pp 10–11), cancer-specific MIRs were more strongly 
correlated with the Socio-demographic Index (SDI), 
a measure of overall development, than were risk-
standardised death rates. These results, and the dis-
tribution of MIRs by SDI quintile (appendix pp 96–111), 
showed that cancer MIRs provide a more robust signal of 
cancer care access and quality than do risk-standardised 
death rates.
Risk-standardisation of death rates for non-cancer causes
To better isolate differences in mortality associated with 
health-care access and quality from differences associated 
with underlying risk exposure, we risk-standardised 
cause-specific deaths to global levels of risk exposure.32 
We did not risk-standardise differences in exposure to 
three metabolic risk factors (high systolic blood pressure, 
high total cholesterol, and high fasting plasma glucose) 
given their amenability to health care (eg, diagnosis and 
treat ment of hypertension in primary care). For the 
Amenable age range 
(years)
Communicable, maternal, neonatal, and nutritional diseases
Tuberculosis 0–74
Diarrhoea, lower respiratory, and other common infectious diseases
Diarrhoeal diseases 0–14
Lower respiratory infections 0–74
Upper respiratory infections 0–74
Diphtheria 0–74
Whooping cough 0–14
Tetanus 0–74
Measles 1–14
Maternal disorders 0–74
Neonatal disorders 0–74
Non-communicable diseases
Neoplasms
Colon and rectum cancer 0–74
Non-melanoma skin cancer (squamous-cell 
carcinoma)
0–74
Breast cancer 0–74
Cervical cancer 0–74
Uterine cancer 0–44
Testicular cancer 0–74
Hodgkin’s lymphoma 0–74
Leukaemia 0–44
Cardiovascular diseases
Rheumatic heart disease 0–74
Ischaemic heart disease 0–74
Cerebrovascular disease 0–74
Hypertensive heart disease 0–74
Chronic respiratory diseases 1–14
Digestive diseases
Peptic ulcer disease 0–74
Appendicitis 0–74
Inguinal, femoral, and abdominal hernia 0–74
Gallbladder and biliary diseases 0–74
Neurological disorders
Epilepsy 0–74
Diabetes, urogenital, blood, and endocrine diseases
Diabetes 0–49
Chronic kidney disease 0–74
Other non-communicable diseases
Congenital heart anomalies 0–74
Injuries
Unintentional injuries
Adverse effects of medical treatment 0–74
Although 0 (at birth) to 1 are listed as the lower bound of age ranges, age 
restrictions are applied for many causes such that mortality estimates are not 
produced before a given age group (eg, 15–19 years for many non-communicable 
diseases). Causes are ordered on the basis of the GBD cause list and corresponding 
group hierarchies. GBD=Global Burden of Disease.
Table 1: Causes for which mortality is amenable to health care, mapped 
to GBD causes, and amenable age range
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24 non-cancer causes, we risk-standardised deaths by re-
moving the joint effects of location-specific behavioural 
and environmental risk exposure, and replaced these 
estimates with the global level of joint risk exposure 
(appendix pp 9–10).
Joint population attributable fraction (PAF) estimation 
accounts for effects of multiple risks combined, including 
the mediation of different risk factors through each 
other. More detail on the PAF calculations and risk-
standardisation is provided in the appendix (pp 9–10). 
Since GBD 2015,36 five risk factors were added, 
most notably low birthweight and short gestation,32 
which enabled the risk-standardisation of neonatal dis-
order deaths. Risk-standardised deaths equalled observed 
deaths for causes in which no risk–outcome pairs 
have met evidence thresholds for inclusion in GBD 
(eg, diphtheria, appendicitis).
Age-standardisation
Using the GBD world population data,37 we age-
standardised risk-standardised death rates, as well 
as cancer mortality and incidence estimates, before pro-
ducing MIRs. We rescaled age weights to equal 1, by 
cause, a necessary step since included age groups rep-
resented a subset of the age groups comprising the world 
population standard.
Constructing the HAQ Index
By cause, we log-transformed age-standardised risk-
standardised death rates (or MIRs for cancers) and scaled 
them from 0 to 100 across locations from 1990–2016. 
Zero was determined by the first percentile observed (ie, 
highest death rates or MIRs), and 100 was applied to the 
99th percentile (ie, lowest death rates or MIRs). This 
scaling approach differs somewhat from that of 
GBD 2015,20 wherein maximum values determined zero 
and mini mum values set 100. Using a percentile-based 
approach more closely aligns with other index con-
struction methods used in GBD,38 and is less sensitive to 
outliers or fluctuations in estimates over time. We then 
applied cause-specific thresholds set by the national level 
to subnational locations.
We used PCA to construct the HAQ Index on the basis 
of scaled cause values, resulting in an overall score on a 
scale of 0–100. The GBD 2016 HAQ Index differed in 
three main ways from GBD 2015. First, no cause had 
negative PCA weights (ie, implying that higher death 
rates were associated with access to higher-quality health 
care), so all causes contributed to the final index. In GBD 
2015, colon and breast cancers had negative PCA weights 
in the first PCA iteration, so their weights were ultimately 
set to zero. Second, some cancers had PCA weights more 
similar to communicable, maternal, and neonatal causes, 
which meant these causes were weighted more equally 
(appendix p 157). Finally, we derived PCA weights from 
country-level estimates and applied them to subnational 
results; this approach provides greater stability across 
GBD iterations, particularly as the GBD continues to 
expand its subnational assessments.
Examining correlates of HAQ Index performance
The HAQ Index reflects many factors that affect service 
access and quality across the continuums of care and 
therapeutic areas, and thus it is challenging to distinguish 
the unique contribution of access versus quality from 
other potential drivers.39 To provide an initial examination 
of correlates with HAQ Index performance, we ran 
Pearson correlations between location-specific HAQ 
Index values with financial measures (eg, total health 
spending per capita),40 and health system inputs and 
outputs (eg, outpatient and inpatient utilisation).33 We 
selected these indicators on the basis of data availability 
in relation to GBD locations, and thus they do not 
represent all possible correlates.
Comparing performance on the HAQ Index across the 
development spectrum
As well as examining global patterns, we report differ-
ences in the HAQ Index across levels of development. To 
do this, we used SDI, a summary measure of overall 
develop ment based on average income per capita, edu-
cational attainment, and total fertility rates.41 Countries are 
grouped by SDI quintiles, as established in GBD 2016, on 
the basis of their 2016 SDI values.31
Uncertainty analysis
GBD aims to propagate uncertainty throughout its 
estimation process, which results in uncertainty intervals 
(UIs) accompanying each estimate. We estimated the 
HAQ Index for each location-year on the basis of 
1000 draws from the posterior distribution for each 
included cause of death. 95% UIs were based on the 
2·5th and 97·5th quantiles of the draws for each measure.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
National and subnational patterns in personal health-
care access and quality
The HAQ Index performance followed distinct geo-
graphical patterns in 2016 (figure 1), with most countries 
in the highest decile clustered in Europe or nearby 
(ie, Iceland), and almost all countries in the lowest decile 
located in sub-Saharan Africa. Exceptions to this pattern 
included Canada, Japan, Australia, and New Zealand in 
the tenth decile, and Afghanistan in the first decile. 
More heterogeneity emerged among the next deciles of 
performance (eg, USA, UK, Malta, Lebanon, Singapore, 
and South Korea, in the ninth decile; Cuba, Chile, 
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Saudi Arabia, and Russia, in the eighth decile). 
Most Latin American countries scored between 
the fourth and sixth deciles, whereas southeast Asia fea-
tured a broader range, spanning from the seventh 
(Thailand and Sri Lanka) to third deciles (Cambodia, 
Indonesia, Laos, Myanmar, and Timor-Leste). By 2016, 
many sub-Saharan African coun tries improved their 
performance from 1990 and 2000 (appendix pp 113–14), 
such as South Africa and Botswana rising to the 
fourth decile, and several locations moving to the third 
decile (eg, Kenya, Rwanda, Namibia, Nigeria, Ghana). 
African countries that remained in the first decile since 
1990 were generally concentrated in central and eastern 
sub-Saharan Africa.
We applied the deciles set by national HAQ Index scores 
in 2016 to subnational locations (figure 2), and a more 
nuanced landscape surfaced regarding inequalities in 
personal health-care access and quality. China was in the 
eighth decile in 2016, and had provinces spanning from 
the tenth decile (Beijing 91·5, 95% UI 89·1–93·6) to the 
fourth decile (Tibet 48·0, 43·5–53·2), with a higher 
performance (ie, eighth and ninth deciles) among eastern 
provinces and lower (ie, fifth and sixth deciles) in western 
provinces. For India, which was in the third decile in 2016, 
subnational performance ranged from the sixth (Goa 64·8, 
59·6–68·8; Kerala 63·9, 58·6–67·0) to the second deciles 
(Assam 34·0, 30·3–38·1; and Uttar Pradesh 34·9, 
31·1–38·4). Brazil and Mexico, each in the sixth decile 
nationally for 2016, had variable subnational patterns. In 
Brazil, performance was as high as the eighth decile for 
the Federal District (75·4, 72·3–78·1), but most states, 
particularly northern ones, were in the fifth decile. 
Conversely, Mexico featured six states in the seventh decile, 
whereas most others were in the sixth decile; four states, 
all along Mexico’s southern border, fell within the 
fifth decile. Both occupying the ninth decile nationally, 
England and the USA had subnational locations spanning 
from the tenth to seventh deciles in 2016; Blackpool 
(79·7 [76·6–82·8]) had the lowest HAQ Index score in 
England and Mississippi (81·5 [78·6–84·2]) had the lowest 
score in the USA. The USA’s highest HAQ Index scores 
were limited to a subset of northeastern states, Minnesota, 
and Washington state, and higher performance was 
primarily dispersed across southern England. Nearly all 
Japanese prefectures occupied the top decile of HAQ 
Index performance in 2016. The appendix contains a more 
in-depth exploration of subnational trends over time by 
country (pp 115–28).
Patterns of performance on the overall HAQ Index and 
health areas varied considerably across countries in 
Figure 1: Map of HAQ Index values, by decile, in 2016
Deciles are based on the distribution of HAQ Index values in 2016. Where lower and upper bounds of deciles appear to overlap, they should be interpreted as values up to but not equalling the upper 
bound in the preceding decile (ie, exclusive of the upper bound value) and values equalling the lower bound of the following decile (ie, inclusive of the lower bound value). HAQ Index=Healthcare 
Access and Quality Index. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. FSM=Federated States of Micronesia. TLS=Timor-Leste.
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2016 (figure 3). Locations that scored approximately 90 or 
higher on the HAQ Index had generally high scores 
across broader causes, including vaccine-preventable dis-
eases, infectious diseases and maternal and child health, 
and causes that require complex case management 
(eg, epilepsy, diabetes, and chronic kidney disease). 
Nonetheless, many of these countries had lower scores 
for cancers and some non-communicable diseases. 
Greater heterogeneity occurred across causes for countries 
that scored below 90 on the HAQ Index, though many 
locations achieved greater consistency, and high scores, 
for vaccine-preventable diseases and gastrointestinal 
causes for which surgery could avert death. For these 
countries, a mixture of relatively low values on cancers 
and some non-communicable diseases, and then 
comparably better performance on other health areas, was 
commonplace. Among countries with lower HAQ Index 
scores in 2016 (ie, lower than approximately 50), most 
fared poorly across health areas and recorded particularly 
low scores on cancers, some infectious causes like 
tuberculosis, and maternal and child health. Nonetheless, 
many still exceeded a score of 90 for some causes 
(eg, diphtheria, upper respiratory infections).
Progress on personal health-care access and quality
Although global gaps between the highest and low est 
HAQ Index values slightly widened over time (from 76·4 in 
1990 to 78·5 in 2016), changes by SDI quintile showed 
more diverse trends (figure 4A). Low-middle-SDI countries 
saw some differences increase since 1990, with HAQ 
Index scores ranging from 29·0 to 67·2 by 2016. 
Conversely, disparities considerably narrowed among 
middle-SDI countries from 1990 (a 46·8-point difference) 
to 2016 (a 30·6-point difference). Among countries with 
subnational HAQ Index estimates (figure 4B), there was 
variation in when and how much local inequalities 
changed. In the USA, state-level differences decreased 
since 1990, but then comparably little progress occurred 
from 2000 to 2016. On the other hand, in Japan, absolute 
differences between prefectures narrowed to a 4·8-point 
difference between 2000 and 2016. In England, disparities 
slightly increased since 1990, from a 13·7-point difference 
in 1990, to a 16·9-point difference in 2016. China’s overall 
gains quickened since 2000, though absolute differences 
between Chinese provinces remained high in 2016 
(a 43·5-point gap). Mexico’s progress on the HAQ Index 
was much faster from 1990 to 2000, than from 2000 to 2016, 
although absolute inequalities somewhat narrowed by 
2016 (ie, a 20·9-point difference to a 17·0-point difference). 
Brazil’s state-level disparities slightly widened after 2000, 
rising from an absolute difference of 17·2 in 1990, 
to 20·4 in 2016. However, compared with Mexico, Brazil’s 
overall progress was more consistent across time periods. 
Although India’s improvements on the HAQ Index 
hastened from 2000 to 2016, the gap between the country’s 
highest and lowest scores widened (23·4-point difference 
in 1990, and 30·8-point difference in 2016).
From 1990 to 2016, 186 of 195 countries and territor ies 
significantly increased their HAQ Index score, with 
several middle-SDI countries, including China, the 
Maldives, Equatorial Guinea, Peru, and Thailand achiev-
ing among the most pronounced gains (table 2; 
appendix p 130). South Korea, Taiwan (Province of China), 
and Cyprus  recorded the largest improvements among 
high-SDI countries, and Lebanon, Turkey, and Saudi 
Arabia had the most progress for high-middle-SDI 
countries. For many low-middle-SDI and low-SDI coun-
tries, advances in the HAQ Index either primarily took 
place or accelerated from 2000 to 2016 (figure 5; 
appendix pp 133–35). Bangladesh, Myanmar, Bhutan, 
Figure 2: Map of HAQ Index values for selected subnational locations in 2016
Deciles are based on the distribution of HAQ Index values for countries and territories in 2016 (as shown in 
figure 1), and then applied for subnational locations. Where lower and upper bounds of deciles appear to overlap, 
they should be interpreted as values up to but not equalling the upper bound in the preceding decile (ie, exclusive 
of the upper bound value) and values equalling the lower bound of the following decile (ie, inclusive of the lower 
bound value). HAQ Index=Healthcare Access and Quality Index.
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Cambodia, and Laos (low-middle SDI), and Rwanda and 
Ethiopia (low SDI), exemplified this trend. Some 
countries in eastern Europe and central Asia (eg, Russia, 
Belarus, Kazakhstan) also experienced substantive 
progress from 2000 to 2016, after stalled gains or falter-
ing performance from 1990 to 2000. A sub set of countries, 
including Vietnam and Nepal, rec orded more comparable 
rates of change for each time period, whereas others, 
including several countries in Latin America and the 
Caribbean (eg, Guatemala, Mexico, Dominican Republic; 
table 2, appendix pp 133–35), had much slower progress 
after making considerable gains from 1990 to 2000. 
Nine countries, all low-to-middle SDI, did not record 
significant increases from 1990 to 2016. Table 2 and the 
appendix (pp 158–64) provide estimates of HAQ Index 
values, as well as absolute change and annualised rates of 
change for 1990–2000, 2000–16, and 1990–2016.
Focusing on 2000–16, examining improvement across 
health areas highlights a mixture of progress and 
potential for worsening performance if past trends are 
not addressed (appendix pp 136–41). Across locations, 
the largest gains primarily took place for vaccine-
prevent able diseases (eg, measles), some infectious 
diseases (eg, diarrhoeal diseases), some cancers (eg, 
leukaemia), and some non-communicable diseases. 
Such advances were most pronounced among coun-
tries that also recorded substantive increases in their 
overall HAQ Index (eg, China, Turkey). At the same 
time, many low-to-middle SDI countries experienced 
relatively few gains across most non-communicable 
diseases. Further more, countries with minimal pro-
gress on overall HAQ Index performance had com-
paratively small advances, even for health areas in 
which improvements have been more widespread. The 
main exception was vaccine-preventable diseases, 
especially measles, for low-SDI to middle-SDI countries 
(appendix pp 136–41).
Correlates of HAQ Index performance 
Although total health spending per capita was strongly 
correlated with HAQ Index performance in 2016 
(r=0·94; figure 6), large variation existed at similar 
spending levels. For instance, some countries with 
HAQ Index scores between 40 and 70 spent at least 
three times more than did peers with similar 
performance. Govern ment spending as a fraction of 
total health spending had positive, albeit moderate, 
correlation with HAQ Index performance in 2016 
(r=0·76; appendix p 145), whereas develop ment assist -
ance for health showed an opposite pattern (r=–0·71; 
appendix p 147). Country-level HAQ Index scores in 
2016 were positively associ ated with physicians, nurses, 
and midwives per 1000 (r=0·79), and similar, though 
more moderate, corre lations were found for hospital 
beds per 1000 and utilisation (appendix pp 149–52). 
Nonetheless, sizeable heterogeneity emerged across 
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Figure 3: Performance on the HAQ Index and 32 individual causes, by country or territory, in 2016
Countries are ranked by their HAQ Index score from highest to lowest in 2016. The HAQ Index and individual causes are reported on a scale of 0–100, with 
0 representing the worst levels observed from 1990 to 2016, and 100 reflecting the best during that time. HAQ Index=Healthcare Access and Quality Index. 
LRIs=lower respiratory infections. URIs=upper respiratory infections. NM=non-melanoma. SCC=squamous-cell carcinoma. Colon cancer=colon and rectum cancer. 
HD=heart disease. Chronic respiratory=chronic respiratory diseases. Peptic ulcer=peptic ulcer disease. Hernia=inguinal, femoral, and abdominal hernia. 
Gallbladder=gallbladder and biliary diseases. Chronic kidney=chronic kidney disease. Congenital heart=congenital heart anomalies. Adverse med treat=adverse effects 
of medical treatment.
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these health system measures and their relationships 
to the HAQ Index, particularly among middle-to-high 
SDI countries. All correlations and additional figures 
are in the appendix (pp 142–52, 165).
Discussion
Summary of findings
Amid gains on personal health-care access and quality, 
striking disparities remained regarding HAQ Index 
scores achieved by 2016, and how quickly locations 
improved over time. In 2016, HAQ Index performance 
diverged along the development spectrum, ranging 
from more than 97 in Iceland to less than 20 in the 
Central African Republic and Somalia. Subnational 
inequalities were particularly pronounced in China 
and India, although high-income countries, including 
England and the USA, also saw considerable local gaps 
in performance. The global pace of progress accel-
erated from 2000 to 2016, a trend fuelled by many 
low-SDI and low-middle-SDI countries in sub-
Saharan Africa and southeast Asia. By contrast, several 
countries saw slowed or minimal improvement from 
2000 to 2016 after recording larger gains from 1990 
to 2000. Examining patterns in broader causes 
unveiled considerable heterogeneity in country-level 
im prove ments across health areas. These findings, 
coupled with the variable relationships between 
national HAQ Index values and potential correlates of 
per formance, underscore the complexities of orienting 
health systems toward providing access to quality 
services across health needs and along continuums 
of care.
Inequalities in personal health-care access and quality 
within countries
Our subnational assessment of HAQ Index per-
formance shows the importance of monitoring health-
care gaps and gains at more local levels. Further, 
because some factors might be more uniform because 
of country-level policy or health-care characteristics 
(eg, national insurance schemes, federally-maintained 
referral sys tems), this analysis offers the opportunity to 
consider if or how challenges in access and quality are 
experienced within countries. For instance, Mexico’s 
subnational differ ences could be more related to state-
level vari ations in quality given the country’s concerted 
efforts to expand access and service coverage through 
a tiered insurance system.42,43 Similar factors might 
under lie disparities in England, where the National 
Health Service ought to minimise financial barriers to 
accessing health care.30 Nonetheless, other obstacles 
probably exist, including inadequate utilisation of 
care across Mexican states,44 and local variations in 
health funding45 or human resource constraints within 
England.46 Striking disparities in China and India 
might represent myriad factors, including large vari-
ations in physical access to health facilities, health 
system infrastructure and scale-up of medical tech-
nologies, and provision of effective services across 
continuums of care. Brazil’s universal health coverage-
focused initiatives, includ ing expanding community-
based health programmes and governance functions, 
seem to have contributed to local reductions in 
amenable mortality from 2000 to 2012.14 However, state-
level progress on the HAQ Index was generally 
faster from 1990 to 2000 than from 2000 to 2016, 
suggest ing that advances in access might not always 
be accompanied by improved quality of care ac ross 
health services, especially for non-communicable 
dis eases. State-level differences in the USA could be 
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Figure 4: Median, IQR, and range of the HAQ Index in 1990, 2000, and 2016, globally and by SDI quintile (A), 
and for seven countries with subnational estimates (B)
Black lines represent the median, dark-coloured boxes represent the IQR, and the light-coloured boxes represent the 
full range of values within a given group. Subnational locations represented in panel B are as follows: 47 prefectures 
in Japan; 150 local government areas in England; 50 states and the District of Columbia in the USA; 33 provinces and 
special administrative regions in China; 32 states in Mexico; 26 states and the Federal District in Brazil; and 31 states 
and union territories in India. HAQ Index=Healthcare Access and Quality Index. SDI=Socio-demographic Index.
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HAQ Index (95% UI) Absolute change (95% UI) Annualised rate of change (95% UI) 
1990 2000 2016 1990–2016 1990–2000 2000–16 1990–2016 1990–2000 2000–16
Global 37·6 
(36·8 to 38·8)
42·4  
(41·6 to 43·2)
54·4 
(53·5 to 55·4)
16·8  
(15·2 to 18·0)*
4·7  
(4·0 to 5·4)*
12·0  
(10·9 to 13·1)*
1·42  
(1·28 to 1·53)*
1·18  
(0·99 to 1·36)*
1·56  
(1·42 to 1·70)*
Southeast Asia, east Asia, 
and Oceania†
37·1 
(35·9 to 38·6)
44·9 
(43·9 to 46·2)
62·9  
(61·8 to 64·2)
25·9  
(24·1 to 27·3)*
7·8  
(6·9 to 8·8)*
18·0  
(16·6 to 19·4)*
2·04  
(1·88 to 2·16)*
1·92  
(1·67 to 2·17)*
2·11  
(1·93 to 2·27)*
East Asia 42·8 
(41·4 to 44·6)
53·3 
(52·1 to 54·9)
77·0 
(75·5 to 78·1)
34·2 
(31·7 to 35·9)*
10·5 
(8·8 to 12·2)*
23·7 
(21·7 to 25·3)*
2·26 
(2·08 to 2·39)*
2·20 
(1·80 to 2·56)*
2·30 
(2·11 to 2·46)*
China 42·6  
(41·2 to 44·5)
53·3  
(52·0 to 55·1)
77·9  
(76·5 to 78·9)
35·3  
(32·8 to 37·0)*
10·8  
(8·8 to 12·6)*
24·6  
(22·4 to 26·2)*
2·33  
(2·13 to 2·46)*
2·25  
(1·83 to 2·63)*
2·37  
(2·15 to 2·54)*
North Korea 49·6  
(46·2 to 52·9)
47·6  
(44·1 to 51·2)
53·4  
(49·6 to 56·9)
3·8  
(–1·3 to 8·2)
–1·9  
(–6·2 to 2·0)
5·7  
(1·2 to 10·2)*
0·28  
(–0·10 to 0·62)
–0·40  
(–1·26 to 0·41)
0·71  
(0·15 to 1·26)*
Taiwan (Province of 
China)
60·6  
(58·6 to 62·7)
71·8  
(69·9 to 73·7)
85·4  
(82·5 to 88·2)
24·8  
(21·4 to 28·1)*
11·2  
(8·6 to 13·6)*
13·6 
(10·2 to 16·7)*
1·32  
(1·14 to 1·49)*
1·70  
(1·30 to 2·07)*
1·08  
(0·82 to 1·32)*
Oceania 27·2  
(22·9 to 31·0)
32·4  
(28·4 to 36·3)
36·0  
(31·8 to 40·4)
8·8  
(4·0 to 13·5)*
5·2  
(1·9 to 8·5)*
3·6 
(–0·5 to 7·8)
1·08  
(0·49 to 1·66)*
1·76  
(0·62 to 2·97)*
0·66  
(–0·10 to 1·44)
American Samoa 47·6  
(44·6 to 50·6)
55·9  
(52·9 to 59·1)
59·5  
(55·0 to 64·1)
11·9  
(6·5 to 17·4)*
8·3  
(4·1 to 12·5)*
3·6  
(–1·8 to 8·9)
0·86  
(0·46 to 1·23)*
1·61  
(0·79 to 2·42)*
0·38  
(–0·20 to 0·96)
Federated States of 
Micronesia
27·9  
(23·4 to 32·5)
32·2  
(27·2 to 37·1)
41·6  
(34·8 to 49·1)
13·7  
(5·8 to 21·4)*
4·3  
(0·0 to 8·0)
9·4  
(2·3 to 17·2)*
1·54  
(0·68 to 2·40)*
1·44  
(0·02 to 2·72)*
1·59  
(0·44 to 2·77)*
Fiji 41·0  
(34·8 to 47·2)
43·3  
(39·7 to 47·0)
47·9  
(41·9 to 54·3)
6·8  
(–1·9 to 15·4)
2·2  
(–4·0 to 8·6)
4·6  
(–2·4 to 11·8)
0·59  
(–0·17 to 1·35)
0·55  
(–0·92 to 2·16)
0·62  
(–0·34 to 1·59)
Guam 61·9  
(59·0 to 64·9)
71·3  
(68·7 to 74·0)
68·7  
(64·8 to 72·9)
6·7  
(2·0 to 11·6)*
9·4  
(5·6 to 13·4)*
–2·7  
(–7·5 to 2·5)
0·40  
(0·12 to 0·67)*
1·41  
(0·83 to 2·03)*
–0·24  
(–0·67 to 0·21)
Kiribati 20·3  
(17·0 to 23·8)
23·0  
(19·9 to 26·3)
26·5  
(21·4 to 31·1)
6·2  
(1·0 to 11·1)*
2·7  
(–1·0 to 6·0)
3·4  
(–1·1 to 7·9)
1·02  
(0·19 to 1·81)*
1·27 
(–0·49 to 2·79)
0·86  
(–0·27 to 1·95)
Marshall Islands 33·1  
(30·4 to 36·1)
34·5  
(31·1 to 38·0)
43·0  
(38·0 to 48·2)
9·9  
(4·3 to 15·1)*
1·3  
(–2·5 to 5·3)
8·6  
(3·5 to 13·7)*
1·00  
(0·46 to 1·50)*
0·38  
(–0·76 to 1·54)
1·39  
(0·56 to 2·17)*
Northern Mariana 
Islands
61·5  
(56·0 to 67·0)
71·9  
(67·7 to 75·9)
73·7  
(69·2 to 78·3)
12·2  
(5·4 to 19·4)*
10·4  
(5·6 to 15·1)*
1·8  
(–3·8 to 7·4)
0·70  
(0·30 to 1·12)*
1·56  
(0·83 to 2·37)*
0·15  
(–0·33 to 0·64)
Papua New Guinea 22·9  
(17·8 to 27·7)
28·5  
(23·2 to 33·6)
31·8  
(26·2 to 37·4)
8·9  
(2·7 to 15·1)*
5·6  
(1·4 to 9·8)*
3·3  
(–2·1 to 8·6)
1·27 
(0·37 to 2·15)*
2·19  
(0·52 to 3·95)*
0·70  
(–0·43 to 1·85)
Samoa 37·4  
(32·8 to 41·7)
43·6  
(38·8 to 48·2)
47·6  
(42·8 to 52·6)
10·3  
(4·5 to 16·1)*
6·3  
(2·6 to 9·7)*
4·0  
(–1·2 to 9·0)
0·93  
(0·41 to 1·48)*
1·56  
(0·67 to 2·43)*
0·55  
(–0·16 to 1·21)
Solomon Islands 26·7  
(21·2 to 32·3)
31·4  
(25·9 to 36·8)
32·4  
(27·1 to 37·7)
5·8  
(–0·9 to 12·3)
4·8  
(0·4 to 8·8)*
1·0  
(–4·6 to 6·2)
0·76  
(–0·11 to 1·65)
1·66  
(0·14 to 3·15)*
0·20  
(–0·87 to 1·24)
Tonga 38·4  
(33·7 to 42·9)
42·8  
(38·4 to 47·2)
49·6  
(44·4 to 54·4)
11·2  
(5·0 to 17·4)*
4·4  
(0·4 to 8·3)*
6·8  
(1·7 to 11·8)*
0·99  
(0·44 to 1·55)*
1·10  
(0·08 to 2·11)*
0·92  
(0·22 to 1·60)*
Vanuatu 28·2  
(23·2 to 33·1)
28·7  
(24·0 to 33·2)
32·4  
(26·9 to 37·5)
4·3  
(–2·0 to 10·3)
0·6  
(–3·4 to 4·8)
3·7  
(–1·9 to 8·9)
0·55  
(–0·26 to 1·36)
0·21  
(–1·17 to 1·73)
0·75  
(–0·39 to 1·82)
Southeast Asia 29·3  
(27·8 to 30·8)
34·5  
(33·0 to 36·0)
47·5  
(45·9 to 49·2)
18·1  
(16·4 to 20·0)*
5·1  
(4·0 to 6·2)*
13·0  
(11·4 to 14·6)*
1·85  
(1·67 to 2·05)*
1·61  
(1·25 to 1·97)*
2·00  
(1·76 to 2·27)*
Cambodia 20·3  
(17·7 to 23·6)
23·0  
(20·9 to 25·3)
39·4  
(36·4 to 42·5)
19·1  
(14·8 to 23·0)*
2·7  
(–0·7 to 5·7)
16·5  
(13·0 to 19·9)*
2·56  
(1·90 to 3·12)*
1·25  
(–0·33 to 2·76)
3·38  
(2·65 to 4·10)*
Indonesia 28·9  
(26·4 to 31·7)
33·0  
(31·1 to 35·3)
44·5  
(42·6 to 46·8)
15·6  
(12·8 to 18·4)*
4·1  
(1·8 to 6·0)*
11·5  
(9·2 to 13·8)*
1·67  
(1·33 to 2·01)*
1·34  
(0·57 to 2·00)*
1·87  
(1·49 to 2·27)*
Laos 18·0  
(15·4 to 21·4)
21·8  
(18·8 to 24·7)
36·6  
(32·6 to 41·1)
18·6  
(13·6 to 24·0)*
3·8  
(0·4 to 7·1)*
14·8  
(10·2 to 19·6)*
2·74  
(1·97 to 3·51)*
1·94  
(0·21 to 3·58)*
3·24  
(2·23 to 4·25)*
Malaysia 44·2  
(42·5 to 46·1)
54·2  
(52·6 to 55·9)
68·1  
(65·9 to 70·2)
23·9  
(21·3 to 26·6)*
10·0  
(7·8 to 12·3)*
13·9  
(11·5 to 16·2)*
1·66  
(1·47 to 1·85)*
2·05  
(1·59 to 2·51)*
1·43  
(1·19 to 1·66)*
Maldives 37·6  
(33·6 to 41·0)
52·7  
(49·9 to 55·4)
70·4  
(65·7 to 74·8)
32·8  
(26·9 to 39·1)*
15·1  
(11·9 to 18·6)*
17·6  
(11·9 to 22·8)*
2·41  
(1·98 to 2·92)*
3·39  
(2·62 to 4·32)*
1·80  
(1·24 to 2·29)*
Mauritius 53·9  
(52·6 to 55·3)
61·9  
(60·4 to 63·2)
68·7  
(65·5 to 71·9)
14·8  
(11·6 to 18·0)*
8·0  
(6·4 to 9·4)*
6·8  
(3·6 to 10·0)*
0·93  
(0·75 to 1·12)*
1·38  
(1·10 to 1·64)*
0·65  
(0·35 to 0·94)*
Myanmar 19·9  
(17·2 to 22·6)
23·1  
(20·2 to 26·0)
41·6  
(38·0 to 45·5)
21·7  
(17·4 to 26·4)*
3·1  
(–0·2 to 6·2)
18·6  
(14·5 to 22·5)*
2·84  
(2·29 to 3·44)*
1·46  
(–0·08 to 2·86)
3·70  
(2·82 to 4·54)*
Philippines 39·0  
(37·3 to 40·6)
42·7  
(40·7 to 44·5)
51·2  
(47·9 to 54·4)
12·2  
(8·7 to 15·8)*
3·8  
(1·9 to 5·7)*
8·4  
(4·8 to 11·9)*
1·05  
(0·76 to 1·33)*
0·92  
(0·46 to 1·41)*
1·12  
(0·65 to 1·56)*
Seychelles 45·9  
(43·8 to 48·1)
57·3  
(55·2 to 59·4)
65·6  
(62·2 to 68·9)
19·8  
(16·1 to 23·5)*
11·4  
(8·6 to 14·0)*
8·4  
(4·6 to 12·0)*
1·38  
(1·12 to 1·63)*
2·22  
(1·67 to 2·75)*
0·85  
(0·48 to 1·22)*
(Table 2 continues on next page)
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HAQ Index (95% UI) Absolute change (95% UI) Annualised rate of change (95% UI) 
1990 2000 2016 1990–2016 1990–2000 2000–16 1990–2016 1990–2000 2000–16
(Continued from previous page)
Sri Lanka 47·4 
(45·1 to 49·8)
54·4  
(52·1 to 56·9)
70·6  
(66·3 to 75·3)
23·2  
(18·5 to 28·1)*
7·0  
(3·8 to 10·2)*
16·2  
(11·5 to 21·0)*
1·53  
(1·24 to 1·84)*
1·38  
(0·75 to 2·02)*
1·62  
(1·16 to 2·08)*
Thailand 44·4  
(42·4 to 46·6)
54·7  
(52·2 to 57·4)
69·5  
(66·5 to 72·6)
25·1  
(21·4 to 28·7)*
10·3  
(7·2 to 13·3)*
14·8  
(10·9 to 18·6)*
1·72  
(1·46 to 1·95)*
2·09  
(1·49 to 2·66)*
1·49  
(1·09 to 1·88)*
Timor–Leste 22·2  
(17·2 to 27·8)
27·3  
(23·0 to 34·5)
43·4  
(37·2 to 51·9)
21·2  
(12·9 to 29·8)*
5·2  
(–0·9 to 12·3)
16·0  
(9·3 to 22·8)*
2·60  
(1·51 to 3·68)*
2·12  
(–0·33 to 4·94)
2·89  
(1·61 to 4·06)*
Vietnam 36·6  
(33·1 to 40·4)
44·7  
(41·6 to 48·2)
60·3  
(56·3 to 64·1)
23·7  
(18·1 to 29·0)*
8·1  
(4·2 to 12·1)*
15·6  
(10·8 to 20·3)*
1·92  
(1·46 to 2·40)*
2·01  
(1·01 to 3·05)*
1·87  
(1·28 to 2·47)*
Central Europe, eastern 
Europe, and central Asia†
57·1  
(55·8 to 58·6)
59·5  
(58·1 to 60·8)
71·4  
(68·1 to 74·3)
14·3  
(10·9 to 17·4)*
2·5  
(0·6 to 4·2)*
11·8  
(8·4 to 14·9)*
0·86  
(0·66 to 1·03)*
0·43  
(0·10 to 0·73)*
1·13  
(0·82 to 1·41)*
Central Asia 48·4  
(47·0 to 49·9)
49·6  
(48·2 to 51·0)
60·2  
(58·2 to 62·4)
11·8  
(9·5 to 14·1)*
1·2  
(–0·5 to 2·8)
10·6  
(8·3 to 12·9)*
0·84  
(0·68 to 1·00)*
0·25  
(–0·10 to 0·58)
1·21  
(0·96 to 1·47)*
Armenia 55·7  
(53·6 to 58·0)
58·9  
(57·2 to 61·0)
70·7  
(67·8 to 73·5)
15·0  
(11·9 to 18·0)*
3·2  
(1·1 to 5·3)*
11·7  
(8·9 to 14·8)*
0·92  
(0·74 to 1·10)*
0·56  
(0·18 to 0·94)*
1·14  
(0·87 to 1·42)*
Azerbaijan 49·6  
(47·0 to 52·1)
51·9  
(49·4 to 54·4)
65·6  
(61·2 to 69·6)
16·1  
(11·1 to 20·6)*
2·3  
(–1·1 to 5·6)
13·8  
(9·2 to 18·4)*
1·08  
(0·76 to 1·37)*
0·46  
(–0·21 to 1·10)
1·47  
(1·00 to 1·93)*
Georgia 61·2  
(59·0 to 63·5)
63·4  
(60·8 to 65·4)
67·1  
(62·7 to 71·0)
5·9  
(1·1 to 10·7)*
2·1  
(–0·7 to 4·7)
3·7  
(–0·8 to 7·9)
0·35  
(0·07 to 0·63)*
0·34  
(–0·11 to 0·76)
0·36  
(–0·08 to 0·76)
Kazakhstan 55·5  
(53·1 to 57·6)
54·1  
(51·4 to 56·5)
69·1  
(64·7 to 73·2)
13·6  
(9·3 to 18·0)*
–1·4  
(–4·3 to 1·5)
15·0  
(10·2 to 19·6)*
0·84  
(0·58 to 1·10)*
–0·25  
(–0·80 to 0·27)
1·53  
(1·05 to 1·97)*
Kyrgyzstan 50·9  
(49·5 to 53·1)
52·6  
(51·3 to 54·2)
60·6  
(58·3 to 62·8)
9·7  
(6·7 to 12·4)*
1·8  
(0·1 to 3·3)*
8·0  
(5·2 to 10·3)*
0·67  
(0·46 to 0·85)*
0·34  
(0·02 to 0·63)*
0·88  
(0·57 to 1·13)*
Mongolia 36·6  
(34·0 to 39·3)
38·7  
(36·1 to 41·5)
53·4  
(49·1 to 57·6)
16·8  
(11·3 to 21·9)*
2·2  
(–1·3 to 5·6)
14·6  
(9·5 to 19·7)*
1·45  
(0·98 to 1·86)*
0·58  
(–0·35 to 1·46)
2·00  
(1·32 to 2·65)*
Tajikistan 41·3  
(38·7 to 44·2)
42·6  
(39·9 to 45·5)
51·7  
(47·7 to 55·5)
10·4  
(5·7 to 15·3)*
1·3  
(–2·7 to 5·1)
9·1  
(4·4 to 13·8)*
0·86  
(0·48 to 1·25)*
0·30  
(–0·64 to 1·24)
1·21  
(0·60 to 1·82)*
Turkmenistan 45·4  
(43·8 to 46·9)
49·1  
(47·1 to 51·0)
61·6  
(58·7 to 64·8)
16·2  
(13·0 to 20·2)*
3·6  
(1·3 to 6·1)*
12·6  
(9·8 to 15·3)*
1·17  
(0·96 to 1·44)*
0·77  
(0·27 to 1·29)*
1·43  
(1·12 to 1·71)*
Uzbekistan 50·3  
(48·4 to 52·2)
52·8  
(51·0 to 54·6)
62·9  
(59·3 to 66·0)
12·6  
(8·6 to 16·1)*
2·5  
(0·2 to 4·8)*
10·1  
(6·2 to 13·2)*
0·86  
(0·60 to 1·09)*
0·49  
(0·04 to 0·92)*
1·09  
(0·69 to 1·42)*
Central Europe 58·8  
(57·7 to 60·2)
68·9  
(67·6 to 69·9)
80·6  
(79·2 to 81·7)
21·8  
(19·6 to 23·2)*
10·1  
(8·3 to 11·3)*
11·7  
(10·5 to 12·9)*
1·21  
(1·09 to 1·30)*
1·58  
(1·30 to 1·79)*
0·98  
(0·88 to 1·09)*
Albania 54·8  
(52·7 to 56·9)
63·6  
(61·5 to 65·7)
75·4  
(72·5 to 78·2)
20·6  
(17·2 to 24·0)*
8·8  
(6·1 to 11·7)*
11·8  
(8·4 to 15·0)*
1·23  
(1·03 to 1·42)*
1·49  
(1·03 to 1·96)*
1·06  
(0·77 to 1·35)*
Bosnia and 
Herzegovina
52·3  
(49·4 to 55·2)
61·3  
(58·1 to 64·4)
72·2  
(67·2 to 76·4)
19·9  
(14·8 to 24·6)*
9·0  
(5·8 to 12·3)*
10·9  
(5·9 to 16·1)*
1·24  
(0·94 to 1·52)*
1·59  
(1·01 to 2·18)*
1·02  
(0·56 to 1·51)*
Bulgaria 65·1  
(64·0 to 66·4)
68·0  
(66·5 to 69·0)
77·2  
(73·3 to 80·7)
12·1  
(8·4 to 15·8)*
2·9  
(1·2 to 4·2)*
9·2  
(5·4 to 12·8)*
0·65  
(0·46 to 0·84)*
0·43  
(0·18 to 0·63)*
0·79  
(0·48 to 1·08)*
Croatia 73·9  
(71·9 to 76·2)
78·1  
(76·5 to 79·7)
86·9  
(84·5 to 89·4)
13·0  
(9·7 to 16·4)*
4·2  
(1·6 to 6·7)*
8·8  
(5·8 to 11·8)*
0·63  
(0·46 to 0·79)*
0·55  
(0·21 to 0·90)*
0·67  
(0·45 to 0·89)*
Czech Republic 72·2  
(70·9 to 73·4)
81·4  
(79·8 to 82·4)
89·0  
(87·5 to 90·4)
16·8  
(14·9 to 18·7)*
9·2  
(7·4 to 10·4)*
7·6  
(6·0 to 9·5)*
0·80  
(0·72 to 0·89)*
1·20  
(0·96 to 1·35)*
0·56  
(0·44 to 0·70)*
Hungary 66·4  
(64·8 to 68·6)
74·5  
(73·0 to 76·0)
82·1  
(79·5 to 84·9)
15·7  
(12·6 to 18·7)*
8·0  
(6·0 to 9·9)*
7·6  
(4·7 to 10·7)*
0·81  
(0·66 to 0·96)*
1·14  
(0·83 to 1·41)*
0·61  
(0·38 to 0·84)*
Macedonia 59·3  
(57·2 to 61·6)
65·3  
(63·6 to 67·4)
75·1  
(72·6 to 77·5)
15·7  
(12·3 to 18·9)*
6·0  
(3·4 to 8·4)*
9·7  
(6·7 to 12·6)*
0·90  
(0·71 to 1·09)*
0·96  
(0·54 to 1·36)*
0·87  
(0·61 to 1·11)*
Montenegro 69·1  
(66·5 to 71·7)
70·3  
(68·4 to 72·4)
81·0  
(78·6 to 83·5)
11·9  
(8·3 to 15·5)*
1·1  
(–1·8 to 3·9)
10·8  
(7·8 to 13·9)*
0·61  
(0·42 to 0·80)*
0·16  
(–0·26 to 0·57)
0·89  
(0·64 to 1·14)*
Poland 61·0  
(59·8 to 62·4)
70·8  
(69·1 to 72·0)
82·4  
(79·7 to 84·6)
21·4  
(18·2 to 23·8)*
9·8  
(7·6 to 11·4)*
11·6  
(9·3 to 14·0)*
1·16  
(0·99 to 1·28)*
1·49  
(1·16 to 1·73)*
0·95  
(0·77 to 1·13)*
Romania 59·1  
(57·6 to 61·0)
66·8  
(65·2 to 68·4)
78·3  
(75·9 to 80·7)
19·2  
(16·3 to 21·9)*
7·7  
(5·3 to 9·5)*
11·5  
(8·9 to 14·2)*
1·08  
(0·91 to 1·22)*
1·22  
(0·83 to 1·51)*
0·99  
(0·78 to 1·21)*
Serbia 64·7  
(61·9 to 67·5)
66·9  
(64·9 to 69·2)
77·2  
(74·9 to 79·3)
12·5  
(9·3 to 15·6)*
2·2  
(–0·7 to 5·2)
10·3  
(7·4 to 13·0)*
0·68  
(0·51 to 0·86)*
0·33  
(–0·11 to 0·80)
0·90  
(0·64 to 1·13)*
Slovakia 67·8  
(65·8 to 69·4)
73·6  
(71·6 to 75·4)
83·3  
(80·4 to 86·3)
15·5  
(12·3 to 18·9)*
5·9  
(3·6 to 8·1)*
9·7  
(6·6 to 12·8)*
0·79  
(0·64 to 0·95)*
0·83  
(0·51 to 1·15)*
0·77  
(0·53 to 1·02)*
(Table 2 continues on next page)
Articles
2250 www.thelancet.com   Vol 391   June 2, 2018
HAQ Index (95% UI) Absolute change (95% UI) Annualised rate of change (95% UI) 
1990 2000 2016 1990–2016 1990–2000 2000–16 1990–2016 1990–2000 2000–16
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Slovenia 74·1  
(72·2 to 76·1)
79·5  
(77·8 to 81·3)
90·8  
(88·2 to 93·4)
16·6  
(13·5 to 19·8)*
5·3  
(3·0 to 7·9)*
11·3  
(8·0 to 14·6)*
0·78  
(0·63 to 0·92)*
0·70  
(0·39 to 1·03)*
0·83  
(0·59 to 1·06)*
Eastern Europe 63·5  
(61·7 to 65·3)
63·1  
(61·1 to 64·8)
75·0  
(69·6 to 80·2)
11·5  
(5·7 to 16·5)*
–0·4  
(–3·0 to 1·9)
11·9  
(6·4 to 17·1)*
0·64  
(0·33 to 0·90)*
–0·07  
(–0·48 to 0·29)
1·08  
(0·60 to 1·51)*
Belarus 64·8  
(63·4 to 66·3)
66·1  
(63·7 to 67·6)
79·0  
(75·3 to 82·8)
14·3  
(10·5 to 18·1)*
1·3  
(–1·6 to 3·1)
13·0  
(9·1 to 16·9)*
0·76  
(0·58 to 0·96)*
0·20  
(–0·25 to 0·48)
1·12  
(0·79 to 1·46)*
Estonia 68·2  
(66·8 to 69·8)
71·6  
(70·2 to 72·8)
85·9  
(83·6 to 88·3)
17·7  
(15·1 to 20·6)*
3·4  
(1·7 to 5·0)*
14·3  
(11·8 to 17·0)*
0·89  
(0·76 to 1·03)*
0·48  
(0·25 to 0·72)*
1·14  
(0·94 to 1·35)*
Latvia 67·3 (65·9 to 
68·8)
69·6  
(68·1 to 71·0)
80·7  
(78·0 to 83·3)
13·4  
(10·5 to 16·4)*
2·3  
(0·4 to 4·1)*
11·1  
(8·3 to 14·2)*
0·70  
(0·55 to 0·84)*
0·33  
(0·06 to 0·61)*
0·93  
(0·70 to 1·17)*
Lithuania 69·3  
(68·0 to 70·6)
72·1  
(70·6 to 73·4)
80·5  
(78·7 to 82·3)
11·2  
(9·2 to 13·2)*
2·9  
(1·2 to 4·4)*
8·3  
(6·0 to 10·7)*
0·58  
(0·47 to 0·68)*
0·40  
(0·17 to 0·62)*
0·68  
(0·49 to 0·87)*
Moldova 56·6  
(54·4 to 59·0)
58·1  
(56·0 to 60·2)
67·4  
(64·5 to 70·4)
10·8  
(7·3 to 14·0)*
1·5  
(–1·5 to 4·3)
9·3  
(6·2 to 12·6)*
0·67  
(0·46 to 0·86)*
0·26  
(–0·25 to 0·76)
0·93  
(0·62 to 1·24)*
Russia 63·1  
(60·6 to 65·4)
62·5  
(60·1 to 64·7)
75·1  
(67·7 to 81·7)
11·9  
(4·5 to 19·0)*
–0·6  
(–3·8 to 2·5)
12·6  
(5·0 to 19·4)*
0·66  
(0·26 to 1·01)*
–0·10  
(–0·63 to 0·40)
1·14  
(0·48 to 1·73)*
Ukraine 64·9  
(63·3 to 66·5)
64·0  
(61·8 to 65·8)
74·6  
(68·3 to 79·8)
9·6  
(3·3 to 15·2)*
–1·0  
(–3·6 to 1·2)
10·6  
(4·2 to 16·5)*
0·53  
(0·19 to 0·81)*
–0·15  
(–0·56 to 0·18)
0·95  
(0·39 to 1·45)*
High income† 75·5  
(74·4 to 76·6)
83·2  
(82·3 to 83·8)
89·8  
(89·2 to 90·4)
14·4  
(13·3 to 15·5)*
7·7  
(6·7 to 8·8)*
6·6  
(6·0 to 7·4)*
0·67  
(0·62 to 0·73)*
0·98  
(0·84 to 1·11)*
0·48  
(0·43 to 0·54)*
Australasia 83·2  
(82·4 to 84·0)
89·7  
(89·0 to 90·5)
95·5  
(94·5 to 96·4)
12·3  
(11·2 to 13·3)*
6·5  
(5·8 to 7·3)*
5·8  
(4·8 to 6·8)*
0·53  
(0·48 to 0·57)*
0·76  
(0·67 to 0·85)*
0·39  
(0·32 to 0·46)*
Australia 83·9  
(83·0 to 84·7)
90·4  
(89·6 to 91·2)
95·9  
(94·8 to 96·8)
12·0  
(10·9 to 13·1)*
6·5  
(5·6 to 7·5)*
5·5  
(4·4 to 6·6)*
0·51  
(0·47 to 0·56)*
0·75  
(0·65 to 0·86)*
0·37  
(0·30 to 0·44)*
New Zealand 80·2  
(79·2 to 81·4)
87·0  
(86·0 to 87·8)
92·4  
(90·3 to 94·3)
12·2  
(9·8 to 14·3)*
6·8  
(5·4 to 7·9)*
5·4  
(3·1 to 7·4)*
0·54  
(0·44 to 0·64)*
0·81  
(0·64 to 0·95)*
0·38  
(0·22 to 0·51)*
High-income Asia Pacific 73·7  
(72·1 to 75·6)
81·8  
(80·6 to 83·1)
93·2  
(91·8 to 94·2)
19·5  
(16·9 to 21·5)*
8·1  
(5·9 to 10·0)*
11·4  
(9·7 to 13·0)*
0·90  
(0·78 to 1·00)*
1·04  
(0·75 to 1·30)*
0·81  
(0·69 to 0·93)*
Brunei 62·9  
(60·0 to 65·6)
70·0  
(67·5 to 72·7)
76·4  
(71·9 to 81·0)
13·5  
(8·4 to 18·7)*
7·1  
(3·9 to 10·6)*
6·4  
(1·4 to 11·3)*
0·75  
(0·48 to 1·02)*
1·07  
(0·60 to 1·60)*
0·55  
(0·12 to 0·94)*
Japan 80·9  
(80·3 to 81·7)
86·9  
(86·3 to 87·5)
94·1  
(93·5 to 94·6)
13·3  
(12·2 to 13·9)*
6·1  
(5·4 to 6·4)*
7·2  
(6·6 to 7·8)*
0·58  
(0·54 to 0·62)*
0·72  
(0·65 to 0·77)*
0·50  
(0·45 to 0·54)*
Singapore 69·2  
(66·5 to 72·0)
79·7  
(77·2 to 82·0)
90·6  
(87·2 to 93·3)
21·4  
(17·5 to 25·0)*
10·5  
(7·1 to 13·9)*
10·9  
(7·1 to 14·8)*
1·04  
(0·85 to 1·21)*
1·41  
(0·95 to 1·88)*
0·80  
(0·53 to 1·08)*
South Korea 59·5  
(56·2 to 62·9)
74·4  
(71·4 to 77·0)
90·3  
(85·6 to 93·9)
30·9  
(24·6 to 35·7)*
14·9  
(10·0 to 18·9)*
15·9  
(10·9 to 20·4)*
1·61  
(1·28 to 1·87)*
2·24  
(1·47 to 2·86)*
1·21  
(0·84 to 1·54)*
High-income 
North America
81·0  
(80·1 to 81·7)
87·1  
(86·5 to 87·7)
89·1  
(88·4 to 89·8)
8·1  
(7·4 to 9·0)*
6·1  
(5·5 to 6·8)*
2·0  
(1·5 to 2·6)*
0·37  
(0·34 to 0·41)*
0·73  
(0·66 to 0·81)*
0·14  
(0·11 to 0·18)*
Canada 83·2  
(82·2 to 84·1)
89·3  
(88·4 to 90·2)
93·8  
(92·8 to 94·8)
10·6  
(9·3 to 11·9)*
6·1  
(5·1 to 6·9)*
4·5  
(3·4 to 5·7)*
0·46  
(0·40 to 0·52)*
0·71  
(0·59 to 0·80)*
0·31  
(0·24 to 0·39)*
Greenland 54·0  
(50·6 to 57·5)
59·2  
(56·4 to 62·8)
67·5  
(62·7 to 72·7)
13·5  
(8·0 to 19·0)*
5·2  
(1·6 to 8·9)*
8·3  
(3·3 to 13·5)*
0·86  
(0·52 to 1·19)*
0·92  
(0·29 to 1·55)*
0·82  
(0·33 to 1·31)*
USA 80·7  
(79·8 to 81·5)
86·8  
(86·1 to 87·4)
88·7  
(88·0 to 89·4)
8·0  
(7·2 to 8·8)*
6·1  
(5·5 to 6·7)*
1·9  
(1·4 to 2·5)*
0·36  
(0·33 to 0·40)*
0·72  
(0·65 to 0·81)*
0·13  
(0·10 to 0·18)*
Southern Latin America 54·2  
(52·9 to 55·5)
62·6  
(61·0 to 63·8)
70·0  
(67·9 to 72·0)
15·8  
(13·7 to 17·8)*
8·4  
(6·8 to 9·7)*
7·4  
(5·2 to 9·5)*
0·99  
(0·86 to 1·10)*
1·45  
(1·17 to 1·66)*
0·70  
(0·50 to 0·89)*
Argentina 53·8  
(52·3 to 55·2)
61·7  
(59·8 to 63·1)
68·1  
(65·8 to 70·1)
14·3  
(12·0 to 16·5)*
8·0  
(6·1 to 9·5)*
6·3  
(4·2 to 8·5)*
0·91  
(0·77 to 1·04)*
1·38  
(1·06 to 1·64)*
0·61  
(0·41 to 0·82)*
Chile 56·5  
(54·9 to 58·4)
67·0  
(65·4 to 68·5)
77·9  
(72·3 to 83·7)
21·4  
(15·5 to 27·5)*
10·5  
(8·4 to 12·5)*
10·9  
(5·3 to 16·4)*
1·23  
(0·93 to 1·53)*
1·70  
(1·35 to 2·03)*
0·94  
(0·47 to 1·39)*
Uruguay 57·9  
(56·7 to 59·1)
64·7  
(63·2 to 65·8)
71·0  
(68·9 to 73·0)
13·1  
(10·9 to 15·2)*
6·8  
(5·1 to 8·2)*
6·3  
(4·1 to 8·5)*
0·79  
(0·66 to 0·90)*
1·12  
(0·84 to 1·34)*
0·58  
(0·39 to 0·78)*
Western Europe 78·6  
(77·9 to 79·6)
85·3  
(84·6 to 86·0)
92·6  
(91·7 to 93·3)
13·9  
(12·8 to 14·8)*
6·7  
(6·0 to 7·3)*
7·2  
(6·6 to 7·9)*
0·63  
(0·58 to 0·67)*
0·82  
(0·73 to 0·90)*
0·51  
(0·46 to 0·56)*
Andorra 84·7  
(79·5 to 89·3)
92·8  
(88·9 to 96·0)
94·7  
(91·2 to 97·0)
10·0  
(4·4 to 15·4)*
8·1  
(3·8 to 12·6)*
1·8  
(–2·5 to 5·8)
0·43  
(0·19 to 0·67)*
0·92  
(0·43 to 1·45)*
0·12  
(–0·17 to 0·39)
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Austria 80·9  
(79·9 to 82·2)
87·4  
(86·5 to 88·5)
93·9  
(92·6 to 95·3)
13·1  
(11·3 to 14·7)*
6·6  
(5·6 to 7·6)*
6·5  
(5·1 to 8·0)*
0·58  
(0·50 to 0·65)*
0·78  
(0·66 to 0·91)*
0·45  
(0·36 to 0·55)*
Belgium 80·7  
(79·4 to 82·2)
86·1  
(84·8 to 87·3)
92·9  
(90·7 to 95·0)
12·2  
(9·6 to 14·7)*
5·4  
(3·7 to 7·1)*
6·8  
(4·6 to 9·1)*
0·54  
(0·43 to 0·65)*
0·65  
(0·44 to 0·85)*
0·47  
(0·32 to 0·63)*
Cyprus 68·3  
(66·3 to 70·5)
78·0  
(76·6 to 79·7)
90·3  
(88·8 to 91·8)
22·0 (19·6 to 
24·3)*
9·6  
(7·7 to 11·5)*
12·3  
(10·5 to 14·3)*
1·07  
(0·95 to 1·20)*
1·32  
(1·04 to 1·59)*
0·92  
(0·78 to 1·06)*
Denmark 81·1  
(79·3 to 82·7)
85·0  
(83·5 to 86·8)
92·1  
(89·8 to 94·3)
11·0  
(8·2 to 13·7)*
3·8  
(1·7 to 6·5)*
7·2  
(4·5 to 10·0)*
0·49  
(0·36 to 0·61)*
0·46  
(0·20 to 0·78)*
0·51  
(0·32 to 0·70)*
Finland 81·0  
(79·8 to 82·3)
87·7  
(86·7 to 88·7)
95·9  
(94·6 to 96·9)
14·9  
(13·0 to 16·5)*
6·8  
(5·3 to 8·0)*
8·1  
(6·7 to 9·5)*
0·65  
(0·56 to 0·72)*
0·80  
(0·62 to 0·95)*
0·55  
(0·46 to 0·65)*
France 77·6  
(76·4 to 79·1)
84·1  
(83·0 to 85·3)
91·7  
(90·3 to 93·1)
14·1  
(12·1 to 16·0)*
6·6  
(5·4 to 7·7)*
7·6  
(6·0 to 9·1)*
0·64  
(0·55 to 0·73)*
0·81  
(0·66 to 0·95)*
0·54  
(0·42 to 0·65)*
Germany 78·9  
(77·5 to 80·6)
86·1  
(84·9 to 87·3)
92·0  
(90·4 to 93·6)
13·1  
(10·8 to 15·1)*
7·2  
(5·4 to 8·9)*
5·9  
(4·1 to 8·0)*
0·59  
(0·49 to 0·68)*
0·87  
(0·65 to 1·09)*
0·42  
(0·29 to 0·56)*
Greece 79·5  
(78·4 to 80·5)
85·3  
(84·4 to 86·3)
90·4  
(88·8 to 91·9)
10·9  
(9·1 to 12·6)*
5·8  
(4·8 to 6·8)*
5·1  
(3·5 to 6·7)*
0·49  
(0·42 to 0·57)*
0·70  
(0·58 to 0·84)*
0·36  
(0·25 to 0·47)*
Iceland 87·0  
(85·6 to 88·5)
92·8  
(91·5 to 93·9)
97·1  
(95·8 to 98·1)
10·2  
(8·6 to 11·7)*
5·8  
(4·1 to 7·3)*
4·4  
(2·8 to 6·0)*
0·42  
(0·36 to 0·49)*
0·65  
(0·46 to 0·81)*
0·29  
(0·18 to 0·39)*
Ireland 76·3  
(74·9 to 77·5)
83·9  
(82·4 to 85·4)
94·6  
(91·8 to 96·8)
18·3  
(15·3 to 20·9)*
7·6  
(6·0 to 9·3)*
10·7  
(7·8 to 13·4)*
0·83  
(0·70 to 0·94)*
0·95  
(0·75 to 1·17)*
0·75  
(0·55 to 0·93)*
Israel 71·2  
(68·9 to 73·7)
77·9  
(75·5 to 80·5)
84·8  
(80·7 to 88·4)
13·5  
(8·6 to 18·0)*
6·7  
(3·4 to 10·0)*
6·8  
(2·3 to 10·8)*
0·67  
(0·43 to 0·88)*
0·90  
(0·46 to 1·34)*
0·52  
(0·18 to 0·83)*
Italy 81·5  
(80·6 to 82·4)
88·8  
(87·8 to 89·7)
94·9  
(93·4 to 96·0)
13·3  
(11·8 to 14·7)*
7·2  
(6·3 to 8·1)*
6·1  
(4·7 to 7·4)*
0·58  
(0·52 to 0·64)*
0·85  
(0·74 to 0·96)*
0·41  
(0·32 to 0·51)*
Luxembourg 81·4  
(79·7 to 83·0)
90·3  
(88·8 to 91·6)
96·0  
(94·4 to 97·3)
14·7  
(12·4 to 16·7)*
8·9  
(7·2 to 10·6)*
5·7  
(3·9 to 7·4)*
0·64  
(0·53 to 0·73)*
1·04  
(0·83 to 1·24)*
0·38  
(0·26 to 0·49)*
Malta 75·0  
(73·0 to 77·0)
81·1  
(79·0 to 83·0)
89·9  
(86·3 to 93·0)
14·9  
(10·8 to 18·8)*
6·1  
(3·5 to 8·7)*
8·8  
(4·9 to 12·6)*
0·70  
(0·52 to 0·87)*
0·78  
(0·45 to 1·11)*
0·64  
(0·36 to 0·91)*
Netherlands 84·1  
(82·8 to 85·4)
88·6  
(87·1 to 89·8)
96·1  
(94·5 to 97·3)
11·9  
(10·0 to 13·6)*
4·5  
(3·1 to 6·0)*
7·4  
(5·6 to 9·1)*
0·51  
(0·43 to 0·58)*
0·52  
(0·36 to 0·69)*
0·50  
(0·38 to 0·62)*
Norway 84·0  
(82·9 to 85·1)
90·6  
(89·5 to 91·7)
96·6  
(94·9 to 97·9)
12·6  
(10·6 to 14·3)*
6·6  
(5·4 to 7·9)*
6·0  
(4·1 to 7·6)*
0·54  
(0·46 to 0·61)*
0·76  
(0·62 to 0·91)*
0·40  
(0·27 to 0·51)*
Portugal 67·1  
(65·9 to 68·3)
76·2  
(75·1 to 77·3)
85·7  
(84·1 to 87·3)
18·6  
(16·9 to 20·4)*
9·1  
(8·0 to 10·4)*
9·5  
(7·8 to 11·3)*
0·94  
(0·86 to 1·03)*
1·27  
(1·11 to 1·46)*
0·74  
(0·61 to 0·87)*
Spain 76·2  
(75·2 to 77·2)
84·1  
(83·1 to 84·9)
91·9  
(90·5 to 93·2)
15·7  
(14·2 to 17·3)*
7·9  
(6·9 to 8·8)*
7·8  
(6·5 to 9·2)*
0·72  
(0·65 to 0·79)*
0·99  
(0·87 to 1·11)*
0·56  
(0·46 to 0·65)*
Sweden 85·2  
(84·2 to 86·2)
92·4  
(91·5 to 93·2)
95·5  
(93·4 to 97·2)
10·2  
(7·9 to 12·1)*
7·1  
(6·1 to 8·2)*
3·1  
(1·0 to 5·0)*
0·44  
(0·34 to 0·51)*
0·81  
(0·69 to 0·93)*
0·21  
(0·07 to 0·33)*
Switzerland 86·8  
(85·2 to 88·2)
91·6  
(90·2 to 93·0)
95·6  
(92·4 to 97·8)
8·8  
(5·3 to 11·4)*
4·8  
(3·0 to 6·6)*
4·0  
(0·5 to 6·7)*
0·37  
(0·22 to 0·48)*
0·54  
(0·33 to 0·74)*
0·26  
(0·04 to 0·45)*
UK 78·0  
(77·1 to 78·6)
83·9  
(83·0 to 84·6)
90·5  
(89·6 to 91·3)
12·5  
(11·8 to 13·4)*
6·0  
(5·5 to 6·5)*
6·5  
(5·9 to 7·2)*
0·57  
(0·54 to 0·61)*
0·74  
(0·69 to 0·80)*
0·47  
(0·43 to 0·51)*
Latin America and 
Caribbean†
41·3  
(40·3 to 42·5)
52·6  
(51·3 to 53·7)
61·8  
(60·4 to 63·0)
20·5  
(19·0 to 21·8)*
11·3  
(9·8 to 12·3)*
9·2  
(8·1 to 10·2)*
1·55  
(1·43 to 1·65)*
2·42  
(2·09 to 2·66)*
1·01  
(0·89 to 1·12)*
Andean Latin America 34·1  
(32·4 to 36·0)
46·9  
(45·3 to 48·6)
59·3  
(56·3 to 62·4)
25·2  
(21·4 to 28·8)*
12·8  
(10·0 to 15·0)*
12·4  
(9·5 to 15·3)*
2·13  
(1·82 to 2·42)*
3·19  
(2·47 to 3·76)*
1·47  
(1·14 to 1·77)*
Bolivia 26·2  
(23·6 to 29·0)
36·5  
(34·2 to 38·9)
48·8  
(43·5 to 54·0)
22·6  
(16·6 to 28·1)*
10·3  
(7·1 to 13·2)*
12·3  
(6·8 to 17·6)*
2·39  
(1·82 to 2·93)*
3·31  
(2·27 to 4·38)*
1·81  
(1·08 to 2·51)*
Ecuador 37·8  
(36·1 to 39·9)
51·1  
(48·9 to 52·8)
62·2  
(59·5 to 64·6)
24·3  
(20·8 to 27·4)*
13·3  
(10·4 to 15·6)*
11·1  
(8·8 to 13·4)*
1·91  
(1·63 to 2·15)*
3·01  
(2·35 to 3·55)*
1·22  
(0·98 to 1·47)*
Peru 38·6  
(36·3 to 41·3)
51·0  
(48·8 to 53·4)
64·3  
(59·2 to 69·4)
25·8  
(19·8 to 31·4)*
12·4  
(8·7 to 15·7)*
13·4  
(8·0 to 18·5)*
1·97  
(1·52 to 2·34)*
2·79  
(1·92 to 3·53)*
1·45  
(0·90 to 1·97)*
Caribbean 37·9  
(36·1 to 40·0)
45·6  
(43·6 to 47·7)
54·2  
(51·1 to 57·3)
16·3  
(12·7 to 19·7)*
7·7  
(5·0 to 10·2)*
8·7  
(5·3 to 12·1)*
1·38  
(1·09 to 1·64)*
1·85  
(1·20 to 2·43)*
1·09  
(0·67 to 1·50)*
Antigua and Barbuda 57·0  
(54·5 to 59·5)
62·8  
(60·2 to 65·4)
69·8  
(66·5 to 73·3)
12·8  
(8·7 to 16·7)*
5·8  
(2·7 to 9·0)*
7·0  
(3·2 to 11·2)*
0·78  
(0·53 to 1·01)*
0·97  
(0·46 to 1·51)*
0·66  
(0·31 to 1·04)*
(Table 2 continues on next page)
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Barbados 59·3  
(57·1 to 61·6)
67·3  
(64·3 to 69·7)
70·8  
(67·3 to 73·8)
11·6 
(7·5 to 15·4)*
8·0 
(4·8 to 11·0)*
3·6 
(–0·2 to 7·5)
0·69 
(0·45 to 0·90)*
1·27 
(0·76 to 1·73)*
0·32 
(–0·02 to 0·67)
Belize 46·6  
(44·3 to 48·8)
48·6  
(46·1 to 50·8)
55·7  
(50·8 to 59·9)
9·1 
(4·0 to 13·6)*
2·0 
(–1·0 to 4·8)
7·2 
(2·5 to 11·4)*
0·69 
(0·31 to 1·01)*
0·41 
(–0·21 to 1·02)
0·86 
(0·31 to 1·35)*
Bermuda 63·1  
(60·8 to 65·8)
73·5  
(71·0 to 76·0)
83·1  
(79·7 to 86·3)
20·0 
(15·7 to 24·0)*
10·4 
(6·8 to 13·7)*
9·6 
(5·6 to 13·5)*
1·06 
(0·84 to 1·26)*
1·52 
(0·98 to 2·01)*
0·76 
(0·45 to 1·08)*
Cuba 63·7  
(62·4 to 65·5)
67·3  
(66·2 to 68·6)
75·5  
(73·5 to 77·7)
11·8 
(9·5 to 14·2)*
3·6 
(2·1 to 5·2)*
8·2 
(6·0 to 10·4)*
0·65 
(0·53 to 0·78)*
0·56 
(0·32 to 0·79)*
0·72 
(0·53 to 0·91)*
Dominica 52·4  
(50·1 to 54·8)
58·9  
(56·3 to 61·2)
61·9  
(58·2 to 65·3)
9·5 
(5·3 to 13·2)*
6·5 
(3·8 to 9·3)*
3·0 
(–1·3 to 6·9)
0·64 
(0·37 to 0·88)*
1·18 
(0·69 to 1·67)*
0·31 
(–0·14 to 0·71)
Dominican Republic 38·4  
(35·8 to 41·5)
52·5  
(49·5 to 55·5)
61·2  
(57·3 to 65·6)
22·8 
(17·8 to 27·5)*
14·1 
(9·6 to 18·1)*
8·7 
(4·2 to 13·4)*
1·80 
(1·40 to 2·14)*
3·14 
(2·07 to 3·95)*
0·96 
(0·46 to 1·44)*
Grenada 47·2  
(44·1 to 50·4)
53·2  
(50·4 to 55·8)
58·5  
(54·7 to 62·2)
11·3 
(6·7 to 16·2)*
5·9 
(2·0 to 9·6)*
5·3 
(1·2 to 9·7)*
0·82 
(0·49 to 1·19)*
1·19 
(0·40 to 1·95)*
0·60 
(0·13 to 1·07)*
Guyana 38·4  
(36·3 to 40·5)
43·2  
(41·0 to 45·1)
49·8  
(46·8 to 53·0)
11·4 
(8·0 to 15·3)*
4·8 
(1·9 to 7·2)*
6·6 
(3·4 to 9·9)*
1·00 
(0·71 to 1·32)*
1·19 
(0·48 to 1·77)*
0·88 
(0·46 to 1·32)*
Haiti 16·7  
(13·8 to 19·8)
23·2  
(19·6 to 26·9)
32·1  
(26·6 to 37·8)
15·4 
(9·5 to 21·4)*
6·5 
(2·0 to 10·9)*
8·9 
(2·7 to 15·1)*
2·51 
(1·59 to 3·48)*
3·30 
(1·02 to 5·61)*
2·02 
(0·65 to 3·35)*
Jamaica 51·1  
(48·2 to 54·2)
56·4  
(52·4 to 59·8)
62·0  
(56·8 to 67·3)
10·8 
(5·0 to 16·7)*
5·2 
(0·7 to 9·2)*
5·6 
(0·2 to 10·9)*
0·74 
(0·35 to 1·12)*
0·97 
(0·13 to 1·69)*
0·59 
(0·03 to 1·12)*
Puerto Rico 67·1  
(65·7 to 68·8)
74·6  
(73·0 to 76·2)
82·7  
(80·2 to 85·0)
15·6 
(12·7 to 18·2)*
7·5 
(5·7 to 9·4)*
8·1 
(5·5 to 10·7)*
0·80 
(0·66 to 0·93)*
1·06 
(0·80 to 1·32)*
0·64 
(0·45 to 0·84)*
Saint Lucia 48·9  
(46·6 to 51·1)
56·8  
(54·5 to 58·9)
63·3  
(60·3 to 66·0)
14·4 
(10·9 to 17·7)*
7·9 
(5·0 to 10·8)*
6·5 
(3·3 to 9·7)*
1·00 
(0·76 to 1·21)*
1·50 
(0·95 to 2·07)*
0·68 
(0·35 to 0·98)*
Saint Vincent and the 
Grenadines
49·6  
(47·2 to 51·7)
53·0  
(50·7 to 55·1)
57·4  
(54·8 to 59·9)
7·8 
(4·6 to 11·1)*
3·4 
(0·9 to 5·8)*
4·4 
(1·5 to 7·6)*
0·56 
(0·34 to 0·79)*
0·66 
(0·18 to 1·14)*
0·50 
(0·17 to 0·86)*
Suriname 41·9  
(39·9 to 44·2)
45·6  
(43·0 to 47·9)
54·5  
(51·2 to 57·6)
12·5 
(8·3 to 16·4)*
3·6 
(0·3 to 6·4)*
8·9 
(5·6 to 12·4)*
1·01 
(0·66 to 1·29)*
0·83 
(0·07 to 1·47)*
1·12 
(0·71 to 1·55)*
The Bahamas 56·1  
(54·0 to 58·3)
63·4  
(61·3 to 65·4)
66·4  
(62·9 to 69·7)
10·3 
(6·3 to 14·0)*
7·3 
(4·7 to 9·8)*
3·0 
(–0·7 to 6·4)
0·65 
(0·40 to 0·88)*
1·22 
(0·79 to 1·67)*
0·29 
(–0·06 to 0·61)
Trinidad and Tobago 51·2  
(49·7 to 52·6)
55·7  
(53·7 to 57·3)
64·3  
(60·7 to 67·5)
13·1 
(9·0 to 16·6)*
4·5 
(2·3 to 6·4)*
8·6 
(5·3 to 11·8)*
0·87 
(0·62 to 1·10)*
0·84 
(0·43 to 1·18)*
0·89 
(0·57 to 1·20)*
Virgin Islands 57·2  
(54·6 to 60·4)
65·7  
(63·0 to 68·8)
74·0  
(70·0 to 79·1)
16·8 
(11·9 to 21·9)*
8·5 
(4·9 to 12·1)*
8·3 
(4·0 to 13·2)*
0·99 
(0·72 to 1·28)*
1·38 
(0·80 to 1·96)*
0·75 
(0·36 to 1·18)*
Central Latin America 43·3  
(42·3 to 44·5)
55·8  
(54·2 to 56·8)
64·4  
(62·6 to 65·6)
21·1 
(19·3 to 22·6)*
12·5 
(10·8 to 13·7)*
8·6 
(7·6 to 9·7)*
1·53 
(1·40 to 1·63)*
2·54 
(2·20 to 2·78)*
0·90 
(0·79 to 1·01)*
Colombia 48·5  
(46·7 to 50·6)
57·6  
(55·9 to 59·0)
68·5  
(65·8 to 70·9)
20·0 
(16·6 to 23·0)*
9·1 
(6·9 to 11·0)*
10·9 
(8·3 to 13·4)*
1·33 
(1·11 to 1·53)*
1·72 
(1·29 to 2·11)*
1·09 
(0·84 to 1·31)*
Costa Rica 60·7  
(59·2 to 61·9)
64·7  
(63·2 to 65·9)
73·7  
(71·2 to 76·0)
13·0 
(10·4 to 15·5)*
4·0 
(2·5 to 5·5)*
9·0 
(6·5 to 11·6)*
0·75 
(0·60 to 0·88)*
0·64 
(0·40 to 0·88)*
0·82 
(0·60 to 1·04)*
El Salvador 38·1  
(35·9 to 41·8)
52·1  
(49·5 to 54·5)
63·2  
(58·9 to 67·2)
25·1 
(17·9 to 29·7)*
14·0 
(8·5 to 17·2)*
11·1 
(7·6 to 15·0)*
1·95 
(1·38 to 2·27)*
3·14 
(1·86 to 3·86)*
1·20 
(0·84 to 1·60)*
Guatemala 30·4  
(27·4 to 33·4)
42·0  
(38·3 to 45·7)
51·5  
(45·3 to 57·7)
21·1  
(14·5 to 27·5)*
11·6 
(7·1 to 16·1)*
9·4 
(2·8 to 16·2)*
2·02 
(1·42 to 2·57)*
3·24 
(1·97 to 4·51)*
1·26 
(0·38 to 2·10)*
Honduras 28·1  
(24·8 to 31·3)
38·1  
(33·1 to 43·3)
46·5  
(40·1 to 53·1)
18·5  
(11·4 to 25·5)*
10·0 
(5·5 to 15·2)*
8·5 
(2·1 to 15·1)*
1·94 
(1·26 to 2·65)*
3·04 
(1·73 to 4·52)*
1·25 
(0·32 to 2·21)*
Mexico 45·5  
(44·5 to 46·9)
59·0  
(57·6 to 59·9)
66·3  
(64·9 to 67·4)
20·8  
(19·5 to 22·0)*
13·5 
(12·0 to 14·6)*
7·3 
(6·4 to 8·2)*
1·45 
(1·34 to 1·54)*
2·61 
(2·29 to 2·82)*
0·73 
(0·64 to 0·82)*
Nicaragua 43·1  
(41·0 to 46·2)
49·8  
(47·9 to 52·0)
61·2  
(57·0 to 65·4)
18·1  
(11·9 to 22·9)*
6·7 
(3·1 to 9·6)*
11·4 
(7·2 to 15·7)*
1·35 
(0·88 to 1·67)*
1·45 
(0·65 to 2·09)*
1·28 
(0·83 to 1·74)*
Panama 52·1  
(49·3 to 55·5)
60·8  
(58·6 to 62·9)
68·3  
(64·6 to 71·9)
16·1  
(10·8 to 21·2)*
8·7 
(5·0 to 12·0)*
7·4 
(3·3 to 11·6)*
1·04 
(0·69 to 1·36)*
1·55 
(0·86 to 2·15)*
0·72 
(0·33 to 1·11)*
Venezuela 51·3  
(49·0 to 53·9)
60·0  
(58·0 to 61·8)
67·8  
(63·6 to 71·8)
16·5  
(11·1 to 21·5)*
8·7 
(5·4 to 11·6)*
7·8 
(3·5 to 11·9)*
1·07 
(0·74 to 1·38)*
1·57 
(0·97 to 2·10)*
0·76 
(0·35 to 1·15)*
Tropical Latin America 46·1  
(44·9 to 47·2)
54·9  
(53·6 to 55·9)
63·4  
(62·0 to 64·4)
17·3  
(16·1 to 18·5)*
8·9 
(7·9 to 9·7)*
8·4 
(7·3 to 9·6)*
1·23 
(1·14 to 1·31)*
1·76 
(1·57 to 1·94)*
0·89 
(0·77 to 1·02)*
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Brazil 46·5 
(45·2 to 47·7)
55·3 
(53·9 to 56·4)
63·8 
(62·3 to 64·9)
17·3 
(16·1 to 18·5)*
8·8 
(8·0 to 9·6)*
8·5 (7·4 
to 9·6)*
1·22 
(1·13 to 1·30)*
1·74 
(1·57 to 1·90)*
0·89 
(0·78 to 1·02)*
Paraguay 43·1 
(41·1 to 45·1)
49·8 
(46·8 to 52·3)
56·7 
(53·1 to 60·2)
13·6 
(9·9 to 17·4)*
6·8 
(3·7 to 9·5)*
6·9 
(3·4 to 10·3)*
1·06 
(0·78 to 1·32)*
1·46 
(0·82 to 2·07)*
0·81 
(0·41 to 1·20)*
North Africa and  Middle 
East†
35·9 
(33·7 to 37·9)
42·3 
(40·5 to 44·0)
55·8 
(54·0 to 57·8)
19·9 
(17·6 to 22·2)*
6·4 
(5·1 to 7·6)*
13·5 
(11·6 to 15·5)*
1·70 
(1·49 to 1·93)*
1·63 
(1·29 to 2·00)*
1·73 
(1·50 to 2·00)*
North Africa and Middle 
East
35·9 
(33·7 to 37·9)
42·3 
(40·5 to 44·0)
55·8 
(54·0 to 57·8)
19·9 
(17·6 to 22·2)*
6·4 
(5·1 to 7·6)*
13·5 
(11·6 to 15·5)*
1·70 
(1·49 to 1·93)*
1·63 
(1·29 to 2·00)*
1·73 
(1·50 to 2·00)*
Afghanistan 15·8 
(12·2 to 19·4)
14·9 
(11·5 to 19·1)
25·9 
(22·0 to 29·5)
10·1 
(5·2 to 14·5)*
–0·9 
(–4·1 to 2·7)
11·0 
(6·4 to 15·4)*
1·93 
(0·96 to 2·83)*
–0·60 
(–2·75 to 1·68)
3·51 
(1·88 to 5·10)*
Algeria 42·8 
(37·6 to 46·7)
50·6 
(46·1 to 54·2)
63·1 
(59·4 to 66·4)
20·2 
(16·0 to 24·6)*
7·8 
(4·2 to 11·6)*
12·4 
(8·7 to 16·7)*
1·49 
(1·16 to 1·90)*
1·68 
(0·89 to 2·56)*
1·38 
(0·95 to 1·88)*
Bahrain 49·9 
(46·7 to 53·1)
59·4 
(56·3 to 62·2)
72·0 
(67·3 to 76·5)
22·1 
(16·5 to 27·2)*
9·5 
(5·4 to 13·6)*
12·6 
(7·3 to 17·9)*
1·41 
(1·07 to 1·73)*
1·75 
(0·98 to 2·51)*
1·20 
(0·71 to 1·68)*
Egypt 34·2 
(31·9 to 37·7)
45·9 
(43·4 to 49·2)
58·0 
(53·9 to 62·5)
23·8 
(19·1 to 28·4)*
11·7 
(8·8 to 14·5)*
12·1 
(8·1 to 16·5)*
2·03 
(1·64 to 2·39)*
2·94 
(2·21 to 3·66)*
1·46 
(1·00 to 1·95)*
Iran 49·3 
(45·0 to 53·5)
61·0 
(57·2 to 64·7)
71·8 
(67·3 to 76·3)
22·4 
(16·3 to 28·6)*
11·6 
(6·4 to 16·7)*
10·8 
(5·0 to 16·3)*
1·44 
(1·04 to 1·87)*
2·12 
(1·16 to 3·11)*
1·02 
(0·47 to 1·54)*
Iraq 42·4 
(38·5 to 47·1)
43·4 
(40·0 to 46·8)
51·1 
(45·9 to 56·6)
8·6 
(1·2 to 15·8)*
0·9 
(–3·8 to 5·6)
7·7 
(1·6 to 13·7)*
0·71 
(0·11 to 1·29)*
0·23 
(–0·87 to 1·34)
1·02 
(0·21 to 1·75)*
Jordan 50·0 
(46·5 to 53·4)
58·3 
(53·8 to 62·7)
70·2 
(64·8 to 75·3)
20·2 
(13·5 to 26·3)*
8·3 
(4·0 to 13·0)*
11·9 
(5·4 to 18·4)*
1·31 
(0·88 to 1·70)*
1·54 
(0·76 to 2·41)*
1·16 
(0·54 to 1·82)*
Kuwait 66·8 
(63·3 to 70·3)
70·8 
(68·3 to 73·5)
80·7 
(75·5 to 86·1)
13·8 
(7·8 to 19·7)*
4·0 
(–0·4 to 8·4)
9·9 
(4·4 to 15·4)*
0·72 
(0·42 to 1·02)*
0·58 
(–0·05 to 1·22)
0·81 
(0·37 to 1·25)*
Lebanon 53·1 
(48·5 to 57·1)
67·2 
(63·6 to 70·6)
85·6 
(82·8 to 88·2)
32·5 
(27·5 to 38·0)*
14·1 
(9·8 to 18·5)*
18·4 
(14·2 to 23·0)*
1·84 
(1·52 to 2·21)*
2·36 
(1·60 to 3·19)*
1·52 
(1·15 to 1·93)*
Libya 50·9 
(46·8 to 54·5)
57·9 
(54·5 to 61·0)
71·1 
(67·4 to 74·6)
20·2 
(15·7 to 24·7)*
7·0 
(4·1 to 9·9)*
13·2 
(9·5 to 16·8)*
1·29 
(1·00 to 1·60)*
1·30 
(0·74 to 1·87)*
1·28 
(0·93 to 1·65)*
Morocco 37·5 
(34·7 to 40·7)
44·6 
(41·5 to 47·5)
57·6 
(54·5 to 60·8)
20·1 
(16·2 to 23·6)*
7·1 
(4·1 to 10·0)*
13·0 
(9·9 to 16·1)*
1·65 
(1·33 to 1·95)*
1·73 
(0·99 to 2·45)*
1·60 
(1·23 to 2·00)*
Oman 52·5 
(49·6 to 55·5)
63·4 
(61·1 to 65·9)
76·2 
(74·0 to 78·6)
23·7 
(20·4 to 27·1)*
10·9 
(8·4 to 13·6)*
12·8 
(10·0 to 15·4)*
1·43 
(1·21 to 1·67)*
1·89 
(1·44 to 2·38)*
1·15 
(0·89 to 1·38)*
Palestine 48·1 
(43·1 to 53·5)
54·1 
(51·2 to 57·6)
57·4 
(54·1 to 60·6)
9·3 
(2·7 to 15·3)*
6·0 
(0·4 to 11·7)*
3·3 
(–1·0 to 7·2)
0·68 
(0·20 to 1·15)*
1·19 
(0·07 to 2·37)*
0·37 
(–0·11 to 0·80)
Qatar 57·7 
(53·3 to 62·2)
64·6 
(60·3 to 69·1)
81·7 
(75·9 to 86·6)
23·9 
(16·8 to 30·8)*
6·9 
(1·0 to 12·9)*
17·0 
(10·4 to 24·0)*
1·33 
(0·94 to 1·74)*
1·13 
(0·16 to 2·11)*
1·46 
(0·89 to 2·03)*
Saudi Arabia 49·9 
(47·0 to 53·0)
56·6 
(54·8 to 58·7)
77·1 
(74·9 to 79·3)
27·2 
(23·4 to 31·2)*
6·7 
(3·9 to 9·7)*
20·5 
(17·8 to 23·2)*
1·67 
(1·42 to 1·95)*
1·26 
(0·72 to 1·85)*
1·93 
(1·69 to 2·18)*
Sudan 28·6 
(24·3 to 31·8)
33·7 
(29·8 to 36·7)
45·8 
(41·0 to 50·0)
17·2 
(13·1 to 21·3)*
5·1 
(2·5 to 8·0)*
12·1 
(8·0 to 16·0)*
1·81 
(1·37 to 2·28)*
1·65 
(0·76 to 2·66)*
1·91 
(1·31 to 2·51)*
Syria 45·5 
(42·6 to 48·3)
56·7 
(54·6 to 58·8)
67·2 
(64·4 to 70·2)
21·7 
(17·9 to 25·7)*
11·2 
(8·1 to 14·5)*
10·5 
(7·1 to 14·0)*
1·50 
(1·23 to 1·79)*
2·21 
(1·58 to 2·94)*
1·06 
(0·74 to 1·41)*
Tunisia 47·6 
(43·2 to 50·9)
59·0 
(55·3 to 62·3)
69·4 
(65·4 to 73·7)
21·8 
(17·1 to 26·8)*
11·4 
(8·1 to 14·7)*
10·4 
(6·6 to 14·3)*
1·45 
(1·14 to 1·83)*
2·15 
(1·50 to 2·85)*
1·02 
(0·64 to 1·40)*
Turkey 42·5 
(38·8 to 46·3)
53·9 
(50·8 to 56·8)
74·4 
(70·0 to 78·4)
31·9 
(26·2 to 37·3)*
11·4 
(7·9 to 15·2)*
20·4 
(15·5 to 25·2)*
2·16 
(1·76 to 2·53)*
2·39 
(1·61 to 3·22)*
2·01 
(1·53 to 2·50)*
United Arab Emirates 49·8 
(43·7 to 55·4)
60·2 
(56·0 to 64·4)
70·3 
(65·5 to 75·4)
20·5 
(12·8 to 28·6)*
10·4 
(5·2 to 15·8)*
10·1 
(4·1 to 16·6)*
1·33 
(0·81 to 1·90)*
1·91 
(0·93 to 3·00)*
0·97 
(0·39 to 1·59)*
Yemen 25·2 
(20·8 to 29·1)
31·4 
(26·9 to 35·6)
43·3 
(38·3 to 47·9)
18·1 
(12·9 to 22·7)*
6·2 
(2·6 to 9·9)*
11·9 
(7·5 to 16·2)*
2·09 
(1·45 to 2·72)*
2·20 
(0·92 to 3·57)*
2·01 
(1·22 to 2·75)*
South Asia† 23·8 
(22·3 to 25·6)
27·6 
(26·1 to 29·3)
40·4 
(38·7 to 42·2)
16·6 
(14·0 to 18·9)*
3·8 
(2·1 to 5·2)*
12·9 
(10·9 to 14·8)*
2·04 
(1·70 to 2·32)*
1·47 
(0·84 to 2·09)*
2·39 
(2·01 to 2·77)*
South Asia 23·8 
(22·3 to 25·6)
27·6 
(26·1 to 29·3)
40·4 
(38·7 to 42·2)
16·6 
(14·0 to 18·9)*
3·8 
(2·1 to 5·2)*
12·9 
(10·9 to 14·8)*
2·04 
(1·70 to 2·32)*
1·47 
(0·84 to 2·09)*
2·39 
(2·01 to 2·77)*
Bangladesh 17·8 
(15·0 to 20·7)
27·5 
(25·2 to 30·0)
47·6 
(44·3 to 50·9)
29·8 
(25·7 to 34·2)*
9·7 
(6·5 to 12·8)*
20·1 
(16·3 to 23·8)*
3·80 
(3·18 to 4·50)*
4·36 
(2·84 to 6·05)*
3·44 
(2·78 to 4·09)*
(Table 2 continues on next page)
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Bhutan 20·0 
(16·2 to 23·9)
29·6 
(26·1 to 33·1)
47·3 
(42·6 to 52·0)
27·2 
(22·1 to 32·6)*
9·6 
(5·7 to 13·5)*
17·7 
(13·1 to 22·3)*
3·32 
(2·58 to 4·11)*
3·94 
(2·29 to 5·80)*
2·93 
(2·18 to 3·70)*
India 24·7 
(22·9 to 27·2)
28·0 
(26·3 to 30·3)
41·2 
(39·1 to 43·4)
16·5 
(13·4 to 19·4)*
3·3 
(1·3 to 5·5)*
13·2 
(10·7 to 15·6)*
1·97 
(1·56 to 2·31)*
1·27 
(0·46 to 2·03)*
2·41 
(1·93 to 2·85)*
Nepal 21·0 
(18·1 to 24·1)
26·5 
(23·7 to 29·4)
40·0 
(36·5 to 44·4)
19·1 
(14·6 to 23·9)*
5·5 
(2·5 to 8·5)*
13·6 
(10·0 to 17·6)*
2·49 
(1·90 to 3·14)*
2·33 
(1·05 to 3·69)*
2·59 
(1·94 to 3·31)*
Pakistan 26·8 
(24·0 to 30·0)
27·4 
(24·9 to 30·5)
37·6 
(33·7 to 41·9)
10·8 
(6·1 to 15·5)*
0·6 
(–2·4 to 3·5)
10·2 
(5·7 to 14·6)*
1·30 
(0·73 to 1·86)*
0·22 
(–0·86 to 1·32)
1·98 
(1·11 to 2·77)*
Sub–Saharan Africa† 19·6 
(18·2 to 21·1)
22·3 
(20·9 to 23·8)
31·9 
(30·5 to 33·7)
12·3 
(10·5 to 14·1)*
2·7 
(1·4 to 4·1)*
9·6 
(8·0 to 11·3)*
1·88 
(1·58 to 2·17)*
1·30 
(0·65 to 1·96)*
2·24 
(1·85 to 2·65)*
Central sub–Saharan 
Africa
19·6 
(16·6 to 22·9)
20·6 
(17·4 to 24·2)
29·2 
(25·8 to 32·7)
9·7 
(6·0 to 13·1)*
1·1 
(–1·7 to 3·8)
8·6 
(5·2 to 11·8)*
1·55 
(0·96 to 2·19)*
0·54 
(–0·86 to 1·87)
2·18 
(1·26 to 3·11)*
Angola 18·4 
(12·7 to 24·4)
20·6 
(14·2 to 27·2)
33·4 
(25·5 to 40·4)
14·9 
(7·2 to 22·6)*
2·2 
(–2·6 to 6·9)
12·8 
(6·1 to 19·7)*
2·31 
(1·09 to 3·64)*
1·11 
(–1·26 to 3·57)
3·06 
(1·34 to 4·95)*
Central African 
Republic
15·8 
(12·7 to 19·6)
16·1 
(11·2 to 22·1)
18·6 
(13·1 to 24·4)
2·7 
(–3·2 to 8·9)
0·3 
(–4·7 to 5·4)
2·4 
(–3·6 to 8·6)
0·59 
(–0·80 to 1·85)
0·10 
(–3·25 to 2·99)
0·89 
(–1·33 to 3·19)
Congo (Brazzaville) 21·0 
(17·0 to 25·1)
21·9 
(18·0 to 25·9)
34·1 
(28·4 to 40·4)
13·0 
(6·7 to 20·0)*
0·8 
(–3·3 to 5·2)
12·2 
(6·4 to 18·6)*
1·86 
(0·96 to 2·84)*
0·40 
(–1·49 to 2·44)
2·77 
(1·49 to 4·19)*
Democratic Republic 
of the Congo
21·7 
(17·6 to 26·4)
22·1 
(17·5 to 27·0)
29·6 
(25·7 to 33·7)
7·9 
(2·8 to 12·7)*
0·4 
(–3·6 to 4·4)
7·5 
(2·9 to 11·7)*
1·21 
(0·44 to 2·00)*
0·19 
(–1·59 to 1·98)
1·85 
(0·69 to 2·94)*
Equatorial Guinea 13·9 
(8·9 to 19·3)
25·7 
(18·7 to 34·1)
49·3 
(38·3 to 62·0)
35·4 
(24·4 to 47·7)*
11·8 
(6·1 to 18·5)*
23·6 
(13·3 to 33·8)*
4·90 
(3·41 to 6·58)*
6·18 
(3·18 to 9·59)*
4·11 
(2·43 to 5·84)*
Gabon 27·7 
(24·2 to 31·4)
28·6 
(24·5 to 32·9)
40·4 
(35·0 to 46·1)
12·7 
(6·6 to 18·9)*
0·9 
(–3·7 to 5·4)
11·8 
(5·4 to 17·9)*
1·45 
(0·76 to 2·13)*
0·30 
(–1·35 to 1·87)
2·17 
(1·01 to 3·30)*
Eastern sub–Saharan 
Africa
15·0 
(13·3 to 16·8)
18·8 
(17·0 to 20·6)
29·2 
(27·3 to 31·3)
14·2 
(11·9 to 16·4)*
3·7 
(1·9 to 5·5)*
10·5 
(8·4 to 12·5)*
2·56 
(2·11 to 3·03)*
2·22 
(1·12 to 3·31)*
2·77 
(2·18 to 3·34)*
Burundi 14·3 
(10·7 to 18·2)
17·7 
(14·2 to 21·3)
27·4 
(23·1 to 32·1)
13·1 
(7·3 to 18·2)*
3·4 
(–0·8 to 7·5)
9·7 
(4·6 to 14·5)*
2·52 
(1·40 to 3·70)*
2·19 
(–0·51 to 4·93)
2·73 
(1·29 to 4·14)*
Comoros 19·4 
(16·1 to 23·1)
23·4 
(20·3 to 26·4)
33·0 
(29·5 to 36·7)
13·6 
(8·5 to 18·2)*
3·9 
(0·5 to 7·4)*
9·6 
(5·6 to 13·7)*
2·05 
(1·24 to 2·82)*
1·87 
(0·20 to 3·57)*
2·16 
(1·25 to 3·06)*
Djibouti 23·1 
(20·2 to 26·6)
24·3 
(19·8 to 30·0)
35·0 
(29·7 to 42·0)
11·8 
(5·8 to 19·1)*
1·1 
(–3·5 to 6·3)
10·7 
(5·6 to 15·9)*
1·58 
(0·78 to 2·41)*
0·45 
(–1·58 to 2·47)
2·29 
(1·22 to 3·43)*
Eritrea 12·2 
(9·2 to 15·6)
20·7 
(17·3 to 24·3)
27·6 
(23·7 to 31·3)
15·4 
(10·7 to 19·9)*
8·5 
(5·1 to 12·1)*
6·9 
(2·8 to 10·8)*
3·16 
(2·12 to 4·28)*
5·33 
(3·13 to 7·94)*
1·81 
(0·71 to 2·89)*
Ethiopia 10·6 
(7·8 to 14·1)
14·0 
(11·1 to 17·3)
28·1 
(24·3 to 32·2)
17·5 
(12·2 to 22·1)*
3·5 
(–0·5 to 7·2)
14·1 
(9·3 to 18·9)*
3·79 
(2·53 to 5·04)*
2·88 
(–0·38 to 6·12)
4·36 
(2·85 to 6·01)*
Kenya 32·4 
(27·6 to 37·4)
32·3 
(28·0 to 36·8)
39·5 
(35·0 to 43·9)
7·1 
(3·3 to 11·0)*
–0·1 
(–3·1 to 2·6)
7·2 
(4·2 to 10·2)*
0·76 
(0·33 to 1·20)*
–0·03 
(–0·96 to 0·82)
1·26 
(0·73 to 1·81)*
Madagascar 20·6 
(18·0 to 23·2)
23·8 
(21·0 to 26·9)
29·6 
(24·3 to 35·1)
9·0 
(3·5 to 15·0)*
3·3 
(0·1 to 6·6)*
5·8 
(–0·1 to 11·6)
1·39 
(0·57 to 2·23)*
1·47 
(0·05 to 2·94)*
1·34 
(–0·02 to 2·61)
Malawi 19·0 
(13·9 to 25·5)
21·5 
(14·8 to 31·9)
32·2 
(26·9 to 38·2)
13·2 
(6·3 to 20·1)*
2·5 
(–2·7 to 8·9)
10·7 
(1·0 to 19·3)*
2·06 
(0·96 to 3·30)*
1·15 
(–1·45 to 3·95)
2·63 
(0·19 to 5·04)*
Mozambique 13·8 
(11·0 to 17·0)
21·1 
(15·9 to 28·1)
30·0 
(25·3 to 35·0)
16·3 
(11·2 to 21·4)*
7·3 
(2·2 to 13·6)*
9·0 
(2·0 to 15·2)*
3·01 
(2·10 to 3·93)*
4·19 
(1·50 to 7·25)*
2·27 
(0·45 to 4·02)*
Rwanda 16·7 
(13·0 to 20·8)
18·6 
(14·4 to 22·8)
36·0 
(31·6 to 40·5)
19·2 
(14·1 to 24·1)*
1·8 
(–2·1 to 5·6)
17·4 
(12·1 to 22·7)*
2·96 
(2·06 to 3·90)*
1·05 
(–1·22 to 3·27)
4·16 
(2·77 to 5·75)*
Somalia 12·8 
(8·2 to 18·3)
13·5 
(9·1 to 19·1)
19·0 
(14·3 to 23·7)
6·2 
(0·6 to 11·1)*
0·7 
(–2·8 to 3·7)
5·5 
(0·5 to 9·8)*
1·56 
(0·13 to 3·01)*
0·56 
(–2·17 to 3·03)
2·19 
(0·19 to 4·19)*
South Sudan 22·0 
(16·8 to 28·9)
23·6 
(17·4 to 30·7)
26·8 
(21·0 to 33·1)
4·9 
(–2·0 to 11·2)
1·6 
(–3·4 to 6·6)
3·3 
(–2·7 to 9·0)
0·78 
(–0·31 to 1·81)
0·69 
(–1·51 to 2·87)
0·84 
(–0·66 to 2·31)
Tanzania 21·9 
(18·7 to 25·5)
24·7 
(20·5 to 30·1)
33·9 
(30·0 to 38·4)
11·9 
(7·3 to 16·6)*
2·7 
(–1·5 to 7·4)
9·2 
(4·1 to 14·3)*
1·67 
(1·01 to 2·35)*
1·15 
(–0·68 to 2·99)
2·00 
(0·83 to 3·19)*
Uganda 19·3 
(15·6 to 23·5)
23·7 
(20·0 to 27·7)
31·4 
(27·2 to 35·6)
12·1 
(7·2 to 16·8)*
4·4 
(0·5 to 8·4)*
7·8 
(3·2 to 12·4)*
1·89 
(1·11 to 2·70)*
2·06 
(0·25 to 3·95)*
1·78 
(0·73 to 2·88)*
Zambia 21·9 
(17·6 to 27·2)
17·2 
(13·0 to 22·7)
29·0 
(23·0 to 35·4)
7·1 
(0·4 to 14·8)*
–4·7 
(–9·2 to 0·3)
11·7 
(5·0 to 19·1)*
1·08 
(0·07 to 2·22)*
–2·44 
(–4·83 to 0·13)
3·28 
(1·32 to 5·30)*
(Table 2 continues on next page)
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Southern sub–Saharan 
Africa
38·2 
(36·3 to 40·4)
37·8 
(34·8 to 40·6)
44·7 
(42·4 to 47·0)
6·5 
(3·8 to 9·1)*
–0·4 
(–3·0 to 2·2)
7·0 
(3·8 to 10·1)*
0·61 
(0·34 to 0·84)*
–0·11 
(–0·81 to 0·55)
1·06 
(0·58 to 1·56)*
Botswana 36·5 
(30·6 to 43·0)
39·7 
(22·3 to 55·7)
51·5 
(40·8 to 69·2)
15·0 
(3·5 to 32·8)*
3·2 
(–11·5 to 17·2)
11·8 
(–8·6 to 34·7)
1·31 
(0·32 to 2·57)*
0·54 
(–4·08 to 3·84)
1·79 
(–1·07 to 5·36)
Lesotho 30·3 
(25·9 to 35·5)
29·2 
(23·0 to 38·0)
32·0 
(24·6 to 40·3)
1·6 
(–6·2 to 10·0)
–1·2 
(–7·8 to 7·5)
2·8 
(–6·1 to 12·2)
0·19 
(–0·81 to 1·17)
–0·46 
(–2·73 to 2·36)
0·59 
(–1·18 to 2·52)
Namibia 27·5 
(24·6 to 31·1)
32·2 
(24·1 to 43·3)
44·6 
(36·4 to 56·2)
17·1 
(9·4 to 27·7)*
4·7 
(–2·9 to 15·7)
12·4 
(3·2 to 20·9)*
1·84 
(1·14 to 2·71)*
1·45 
(–1·08 to 4·60)
2·09 
(0·49 to 3·62)*
South Africa 40·1 
(38·0 to 42·3)
40·9 
(38·2 to 43·8)
49·7 
(47·2 to 52·4)
9·6 
(6·6 to 12·7)*
0·8 
(–2·3 to 3·9)
8·8 
(5·4 to 12·1)*
0·83 
(0·57 to 1·08)*
0·19 
(–0·56 to 0·95)
1·23 
(0·75 to 1·70)*
Swaziland 32·0 
(27·3 to 37·0)
34·4 
(22·6 to 43·6)
40·5 
(30·4 to 52·2)
8·5 
(–1·2 to 18·4)
2·4 
(–11·1 to 13·5)
6·1 
(–9·6 to 20·6)
0·88 
(–0·14 to 1·78)
0·59 
(–3·91 to 3·86)
1·06 
(–1·64 to 3·73)
Zimbabwe 37·3 
(31·2 to 48·0)
31·4 
(22·6 to 39·7)
31·2 
(25·8 to 37·0)
–6·1 
(–17·7 to 1·0)
–5·9 
(–12·0 to 0·0)
–0·2 
(–9·5 to 9·2)
–0·68 
(–1·81 to 0·11)
–1·81 
(–3·80 to 0·01)
0·02 
(–1·79 to 2·04)
Western sub–Saharan 
Africa
22·4 
(20·3 to 24·4)
24·8 
(22·4 to 27·2)
34·3 
(31·9 to 36·7)
11·9 
(9·2 to 14·6)*
2·4 
(0·1 to 4·9)*
9·5 
(6·5 to 12·6)*
1·64 
(1·26 to 2·04)*
1·03 
(0·05 to 2·04)*
2·02 
(1·35 to 2·74)*
Benin 19·7 
(16·9 to 22·7)
22·7 
(19·7 to 26·0)
30·8 
(27·8 to 34·0)
11·2 
(7·2 to 15·2)*
3·1 
(–0·1 to 6·4)
8·1 
(4·3 to 11·9)*
1·74 
(1·09 to 2·38)*
1·45 
(–0·06 to 3·08)
1·92 
(0·98 to 2·82)*
Burkina Faso 16·4 
(13·4 to 20·3)
21·9 
(18·7 to 25·6)
30·1 
(27·0 to 33·3)
13·7 
(9·2 to 17·6)*
5·6 
(2·1 to 9·0)*
8·2 
(4·2 to 12·1)*
2·36 
(1·46 to 3·10)*
2·96 
(1·07 to 4·76)*
1·99 
(0·99 to 3·02)*
Cameroon 23·4 
(20·6 to 26·8)
23·8 
(19·7 to 28·1)
31·9 
(26·9 to 37·5)
8·5 
(3·3 to 14·3)*
0·4 
(–3·8 to 4·5)
8·2 
(2·9 to 13·3)*
1·19 
(0·49 to 1·92)*
0·13 
(–1·73 to 1·88)
1·85 
(0·69 to 3·00)*
Cape Verde 38·1 
(35·4 to 41·2)
41·4 
(37·0 to 46·1)
54·8 
(51·2 to 58·9)
16·7 
(12·5 to 21·2)*
3·3 
(–1·3 to 7·8)
13·4 
(7·6 to 19·5)*
1·40 
(1·03 to 1·76)*
0·81 
(–0·34 to 1·91)
1·76 
(0·99 to 2·61)*
Chad 18·3 
(15·6 to 21·4)
18·2 
(15·3 to 21·5)
25·4 
(21·9 to 29·0)
7·1 
(2·8 to 11·6)*
–0·1 
(–3·5 to 3·3)
7·2 
(3·2 to 11·1)*
1·27 
(0·49 to 2·05)*
–0·05 
(–1·92 to 1·81)
2·09 
(0·93 to 3·27)*
Côte d’Ivoire 19·9 
(17·3 to 22·6)
20·7 
(17·1 to 24·3)
27·3 
(24·2 to 31·1)
7·5 
(3·3 to 11·1)*
0·8 
(–2·5 to 4·3)
6·7 
(2·5 to 10·8)*
1·23 
(0·56 to 1·83)*
0·37 
(–1·29 to 2·05)
1·76 
(0·61 to 2·95)*
Ghana 25·6 
(22·5 to 28·9)
29·6 
(26·2 to 33·5)
39·3 
(36·0 to 43·4)
13·6 
(9·1 to 18·4)*
4·0 
(0·1 to 8·0)*
9·7 
(5·1 to 14·1)*
1·64 
(1·08 to 2·25)*
1·45 
(0·04 to 2·82)*
1·77 
(0·93 to 2·62)*
Guinea 17·1 
(14·3 to 20·3)
20·1 
(17·2 to 23·0)
26·4 
(22·6 to 30·2)
9·2 
(4·5 to 14·2)*
2·9 
(–0·6 to 6·3)
6·3 
(2·2 to 10·8)*
1·66 
(0·80 to 2·54)*
1·58 
(–0·31 to 3·49)
1·71 
(0·62 to 2·85)*
Guinea–Bissau 12·8 
(10·0 to 16·0)
15·7 
(12·7 to 19·0)
23·4 
(20·2 to 26·8)
10·6 
(5·9 to 14·9)*
2·9 
(–0·6 to 6·7)
7·7 
(3·6 to 11·9)*
2·34 
(1·25 to 3·36)*
2·03 
(–0·40 to 4·67)
2·53 
(1·17 to 3·97)*
Liberia 20·5 
(17·6 to 23·6)
23·2 
(19·8 to 26·8)
32·2 
(29·3 to 35·4)
11·7 
(8·0 to 15·5)*
2·8 
(–0·7 to 6·6)
8·9 
(4·9 to 13·0)*
1·74 
(1·15 to 2·36)*
1·26 
(–0·31 to 2·98)
2·04 
(1·09 to 3·07)*
Mali 16·7 
(13·7 to 20·5)
23·7 
(20·4 to 27·2)
34·9 
(29·9 to 40·1)
18·2 
(12·6 to 23·8)*
7·0 
(2·9 to 10·6)*
11·2 
(5·8 to 16·7)*
2·85 
(1·97 to 3·68)*
3·53 
(1·38 to 5·44)*
2·43 
(1·30 to 3·59)*
Mauritania 24·0 
(20·8 to 27·5)
29·7 
(25·9 to 36·2)
40·6 
(35·0 to 47·5)
16·6 
(10·7 to 23·7)*
5·7 
(1·8 to 11·5)*
10·9 
(4·9 to 17·2)*
2·02 
(1·35 to 2·70)*
2·13 
(0·68 to 3·91)*
1·95 
(0·86 to 2·98)*
Niger 15·6 
(12·6 to 19·3)
19·1 
(16·0 to 22·3)
28·4 
(23·9 to 33·1)
12·8 
(7·2 to 18·1)*
3·5 
(–0·1 to 7·4)
9·3 
(3·8 to 14·7)*
2·30 
(1·27 to 3·24)*
2·02 
(–0·06 to 4·21)
2·48 
(1·06 to 3·87)*
Nigeria 27·5 
(23·4 to 31·6)
29·8 
(24·9 to 35·3)
41·9 
(37·2 to 47·3)
14·4 
(8·7 to 20·4)*
2·3 
(–2·6 to 7·7)
12·1 
(5·5 to 19·0)*
1·62 
(0·97 to 2·35)*
0·80 
(–0·92 to 2·66)
2·14 
(0·93 to 3·38)*
São Tomé and 
Principe
25·9 
(22·4 to 29·7)
30·0 
(25·7 to 40·5)
39·3 
(34·9 to 44·4)
13·4 
(8·2 to 19·2)*
4·2 
(–0·1 to 13·3)
9·3 
(–0·4 to 14·9)
1·61 
(0·97 to 2·28)*
1·46 
(–0·05 to 4·06)
1·71 
(–0·06 to 2·74)
Senegal 22·4 
(19·8 to 25·1)
24·5 
(22·0 to 27·3)
31·1 
(28·3 to 33·8)
8·6 
(5·3 to 11·9)*
2·0 
(–0·8 to 5·1)
6·6 
(3·4 to 9·7)*
1·26 
(0·75 to 1·77)*
0·87 
(–0·33 to 2·21)
1·49 
(0·73 to 2·21)*
Sierra Leone 20·8 
(17·4 to 24·6)
22·1 
(19·0 to 25·5)
31·0 
(27·4 to 34·5)
10·1 
(5·7 to 14·5)*
1·3 
(–2·0 to 4·6)
8·8 
(4·3 to 12·8)*
1·53 
(0·84 to 2·22)*
0·60 
(–0·94 to 2·25)
2·11 
(1·05 to 3·10)*
The Gambia 27·4 
(23·9 to 30·9)
29·9 
(26·5 to 33·4)
35·7 
(32·3 to 39·3)
8·3 
(4·1 to 12·9)*
2·5 
(–0·7 to 5·6)
5·8 
(1·9 to 9·6)*
1·02 
(0·50 to 1·58)*
0·87 
(–0·24 to 2·02)
1·12 
(0·38 to 1·82)*
     Togo 21·7 
(19·0 to 24·5)
23·0 
(19·1 to 27·9)
32·0 
(28·7 to 35·6)
10·2 
(6·3 to 14·3)*
1·2 
(–3·0 to 6·0)
9·0 
(4·0 to 13·6)*
1·48 
(0·89 to 2·09)*
0·52 
(–1·46 to 2·53)
2·09 
(0·85 to 3·24)*
HAQ Index=Healthcare Access and Quality Index. UI=uncertainty interval. *Significant change during this time period. †Refers to Global Burden of Disease super region.
Table 2: Global, regional, and national or territory estimates of the HAQ Index for 1990, 2000, and 2016, and absolute change and annualised rates of change for 1990–2016, 1990–2000, 
and 2000–16
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linked to the country’s widely acknow ledged challenges 
in provid ing good health-care access to all popu-
lations,13,47 and disparities in the quality of care found 
in its poorer regions.13 As future iterations of GBD 
endeavour to support subnational burden of disease 
assess ments for more countries, we aim to expand 
locally focused monitoring of health-care access and 
quality in tandem.
Figure 5: Absolute change on the HAQ Index, by SDI quintile, 1990–2000 (A) and 2000–16 (B)
Countries and territories are colour-coded by their SDI quintile, and are abbreviated according to their ISO3 codes, which are listed in the appendix (pp 90–95). 
HAQ Index=Healthcare Access and Quality Index. SDI=Socio-demographic Index.
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Pace of past progress and strengthening health systems 
for the next generation
Current HAQ Index estimates represent the culmination 
of past health-care policy actions, and thus offer an 
important entry point for strengthening health systems 
for the future. Recent demographic and epidemiological 
trends point to populations living longer and with higher 
disease burden worldwide,48 portending an escalation 
of health-care challenges if countries cannot more 
expediently shift their models of care away from reactive 
service delivery and toward more proactive continuums 
of care. Such action must be accompanied by efforts 
to further bolster public health programmes and pol-
icies, targeting risk factors and socioeconomic factors 
that are less directly amenable to health care but re-
main leading contributors to preventable disease burden 
(eg, smoking).16
Historically, global health priorities centred on a sub-
set of health services (ie, vaccine-preventable diseases, 
infectious diseases, and maternal and child health), which 
was particularly true during the Millennium Development 
Goal (MDG) era. Successes in scaling up vaccine cover-
age, early diagnosis and treatment of infectious dis-
ease (eg, antibiotics for lower respiratory infections), 
and improving access to and quality of maternal care 
and delivery are illustrated by accelerated HAQ Index 
performance for many low-to-middle SDI countries from 
2000 to 2016. The exact drivers of these improvements vary 
by context (eg, Timor-Leste emerged from years of conflict 
in the late 1990s; political strife and HIV devastated health 
systems throughout sub-Saharan Africa during the 1990s 
and early 2000s), but some combination of domestic 
policy action and increased development assistance for 
health might have hastened progress in many countries.49
In parallel, poor access to or quality of non-communicable 
disease-focused risk man agement and treatment could 
explain slower gains or minimal advances for these causes 
in many countries, a warning sign that health systems are 
not evolving at the same rate as changing population 
health needs. For non-communicable diseases, there was a 
strong divide in performance among high-SDI countries 
and low-to-middle SDI locations, potentially reflecting 
inadequate investments in advancing non-communicable 
disease services across continuums of care, integrating 
care across health areas, or some combination of both. The 
importance of, and potential for, improving non-
communicable disease prevention and treatment is shown 
by trends from eastern Europe and central Asia,50,51 where 
several countries saw substantive HAQ Index gains from 
2000 to 2016 after stagnation or worsening performance 
during the 1990s.
Gains made against vaccine-preventable diseases and 
other causes prioritised during the MDGs must be 
sustained going forward, but not at the expense of 
preparing health systems for the next generation. Amid 
shifting epidemiological profiles,48 countries including 
China, Turkey, Vietnam, and Nepal recorded consistently 
sizeable rates of progress on the HAQ Index from 
Figure 6: Comparing the HAQ Index in 2016 to the log of cumulative total health spending per capita, 2010–15
Total health spending per capita is based on the cumulative per capita spending from 2010 to 2015 in purchasing power parity (PPP) for 2017. Countries and territories 
are colour-coded by their SDI quintile, and are abbreviated according to their ISO3 codes, which are listed in the appendix (pp 90–95). HAQ Index=Healthcare Access 
and Quality Index. SDI=Socio-demographic Index.
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1990 to 2000, and 2000 to 2016. Such trends could reflect 
several factors (eg, health system structures, govern-
ance functions, health insurance expansion),52–55 but also 
could represent successes in re-orienting and integrating 
services to accommodate evolving health-care needs.56
Finally, some countries did not experience such catalytic 
effects during the MDGs and are at risk of falling 
further behind in the SDG era. These locations include 
the Central African Republic, Somalia, and South Sudan, 
which consistently recorded among the lowest HAQ Index 
scores over time; and Zimbabwe and Lesotho, countries 
that have struggled to recover from faltering performance 
during the 1990s and early 2000s. Again, the precise factors 
underlying these countries’ challenges are multifaceted, 
but commonalities include prolonged conflict, widespread 
poverty, and comparatively low levels of development 
assistance for health from development partners.39
Progress towards universal health coverage
Providing access to quality health care is a key component 
of universal health coverage, and the HAQ Index offers a 
robust metric for monitoring progress across health 
service areas. This strength is particularly important since 
achieving universal health coverage is an objective for 
countries across the development spectrum, and thus 
comparable measures are needed for benchmarking 
progress and identifying specific health areas for policy 
action.57 For instance, gains in performance on neonatal 
disorders generally lagged behind those of maternal 
disorders in many low-to-middle SDI countries, which 
suggests that greater investment across the continuum of 
care, from antenatal services to neonatal intensive care 
units, might support faster progress.58 Access to quality 
health care is necessary but far from sufficient for 
achieving universal health coverage, which also requires 
provision of care without financial hardship and en-
compasses services that do not explicitly avert death or 
fully treat specific health conditions (eg, family planning 
services, palliative care).59,60 Substantial debate exists 
around the effects of national insurance schemes and 
government health spending on improving access to high-
quality health care and overall universal health cover-
age. Our exploratory analyses point to positive, albeit 
heterogeneous, relationships between total and govern-
ment health spending and national HAQ Index scores. 
These results highlight the importance of dedicated 
financing for improving health-care access and quality, but 
also indicate that increased health financing alone is not 
adequate. Instead, how well health spending translates into 
heightened access to quality health care is prob ably shaped 
by many factors,61 including health system governance,2 
efficiencies with which financial and health-care resources 
are dispersed,62 and relative distrib utions of health system 
inputs across service areas and subnational locations.63 
Future work should assess the potential effect of 
improvements across these dimensions on advances in 
health-care access and quality.
Future directions for measuring health-care access and 
quality
With its annual cycle, the GBD study supports ongoing 
methodological and conceptual improvements for meas-
uring personal health-care access and quality. One priority 
area, which has been extensively debated, is determining 
how to best update the amenable cause list, both for fatal 
and non-fatal outcomes. One approach would entail a 
systematic review of GBD causes to identify intervention 
effectiveness by cause and then empirically establish 
thresholds at which health care significantly improves 
defined outcomes. Another approach could be to establish 
key health service areas to be represented by the HAQ 
Index and then selecting a set of amenable outcomes, fatal 
and non-fatal, to characterise each health area.57 The 
Nolte and McKee list of causes6–9 includes a range of 
important areas, but how well performance in these high-
priority areas reflects performance in others (eg, vision 
and hearing, trauma services) is not clear.
Using MIRs for cancers instead of risk-standardised 
death rates provided an improved indicator of country-
level differences in access to effective cancer care. The 
quantity and quality of cancer-registry data in GBD 2016 
supported our use of cancer MIRs, but broader MIR use 
might be limited by the sparsity of data and methodological 
demands (eg, reconciling long lag times between disease 
detection and death from causes like diabetes). Future 
iterations should consider whether and how to expand the 
application of MIRs to more GBD causes, particularly 
those where disease-specific registries or surveillance exist 
(eg, renal registries). Revisiting age dimensions related to 
amenable mortality is also warranted, because the current 
limit of 74 years, as defined by Nolte and McKee,6–9 for 
most causes might not fully represent the potential of 
health care to avert death after that age. However, whether 
age-group bounds should be determined by changes in life 
expectancy or age-specific improvements in survival, or 
demarcated by cause-specific advances in reducing 
mortality by age group is not immediately clear. Relatedly, 
age-specific HAQ Index analyses might provide a better 
understanding of how health-care access and quality varies 
across the lifespan. Such work could shed light on how 
well health systems are responding to broader demographic 
shifts and population ageing.64,65
Future work also should seek to disentangle the effects 
of access from quality on HAQ Index performance. We 
found that the HAQ Index was strongly correlated with 
total health spending, but it is not clear how more spending 
on health culminates in improved access (eg, investments 
in health-care infrastructure, financing national insurance 
schemes) versus quality (eg, funding training in effective 
medical care, purchase and maintenance of functional 
medical supplies). Further, the relative effect of improved 
access to, as compared with quality of, health care could 
vary by therapeutic area and the optimal levels of care. For 
instance, good access to hospitals with skilled medical 
personnel and functional surgical equip ment without 
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corresponding access to high-quality primary care could 
have more negative ramifications for vaccine-preventable 
diseases than for conditions mainly addressed by surgery. 
Strengthening the overall continuum of care,66 by and 
across health areas, also warrants prioritisation, since 
efforts to better align primary and specialty care could 
enhance both patient outcomes and systems efficiency.
Going forward, we aim to incorporate improvements in 
measuring health-care access and quality into more 
comprehensive assessments of health system performance. 
Expanding HAQ Index estimation to subnational locations 
directly supports this endeavour, and ongoing work to 
quantify human resources for health and financial risk 
protection within the broader GBD study support the 
assessment of other health system domains. Quanti-
fying inequalities in health system responsiveness re-
quires additional attention if the World Health Report 
2000 framework is to be replicated,1 emphasising the need 
to better parse out the effects of improving quality of care 
versus access. Additionally, combining the HAQ Index 
with measures that reflect the effect of interventions on 
risk factors modifiable by public health programmes 
(eg, child growth failure) could provide a better assessment 
of overarching health-system action. Finally, substantial 
interest exists in translating HAQ Index scores into 
coverage of populations or number of people with access 
to quality health services. Multiplying HAQ Index values by 
population could approximate this (ie, the 0–100 scale 
approximates 0–100%), and the strong correlation between 
PCA-derived HAQ Index scores and the arithmetic mean 
of its component parts (r=0·99; appendix p 153) suggests 
that results might not be overly sensitive to index con-
struction methods.
Comparison with GBD 2015 assessment of personal 
health-care access and quality
Compared with GBD 2015,20 GBD 2016 HAQ Index scores 
are slightly higher for high-SDI countries and lower 
for low-to-middle SDI countries, whereas changes in 
overall rankings followed less consistent SDI patterns 
(appendix pp 154–55). Although individual country-level 
changes might represent several factors (eg, availability of 
new vital registration data, improved cause-specific 
modelling), the use of MIRs for cancers, and thus their 
increased contribution to overall HAQ Index scores, was a 
main contributor. In GBD 2015, many lower-SDI countries 
received relatively high scores for cancers,20 whereas 
conditionalising cancer mortality on incidence resulted in 
a distinct SDI gradient (appendix p 96–111). Subsequently, 
we view these results as substantially improved since 
GBD 2015.
Limitations
Our analysis is subject to limitations beyond those already 
described. First, any limitations in GBD 2016 cause-of-
death estimation are also applicable to this study.27 For 
GBD 2016, we aimed to better account for cause-of-death 
data quality by developing a metric for well-certified 
deaths and using this measure to inform GBD data 
standardisation and correction processes. Nonethe-
less, establishing and maintaining high-quality vital 
registration systems is essential to improved cause-of-
death estimation. For instance, abrupt or prolonged 
conflict can lead to cause-of-death data gaps or lags in 
reporting; subsequently, HAQ Index performance might 
not yet fully capture the ramifications of conflict on health 
care in some locations. Second, continued updates to 
the GBD comparative risk assessment improved risk-
standardisation of amenable causes, but we might not 
account for all possible differences in mortality related to 
underlying risk exposure. Third, our scaling approach 
(ie, transforming each cause to a scale of 0–100) does not 
allow for the potential for additional improvements 
in reducing cause-specific mortality. How to establish 
empirically-derived lower bounds for each cause remains 
unclear, but future work should consider the use of 
alternative scaling methods. Fourth, the HAQ Index does 
not expressly capture possible effects of personal health 
care on causes without substantial mortality. Although 
performance on these causes might be well correlated 
with the current HAQ Index formulation, their inclusion 
could strengthen overall measurement. Fifth, the HAQ 
Index does not explicitly distinguish between the effects of 
primary and secondary care,66 though some causes might 
give a stronger signal on certain health-system dimensions 
(eg, surgical intervention for appendicitis). Improved 
performance in particular therapeutic areas might 
represent a combination of advances in primary care 
(eg, diagnosis and treatment of hypertension) and 
secondary or referral services (eg, stroke unit, cardiology), 
or overall gains in continuums of care. Finally, our 
exploratory analysis of HAQ Index performance did not 
account for all potential factors related to health-care 
access and quality; future work should consider how other 
dimensions of health financing and health care are 
associated with the HAQ Index (eg, catastrophic health 
spending, insurance coverage), as well as broader social 
determinants of health (eg, poverty, accessibility).67
Conclusions
The global ambition towards universal health coverage 
by 2030 necessitates ensuring that all populations have 
good access to quality health services. Progress is 
possible, as shown by accelerated gains on the HAQ 
Index for many low-SDI countries during the MDG era. 
However, such advances are not inevitable, as under-
scored by slowed improvements in several countries and 
for non-communicable diseases that are best targeted by 
quality services coordinated across continuums of care. 
Large geographical inequalities persist across and within 
countries, highlighting an urgent need for policy 
attention toward places at risk of being left behind. 
Current performance represents action from the past, 
and thus the pace of progress could accelerate for many 
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middle-to-low SDI countries if recent investments can be 
translated into health-care gains. To strengthen and 
deliver health systems for the next generation, national 
and international health agencies alike must focus on 
improving health-care access and quality across health 
service areas and reaffirm their commitment to 
accelerating progress for the world’s poorest populations.
GBD 2016 Healthcare Access and Quality Collaborators
Nancy Fullman, Jamal Yearwood, Solomon M Abay, Cristiana Abbafati, 
Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Zegeye Abebe, 
Teshome Abuka Abebo, Victor Aboyans, Haftom Niguse Abraha, 
Daisy M X Abreu, Laith J Abu-Raddad, Akilew Awoke Adane, 
Rufus Adesoji Adedoyin, Olatunji Adetokunboh, Tara Ballav Adhikari, 
Mohsen Afarideh, Ashkan Afshin, Gina Agarwal, Dominic Agius, 
Anurag Agrawal, Sutapa Agrawal, Aliasghar Ahmad Kiadaliri, 
Miloud Taki Eddine Aichour, Mohammed Akibu, 
Rufus Olusola Akinyemi, Tomi F Akinyemiju, Nadia Akseer, 
Faris Hasan Al Lami, Fares Alahdab, Ziyad Al-Aly, Khurshid Alam, 
Tahiya Alam, Deena Alasfoor, Mohammed I Albittar, 
Kefyalew Addis Alene, Ayman Al-Eyadhy, Syed Danish Ali, 
Mehran Alijanzadeh, Syed M Aljunid, Ala’a Alkerwi, François Alla, 
Peter Allebeck, Christine Allen, Mahmoud A Alomari, Rajaa Al-Raddadi, 
Ubai Alsharif, Khalid A Altirkawi, Nelson Alvis-Guzman, 
Azmeraw T Amare, Kebede Amenu, Walid Ammar, 
Yaw Ampem Amoako, Nahla Anber, Catalina Liliana Andrei, 
Sofia Androudi, Carl Abelardo T Antonio, Valdelaine E M Araújo, 
Olatunde Aremu, Johan Ärnlöv, Al Artaman, Krishna Kumar Aryal, 
Hamid Asayesh, Ephrem Tsegay Asfaw, Solomon Weldegebreal Asgedom, 
Rana Jawad Asghar, Mengistu Mitiku Ashebir, Netsanet Abera Asseffa, 
Tesfay Mehari Atey, Sachin R Atre, Madhu S Atteraya, Leticia Avila-Burgos, 
Euripide Frinel G Arthur Avokpaho, Ashish Awasthi, 
Beatriz Paulina Ayala Quintanilla, Animut Alebel Ayalew, 
Henok Tadesse Ayele, Rakesh Ayer, Tambe Betrand Ayuk, 
Peter Azzopardi, Natasha Azzopardi-Muscat, Tesleem Kayode Babalola, 
Hamid Badali, Alaa Badawi, Maciej Banach, Amitava Banerjee, 
Amrit Banstola, Ryan M Barber, Miguel A Barboza, 
Suzanne L Barker-Collo, Till Bärnighausen, Simon Barquera, 
Lope H Barrero, Quique Bassat, Sanjay Basu, Bernhard T Baune, 
Shahrzad Bazargan-Hejazi, Neeraj Bedi, Ettore Beghi, Masoud Behzadifar, 
Meysam Behzadifar, Bayu Begashaw Bekele, Abate Bekele Belachew, 
Saba Abraham Belay, Yihalem Abebe Belay, Michelle L Bell, 
Aminu K Bello, Derrick A Bennett, James R Bennett, Isabela M Bensenor, 
Derbew Fikadu Berhe, Eduardo Bernabé, Robert Steven Bernstein, 
Mircea Beuran, Ashish Bhalla, Paurvi Bhatt, Soumyadeep Bhaumik, 
Zulfiqar A Bhutta, Belete Biadgo, Ali Bijani, Boris Bikbov, 
Charles Birungi, Stan Biryukov, Hailemichael Bizuneh, Ian W Bolliger, 
Kaylin Bolt, Ibrahim R Bou-Orm, Kayvan Bozorgmehr, 
Oliver Jerome Brady, Alexandra Brazinova, Nicholas J K Breitborde, 
Hermann Brenner, Gabrielle Britton, Traolach S Brugha, Zahid A Butt, 
Lucero Cahuana-Hurtado, Ismael Ricardo Campos-Nonato, 
Julio Cesar Campuzano, Josip Car, Mate Car, Rosario Cárdenas, 
Juan Jesus Carrero, Felix Carvalho, Carlos A Castañeda-Orjuela, 
Jacqueline Castillo Rivas, Ferrán Catalá-López, Kelly Cercy, Julian Chalek, 
Hsing-Yi Chang, Jung-Chen Chang, Aparajita Chattopadhyay, 
Pankaj Chaturvedi, Peggy Pei-Chia Chiang, 
Vesper Hichilombwe Chisumpa, Jee-Young J Choi, Hanne Christensen, 
Devasahayam Jesudas Christopher, Sheng-Chia Chung, 
Liliana G Ciobanu, Massimo Cirillo, Danny Colombara, Sara Conti, 
Cyrus Cooper, Leslie Cornaby, Paolo Angelo Cortesi, Monica Cortinovis, 
Alexandre Costa Pereira, Ewerton Cousin, Michael H Criqui, 
Elizabeth A Cromwell, Christopher Stephen Crowe, John A Crump, 
Alemneh Kabeta Daba, Berihun Assefa Dachew, Abel Fekadu Dadi, 
Lalit Dandona, Rakhi Dandona, Paul I Dargan, Ahmad Daryani, 
Maryam Daryani, Jai Das, Siddharth Kumar Das, José das Neves, 
Nicole Davis Weaver, Kairat Davletov, Barbora de Courten, Diego De Leo, 
Jan-Walter De Neve, Robert P Dellavalle, Gebre Demoz, Kebede Deribe, 
Don C Des Jarlais, Subhojit Dey, Samath D Dharmaratne, 
Meghnath Dhimal, Shirin Djalalinia, David Teye Doku, Kate Dolan, 
E Ray Dorsey, Kadine Priscila Bender dos Santos, Kerrie E Doyle, 
Tim R Driscoll, Manisha Dubey, Eleonora Dubljanin, 
Bruce Bartholow Duncan, Michelle Echko, Dumessa Edessa, 
David Edvardsson, Joshua R Ehrlich, Erika Eldrenkamp, Ziad El-Khatib, 
Matthias Endres, Aman Yesuf Endries, Babak Eshrati, 
Sharareh Eskandarieh, Alireza Esteghamati, Mahdi Fakhar, Tamer Farag, 
Mahbobeh Faramarzi, Emerito Jose Aquino Faraon, André Faro, 
Farshad Farzadfar, Adesegun Fatusi, Mir Sohail Fazeli, Valery L Feigin, 
Andrea B Feigl, Netsanet Fentahun, Seyed-Mohammad Fereshtehnejad, 
Eduarda Fernandes, João C Fernandes, Daniel Obadare Fijabi, Irina Filip, 
Florian Fischer, Christina Fitzmaurice, Abraham D Flaxman, 
Luisa Sorio Flor, Nataliya Foigt, Kyle J Foreman, Joseph J Frostad, 
Thomas Fürst, Neal D Futran, Emmanuela Gakidou, Silvano Gallus, 
Ketevan Gambashidze, Amiran Gamkrelidze, Morsaleh Ganji, 
Abadi Kahsu Gebre, Tsegaye Tewelde Gebrehiwot, 
Amanuel Tesfay Gebremedhin, Yalemzewod Assefa Gelaw, 
Johanna M  Geleijnse, Demeke Geremew, Peter W Gething, 
Reza Ghadimi, Khalil Ghasemi Falavarjani, Maryam Ghasemi-Kasman, 
Paramjit Singh Gill, Ababi Zergaw Giref, Maurice Giroud, 
Melkamu Dedefo Gishu, Giorgia Giussani, William W Godwin, 
Srinivas Goli, Hector Gomez-Dantes, Philimon N Gona, 
Amador Goodridge, Sameer Vali Gopalani, Yevgeniy Goryakin, 
Alessandra Carvalho Goulart, Ayman Grada, Max Griswold, 
Giuseppe Grosso, Harish Chander Gugnani, Yuming Guo, Rahul Gupta, 
Rajeev Gupta, Tanush Gupta, Tarun Gupta, Vipin Gupta, 
Juanita A Haagsma, Vladimir Hachinski, Nima Hafezi-Nejad, 
Gessessew Bugssa Hailu, Randah Ribhi Hamadeh, Samer Hamidi, 
Graeme J Hankey, Hilda L Harb, Heather C Harewood, 
Sivadasanpillai Harikrishnan, Josep Maria Haro, Hamid Yimam Hassen, 
Rasmus Havmoeller, Caitlin Hawley, Simon I Hay, Jiawei He, 
Stephen J C Hearps, Mohamed I Hegazy, Behzad Heibati, 
Mohsen Heidari, Delia Hendrie, Nathaniel J Henry, 
Victor Hugo Herrera Ballesteros, Claudiu Herteliu, 
Desalegn Tsegaw Hibstu, Molla Kahssay Hiluf, Hans W Hoek, 
Enayatollah Homaie Rad, Nobuyuki Horita, H Dean Hosgood, 
Mostafa Hosseini, Seyed Reza Hosseini, Mihaela Hostiuc, Sorin Hostiuc, 
Damian G Hoy, Mohamed Hsairi, Aung Soe Htet, Guoqing Hu, 
John J Huang, Kim Moesgaard Iburg, Fachmi Idris, 
Ehimario Uche Igumbor, Chad Ikeda, Bogdan Vasile Ileanu, 
Olayinka S Ilesanmi, Kaire Innos, Seyed Sina Naghibi Irvani, 
Caleb M S Irvine, Farhad Islami, Troy A Jacobs, Kathryn H Jacobsen, 
Nader Jahanmehr, Rajesh Jain, Sudhir Kumar Jain, Mihajlo M Jakovljevic, 
Moti Tolera Jalu, Amr A Jamal, Mehdi Javanbakht, 
Achala Upendra Jayatilleke, Panniyammakal Jeemon, Ravi Prakash Jha, 
Vivekanand Jha, Jacek Józwiak, Oommen John, Sarah Charlotte Johnson, 
Jost B Jonas, Vasna Joshua, Mikk Jürisson, Zubair Kabir, Rajendra Kadel, 
Amaha Kahsay, Rizwan Kalani, Chittaranjan Kar, Marina Karanikolos, 
André Karch, Corine Kakizi Karema, Seyed M Karimi, Amir Kasaeian, 
Dessalegn Haile Kassa, Getachew Mullu Kassa, Tesfaye Dessale Kassa, 
Nicholas J Kassebaum, Srinivasa Vittal Katikireddi, Anil Kaul, 
Norito Kawakami, Konstantin Kazanjan, Seifu Kebede, 
Peter Njenga Keiyoro, Grant Rodgers Kemp, Andre Pascal Kengne, 
Maia Kereselidze, Ezra Belay Ketema, Yousef Saleh Khader, 
Morteza Abdullatif Khafaie, Alireza Khajavi, Ibrahim A Khalil, 
Ejaz Ahmad Khan, Gulfaraz Khan, Md Nuruzzaman Khan, 
Muhammad Ali Khan, Mukti Nath Khanal, Young-Ho Khang, 
Mona M Khater, Abdullah Tawfih Abdullah Khoja, Ardeshir Khosravi, 
Jagdish Khubchandani, Getiye Dejenu Kibret, Daniel Ngari Kiirithio, 
Daniel Kim, Yun Jin Kim, Ruth W Kimokoti, Yohannes Kinfu, 
Sanjay Kinra, Adnan Kisa, Niranjan Kissoon, Sonali Kochhar, 
Yoshihiro Kokubo, Jacek A Kopec, Soewarta Kosen, Parvaiz A Koul, 
Ai Koyanagi, Michael Kravchenko, Kewal Krishan, Kristopher J  Krohn, 
Barthelemy Kuate Defo, G Anil Kumar, Pushpendra Kumar, Michael Kutz, 
Igor Kuzin, Hmwe H Kyu, Deepesh Pravinkumar Lad, 
Alessandra Lafranconi, Dharmesh Kumar Lal, Ratilal Lalloo, Hilton Lam, 
Qing Lan, Justin J Lang, Van C Lansingh, Sonia Lansky, Anders Larsson, 
Arman Latifi, Jeffrey Victor Lazarus, Janet L Leasher, Paul H Lee, 
Yirga Legesse, James Leigh, Cheru Tesema Leshargie, Samson Leta, 
Janni Leung, Ricky Leung, Miriam Levi, Yongmei Li, Juan Liang, 
Misgan Legesse Liben, Lee-Ling Lim, Stephen S Lim, Margaret Lind, 
Shai Linn, Stefan Listl, Patrick Y Liu, Shiwei Liu, Rakesh Lodha, 
Alan D Lopez, Scott A Lorch, Stefan Lorkowski, Paulo A Lotufo, 
Articles
www.thelancet.com   Vol 391   June 2, 2018 2261
Timothy C D Lucas, Raimundas Lunevicius, Grégoire Lurton, 
Ronan A Lyons, Fadi Maalouf, Erlyn Rachelle King Macarayan, 
Mark T Mackay, Emilie R Maddison, Fabiana Madotto, 
Hassan Magdy Abd El Razek, Mohammed Magdy Abd El Razek, 
Marek Majdan, Reza Majdzadeh, Azeem Majeed, Reza Malekzadeh, 
Rajesh Malhotra, Deborah Carvalho Malta, Abdullah A Mamun, 
Helena Manguerra, Treh Manhertz, Mohammad Ali Mansournia, 
Lorenzo G Mantovani, Tsegahun Manyazewal, Chabila C Mapoma, 
Christopher Margono, Jose Martinez-Raga, 
Sheila Cristina Ouriques Martins, Francisco Rogerlândio Martins-Melo, 
Ira Martopullo, Winfried März, Benjamin Ballard Massenburg, 
Manu Raj Mathur, Pallab K Maulik, Mohsen Mazidi, Colm McAlinden, 
John J McGrath, Martin McKee, Suresh Mehata, Ravi Mehrotra, 
Kala M Mehta, Varshil Mehta, Toni Meier, Fabiola Mejia-Rodriguez, 
Kidanu Gebremariam Meles, Mulugeta Melku, Peter Memiah, 
Ziad A Memish, Walter Mendoza, Degu Abate Mengiste, 
Desalegn Tadese Mengistu, Bereket Gebremichael Menota, 
George A Mensah, Atte Meretoja, Tuomo J Meretoja, 
Haftay Berhane Mezgebe, Tomasz Miazgowski, Renata Micha, 
Robert Milam, Anoushka Millear, Ted R Miller, GK Mini, Shawn Minnig, 
Andreea Mirica, Erkin M Mirrakhimov, Awoke Misganaw, 
Philip B Mitchell, Fitsum Weldegebreal Mlashu, Babak Moazen, 
Karzan Abdulmuhsin Mohammad, Roghayeh Mohammadibakhsh, 
Ebrahim Mohammed, Mohammed A Mohammed, Shafiu Mohammed, 
Ali H Mokdad, Glen Liddell D Mola, Mariam Molokhia, 
Fatemeh Momeniha, Lorenzo Monasta, Julio Cesar Montañez Hernandez, 
Mahmood Moosazadeh, Maziar Moradi-Lakeh, Paula Moraga, 
Lidia Morawska, Ilais Moreno Velasquez, Rintaro Mori, Shane D Morrison, 
Mark Moses, Seyyed Meysam Mousavi, Ulrich O Mueller, 
Manoj Murhekar, Gudlavalleti Venkata Satyanarayana Murthy, 
Srinivas Murthy, Jonah Musa, Kamarul Imran Musa, Ghulam Mustafa, 
Saravanan Muthupandian, Chie Nagata, Gabriele Nagel, Mohsen Naghavi, 
Aliya Naheed, Gurudatta A Naik, Nitish Naik, Farid Najafi, Luigi Naldi, 
Vinay Nangia, Jobert Richie Njingang Nansseu, K M Venkat Narayan, 
Bruno Ramos Nascimento, Ionut Negoi, Ruxandra Irina Negoi, 
Charles R Newton, Josephine Wanjiku Ngunjiri, Grant Nguyen, 
Long Nguyen, Trang Huyen Nguyen, Emma Nichols, 
Dina Nur Anggraini Ningrum, Ellen Nolte, Vuong Minh Nong, 
Ole F Norheim, Bo Norrving, Jean Jacques N Noubiap, Alypio Nyandwi, 
Carla Makhlouf Obermeyer, Richard Ofori-Asenso, Felix Akpojene Ogbo, 
In-Hwan Oh, Olanrewaju Oladimeji, Andrew Toyin Olagunju, 
Tinuke Oluwasefunmi Olagunju, Pedro R Olivares, 
Patricia Pereira Vasconcelos de Oliveira, Helen E Olsen, 
Bolajoko Olubukunola Olusanya, Jacob Olusegun Olusanya, Kanyin Ong, 
John Nelson Opio, Eyal Oren, Doris V Ortega-Altamirano, Alberto Ortiz, 
Raziye Ozdemir, Mahesh PA, Amanda W Pain, 
Marcos Roberto Tovani Palone, Adrian Pana, Songhomitra Panda-Jonas, 
Jeyaraj D Pandian, Eun-Kee Park, Hadi Parsian, Tejas Patel, 
Sanghamitra Pati, Snehal T Patil, Ajay Patle, George C Patton, 
Vishnupriya Rao Paturi, Deepak Paudel, Marcel de Moares Pedroso, 
Sandra P Pedroza, David M Pereira, Norberto Perico, Hannah Peterson, 
Max Petzold, Niloofar Peykari, Michael Robert Phillips, Frédéric B Piel, 
David M Pigott, Julian David Pillay, Michael A Piradov, Suzanne Polinder, 
Constance D Pond, Maarten J Postma, Farshad Pourmalek, 
Swayam Prakash, V Prakash, Narayan Prasad, Noela Marie Prasad, 
Caroline Purcell, Mostafa Qorbani, Hedley Knewjen Quintana, 
Amir Radfar, Anwar Rafay, Alireza Rafiei, Kazem Rahimi, 
Afarin Rahimi-Movaghar, Vafa Rahimi-Movaghar, Mahfuzar Rahman, 
Muhammad Aziz Rahman, Sajjad Ur Rahman, Rajesh Kumar Rai, 
Sree Bhushan Raju, Usha Ram, Saleem M Rana, Zane Rankin, 
Davide Rasella, David Laith Rawaf, Salman Rawaf, Sarah E Ray, 
Christian Aspacia Razo-García, Priscilla Reddy, Robert C Reiner, 
Cesar Reis, Marissa B Reitsma, Giuseppe Remuzzi, Andre M N Renzaho, 
Serge Resnikoff, Satar Rezaei, Mohammad Sadegh Rezai, 
Antonio L Ribeiro, Maria Jesus Rios Blancas, Juan A Rivera, 
Leonardo Roever, Luca Ronfani, Gholamreza Roshandel, Ali Rostami, 
Gregory A Roth, Dietrich Rothenbacher, Ambuj Roy, Nobhojit Roy, 
George Mugambage Ruhago, Yogesh Damodar Sabde, 
Perminder S Sachdev, Nafis Sadat, Mahdi Safdarian, Saeid Safiri, 
Rajesh Sagar, Amirhossein Sahebkar, Mohammad Ali Sahraian, 
Haniye Sadat Sajadi, Joseph Salama, Payman Salamati, 
Raphael de Freitas Saldanha, Hamideh Salimzadeh, Joshua A Salomon, 
Abdallah M  Samy, Juan Ramon Sanabria, Parag K Sancheti, 
Maria Dolores Sanchez-Niño, Damian Santomauro, Itamar S Santos, 
Milena M Santric Milicevic, Abdur Razzaque Sarker, Nizal Sarrafzadegan, 
Benn Sartorius, Maheswar Satpathy, Miloje Savic, Monika Sawhney, 
Sonia Saxena, Mete I Saylan, Elke Schaeffner, Josef Schmidhuber, 
Maria Inês Schmidt, Ione J C Schneider, Austin E Schumacher, 
Aletta E Schutte, David C Schwebel, Falk Schwendicke, Mario Sekerija, 
Sadaf G Sepanlou, Edson E Servan-Mori, Azadeh Shafieesabet, 
Masood Ali Shaikh, Marina Shakh-Nazarova, 
Mehran Shams-Beyranvand, Heidar Sharafi, Mahdi Sharif-Alhoseini, 
Sheikh Mohammed Shariful Islam, Meenakshi Sharma, Rajesh Sharma, 
Jun She, Aziz Sheikh, Mebrahtu Teweldemedhin Shfare, Peilin Shi, 
Chloe Shields, Mika Shigematsu, Yukito Shinohara, Rahman Shiri, 
Reza Shirkoohi, Ivy Shiue, Mark G Shrime, Sharvari Rahul Shukla, 
Soraya Siabani, Inga Dora Sigfusdottir, Donald H Silberberg, 
Diego Augusto Santos Silva, João Pedro Silva, 
Dayane Gabriele Alves Silveira, Jasvinder A Singh, Lavanya Singh, 
Narinder Pal Singh, Virendra Singh, Dhirendra Narain Sinha, 
Abiy Hiruye Sinke, Mekonnen Sisay, Vegard Skirbekk, Karen Sliwa, 
Alison Smith, Adauto Martins Soares Filho, Badr H A Sobaih, 
Melek Somai, Samir Soneji, Moslem Soofi, Reed J D Sorensen, 
Joan B Soriano, Ireneous N Soyiri, Luciano A Sposato, 
Chandrashekhar T Sreeramareddy, Vinay Srinivasan, Jeffrey D Stanaway, 
Vasiliki Stathopoulou, Nicholas Steel, Dan J Stein, Mark Andrew Stokes, 
Lela Sturua, Muawiyyah Babale Sufiyan, Rizwan Abdulkader Suliankatchi, 
Bruno F Sunguya, Patrick J Sur, Bryan L Sykes, P N Sylaja, 
Cassandra E I Szoeke, Rafael Tabarés-Seisdedos, 
Santosh Kumar Tadakamadla, Andualem Henok Tadesse, 
Getachew Redae Taffere, Nikhil Tandon, Amare Tariku Tariku, 
Nuno Taveira, Arash Tehrani-Banihashemi, Girma Temam Shifa, 
Mohamad-Hani Temsah, Abdullah Sulieman Terkawi, 
Azeb Gebresilassie Tesema, Dawit Jember Tesfaye, Belay Tessema, 
JS Thakur, Nihal Thomas, Matthew J Thompson, Taavi Tillmann, 
Quyen G To, Ruoyan Tobe-Gai, Marcello Tonelli, Roman Topor-Madry, 
Fotis Topouzis, Anna Torre, Miguel Tortajada, Bach Xuan Tran, 
Khanh Bao Tran, Avnish Tripathi, Srikanth Prasad Tripathy, 
Christopher Troeger, Thomas Truelsen, Derrick Tsoi, Lorainne Tudor Car, 
Kald Beshir Tuem, Stefanos Tyrovolas, Uche S Uchendu, 
Kingsley Nnanna Ukwaja, Irfan Ullah, Rachel Updike, 
Olalekan A Uthman, Benjamin S Chudi Uzochukwu, 
Pascual Rubén Valdez, Job F M van Boven, Santosh Varughese, 
Tommi Vasankari, Narayanaswamy Venketasubramanian, 
Francesco S Violante, Sergey K Vladimirov, Vasiliy Victorovich Vlassov, 
Stein Emil Vollset, Theo Vos, Fasil Wagnew, Yasir Waheed, 
Mitchell T Wallin, Judd L Walson, Yafeng Wang, Yuan-Pang Wang, 
Molla Mesele Wassie, Marcia R Weaver, Elisabete Weiderpass, 
Robert G Weintraub, Jordan Weiss, Kidu Gidey Weldegwergs, 
Andrea Werdecker, T Eoin West, Ronny Westerman, Richard G White, 
Harvey A Whiteford, Justyna Widecka, Andrea Sylvia Winkler, 
Charles Shey Wiysonge, Charles D A Wolfe, Yohanes Ayele Wondimkun, 
Abdulhalik Workicho, Grant M A Wyper, Denis Xavier, Gelin Xu, 
Lijing L Yan, Yuichiro Yano, Mehdi Yaseri, Nigus Bililign Yimer, Peng Yin, 
Paul Yip, Biruck Desalegn Yirsaw, Naohiro Yonemoto, Gerald Yonga, 
Seok-Jun Yoon, Marcel Yotebieng, Mustafa Z Younis, Chuanhua Yu, 
Vesna Zadnik, Zoubida Zaidi, Maysaa El Sayed Zaki, Sojib Bin Zaman, 
Mohammad Zamani, Zerihun Menlkalew Zenebe, Maigeng Zhou, 
Jun Zhu, Stephanie R M Zimsen, Ben Zipkin, Sanjay Zodpey, 
Liesl Joanna Zuhlke, Christopher J L Murray, Rafael Lozano. 
Affiliations
Institute for Health Metrics and Evaluation (N Fullman MPH, 
J Yearwood BA, A Afshin MD, T Alam MPH, C Allen BA, R M Barber BS, 
J R Bennett BA, S Biryukov BS, I W Bolliger BA, K Bolt MPH, 
K Cercy BS, J Chalek BS, D Colombara PhD, L Cornaby BS, 
E A Cromwell PhD, Prof L Dandona MD, Prof R Dandona PhD, 
N Davis Weaver MPH, M Echko BSc, E Eldrenkamp BA, T Farag PhD, 
C Fitzmaurice MD, A D Flaxman PhD, K J Foreman PhD, 
J J Frostad MPH, Prof E Gakidou PhD, W W Godwin BS, 
M Griswold MA, C Hawley MSPH, Prof S I Hay DSc, J He MSCE, 
N J Henry BS/BA, C Ikeda BS, C M S Irvine BA, S C Johnson MSc, 
N J Kassebaum MD, G R Kemp BA, I A Khalil MD, K J Krohn MPH, 
Articles
2262 www.thelancet.com   Vol 391   June 2, 2018
M Kutz BS, H H Kyu PhD, Prof S S Lim PhD, M Lind MPHc, 
P Y Liu MPH, G Lurton Mac, E R Maddison BS, H Manguerra BS, 
T Manhertz BA, C Margono BS, I Martopullo MPH, A Millear BA, 
S Minnig MS, A Misganaw PhD, Prof A H Mokdad PhD, M Moses MHS, 
Prof M Naghavi PhD, G Nguyen MPH, E Nichols BA, H E Olsen MA, 
K Ong PhD, A W Pain MPH, S P Pedroza MPH, H Peterson MS, 
D M Pigott DPhil, C Purcell BS, Z Rankin MPH, S E Ray BS, 
R C Reiner PhD, M B Reitsma BS, G A Roth MD, N Sadat MA, 
J Salama MSc, D Santomauro PhD, A E Schumacher BS, C Shields BS, 
L Singh BS, A Smith BA, R J D Sorensen MPH, V Srinivasan BA, 
J D Stanaway PhD, P J Sur BA, A Torre BS, C Troeger MPH, D Tsoi BS, 
R Updike AB, Prof S Vollset DrPH, Prof T Vos PhD, Prof 
M R Weaver PhD, Prof H A Whiteford PhD, Prof M Zhou PhD, 
S R M Zimsen MA, B Zipkin BS, Prof C J L Murray DPhil, 
Prof R Lozano MD), Division of Hematology, Department of Medicine 
(C Fitzmaurice MD), Center for Health Trends and Forecasts 
(Prof M M Jakovljevic PhD), Department of Global Health 
(S Kochhar MD), and Division of Plastic Surgery, Department of Surgery 
(B B Massenburg MD), University of Washington, Seattle, WA, USA 
(C S Crowe MD, N D Futran MD, R Kalani MD, J Leung PhD, 
S D Morrison MD, Prof M J Thompson DPhil, J L Walson MD, 
T West MD); College of Veterinary Medicine and Agriculture 
(K Amenu PhD) and School of Public Health (K Deribe MPH), Addis 
Ababa University, Addis Ababa, Ethiopia (S M Abay PhD, G Demoz MS, 
A Z Giref PhD, S Leta MS, B G Menota MS, G Temam Shifa MPH, 
B D Yirsaw PhD); La Sapienza University, Rome, Italy (C Abbafati PhD); 
Department of Neurology (Prof F Abd-Allah MD, Prof A Abdelalim MD) 
and Faculty of Medicine (M I Hegazy PhD, M M Khater MD), Cairo 
University, Cairo, Egypt (M M Khater); College of Health and Medical 
Sciences (J Abdela MSc), Haramaya University, Harar, Ethiopia 
(D Edessa MS, M Gishu MS, M T Jalu MPH, D A Mengiste MA, 
F W Mlashu MS, M Sisay MS, Y A Wondimkun MS); College of Medical 
and Health Sciences (B Bekele PhD), Department of Epidemiology and 
Biostatistics, Institute of Public Health (K Alene MPH), and Institute of 
Public Health (B A Dachew MPH, Y A Gelaw MPH), University of 
Gondar, Gondar, Ethiopia (Z Abebe MS, A A Adane MPH, B Biadgo MS, 
A F Dadi MPH, D Geremew MS, M Melku MS, A T Tariku MS, 
B Tessema PhD, M M Wassie MS); College of Medicine and Health 
Sciences (T A Abebo MPH, D T Hibstu MPH, D J Tesfaye MPH), Hawassa 
University, Hawassa, Ethiopia (A K Daba MS); Dupuytren University 
Hospital, Limoges, France (Prof V Aboyans PhD); College of Health 
Sciences (D T Mengistu MS, S Muthupandian PhD, E T Asfaw MS), 
Institute of Biomedical Sciences (S Muthupandian, E T Asfaw), 
Department of Medical Microbiology (S Muthupandian), School of 
Pharmacy (D Berhe MS), School of Public Health (A B Belachew MS, 
G R Taffere PhD, K G Meles MPH, M M Ashebir MPH), and College of 
Health Sciences (K G Meles), Mekelle University, Mekelle, Ethiopia 
(H N Abraha MS, S W Asgedom MS, T Atey MS, A K Gebre MS, 
G B Hailu MSc, A Kahsay MPH, T D Kassa MS, S Kebede MS, 
E B Ketema MS, Y Legesse MS, H B Mezgebe MS, E Mohammed MS, 
A G Tesema MPH, K B Tuem MS, K G Weldegwergs MS, 
Z M Zenebe MS); Federal University of Minas Gerais, Belo Horizonte, 
Brazil (D M X Abreu PhD, V E M Araújo PhD); Infectious Disease 
Epidemiology Group, Weill Cornell Medical College in Qatar, Doha, Qatar 
(L J Abu-Raddad PhD); Queensland Brain Institute 
(Prof J J McGrath PhD), School of Dentistry (Prof R Lalloo PhD), and 
School of Public Health (Y A Gelaw MPH, J Leung, D Santomauro, 
Prof H A Whiteford PhD), University of Queensland, Brisbane, QLD, 
Australia (A A Adane MPH, B A Dachew MPH, Y Guo PhD, 
A A Mamun PhD); Department of Community Health, College of Health 
Sciences (A Fatusi MPH) and Department of Medical Rehabilitation 
(Prof R A Adedoyin PhD), Obafemi Awolowo University, Ile-Ife, Nigeria; 
Stellenbosch University, Cape Town, South Africa (O Adetokunboh MD, 
Prof C S Wiysonge PhD); Faculty of Health Sciences, Unit for Health 
Promotion Research, University of Southern Denmark, Esbjerg, Denmark 
(T B Adhikari MPH); Cancer Research Center (Prof R Shirkoohi PhD), 
Department of Epidemiology and Biostatistics (M Mansournia PhD), 
Department of Health Management and Economics, School of Public 
Health (S Mousavi PhD), Digestive Diseases Research Institute 
(Prof R Malekzadeh MD, G Roshandel PhD, S G Sepanlou PhD), 
Endocrinology and Metabolism Research Center (M Afarideh MD, 
Prof A Esteghamati MD, M Ganji MD, N Hafezi-Nejad MD, 
M Shams-Beyranvand MS), Hematologic Malignancies Research Center 
(A Kasaeian PhD), Hematology-Oncology and Stem Cell Transplantation 
Research Center (A Kasaeian PhD), Iranian National Center for Addiction 
Studies (A Rahimi-Movaghar MD), Knowledge Utilization Research 
Center and Community Based Participatory Research Center 
(Prof R Majdzadeh PhD), MS Research Center, Neuroscience Institute 
(M Sahraian MD), National Institute of Health Research 
(H S Sajadi PhD), Non-Communicable Diseases Research Center 
(F Farzadfar MD, A Khosravi PhD), Non-communicable Diseases 
Research Center, Endocrinology and Metabolism Research Institute 
(B Moazen MS), and Sina Trauma and Surgery Research Center 
(Prof V Rahimi-Movaghar MD, M Safdarian MD, Prof P Salamati MD, 
M Sharif-Alhoseini PhD), Tehran University of Medical Sciences, Tehran, 
Iran (Prof M Hosseini PhD, H Salimzadeh PhD, M Yaseri PhD); 
McMaster University, Hamilton, ON, Canada (G Agarwal PhD, 
T O Olagunju MD); Directorate for Health Information and Research, 
Pieta, Malta (D Agius MD, N Azzopardi-Muscat PhD); Malta College of 
Family Doctors, Gzira, Malta (D Agius MD); CSIR—Institute of 
Genomics and Integrative Biology, Delhi, India (A Agrawal PhD); 
Department of Internal Medicine, Baylor College of Medicine, Houston, 
Texas, USA (A Agrawal PhD); Centre for Control of Chronic Conditions 
(P Jeemon PhD), Indian Institute of Public Health (S Dey PhD, 
Prof G V S Murthy MD), Public Health Foundation of India, Gurugram, 
India (S Agrawal PhD, S Bhaumik MSc, Prof L Dandona, 
Prof R Dandona, G Kumar PhD, D K Lal MD, M R Mathur PhD, 
S Pati MD, Prof S Zodpey PhD); Department of Clinical Sciences Lund, 
Orthopedics, Clinical Epidemiology Unit (A Ahmad Kiadaliri PhD), Skane 
University Hospital, Department of Clinical Sciences Lund, Neurology, 
Lund University, Lund, Sweden (Prof B Norrving PhD); High National 
School of Veterinary Medicine, Algiers, Algeria (M Aichour MD); Debere 
Berhan University, Debre Berhan, Ethiopia (M Akibu MS); University of 
Ibadan, Ibadan, Nigeria (R O Akinyemi PhD); Newcastle University, 
Newcastle upon Tyne, UK (R O Akinyemi PhD); Department of 
Epidemiology (T F Akinyemiju PhD), University of Alabama at 
Birmingham, Birmingham, AL, USA (M Khan MD, G A Naik MPH, 
D C Schwebel PhD, J A Singh MD); Centre for Global Child Health, 
The Hospital for Sick Children, Toronto, ON, Canada (N Akseer MSc, 
Z A Bhutta PhD); Dalla Lana School of Public Health (N Akseer MSc), 
Department of Nutritional Sciences, Faculty of Medicine (A Badawi PhD), 
University of Toronto, Toronto, ON, Canada; Baghdad College of 
Medicine, Baghdad, Iraq (F H Al Lami PhD); Mayo Clinic Foundation for 
Medical Education and Research, Rochester, MN, USA (F Alahdab MD); 
Syrian American Medical Society, Washington, DC, USA (F Alahdab MD); 
Washington University in St. Louis, St. Louis, MO, USA (Z Al-Aly MD); 
School of Population and Global Health, University of Western Australia, 
Perth, WA, Australia (K Alam PhD); International Relations Division 
(A Htet MPhil), Ministry of Health, Al Khuwair, Oman (D Alasfoor MSc); 
Independent Consultant, Damascus, Syria (M I Albittar BS, 
M A Shaikh MD); Department of Global Health, Research School of 
Population Health (K Alene MPH), Australian National University, 
Canberra, ACT, Australia (Prof K E Doyle PhD); King Saud University, 
Riyadh, Saudi Arabia (A Al-Eyadhy MD, K A Altirkawi MD, 
A A Jamal MD, B H A Sobaih MD, M Temsah MD); King Faisal Specialist 
Hospital & Research Center, Riyadh, Saudi Arabia (A Al-Eyadhy MD); 
University of London, London, UK (S Ali BA); SIR Management 
Consultants, Oxford, UK (S Ali BA); Institute and Faculty of Actuaries, 
Oxford, UK (S Ali BA); Qazvin University of Medical Sciences, Qavin, 
Iran (M Alijanzadeh MS); Faculty of Public Health, Kuwait University, 
Kuwait City, Kuwait (Prof S M Aljunid PhD); International Centre for 
Casemix and Clinical Coding, National University of Malaysia, Kuala 
Lumpur, Malaysia (Prof S M Aljunid PhD); Luxembourg Institute of 
Health, Strassen, Luxembourg (A Alkerwi PhD); School of Public Health, 
University of Lorraine, Nancy, France (Prof F Alla PhD); Department of 
Medical Epidemiology and Biostatistics (Prof J J Carrero PhD, 
E Weiderpass PhD), Department of Neurobiology, Care Sciences and 
Society, Division of Family Medicine and Primary Care 
(Prof J Ärnlöv PhD, S Fereshtehnejad PhD), and Department of Public 
Health Sciences (P Allebeck PhD, Z El-Khatib PhD, N Roy MD), 
Karolinska Institutet, Stockholm, Sweden (R Havmoeller PhD, 
L Nguyen MPH); Department of Community Medicine, Public Health 
Articles
www.thelancet.com   Vol 391   June 2, 2018 2263
and Family Medicine (Prof Y S Khader ScD) and Division of Physical 
Therapy, Department of Rehabilitation Sciences, Faculty of Applied 
Medical Sciences (M A Alomari PhD), Jordan University of Science and 
Technology, Irbid, Jordan; College of Medicine, Department of Family and 
Community Medicine, King Abdulaziz University, Jeddah, Saudi Arabia 
(R Al-Raddadi PhD); Charité–Universitätsmedizin Berlin, Berlin, 
Germany (U Alsharif MPH, Prof M Endres MD, Prof E Schaeffner MD, 
Prof F Schwendicke PhD); Universidad de Cartagena, Cartagena de 
Indias, Colombia (Prof N Alvis-Guzman PhD); Discipline of Psychiatry 
(A T Olagunju MD), School of Medicine, (A T Amare MPH, 
Prof B T Baune PhD, L G Ciobanu MS), University of Adelaide, Adelaide, 
SA, Australia; College of Medicine and Health Sciences 
(A T Amare MPH), Bahir Dar University, Bahir Dar, Ethiopia; Ministry of 
Public Health, Beirut, Lebanon (W Ammar PhD, I R Bou-Orm MD, 
H L Harb MPH); Department of Medicine, Komfo Anokye Teaching 
Hospital, Kumasi, Ghana (Y A Amoako MD); Faculty of Medicine 
(Prof M E Zaki PhD), Mansoura University, Mansoura, Egypt 
(N Anber PhD); Carol Davila University of Medicine and Pharmacy, 
Bucharest, Romania (C L Andrei PhD, Prof M Beuran PhD, 
M Hostiuc PhD, S Hostiuc PhD, I Negoi PhD, R I Negoi PhD); University 
of Thessaly, Larissa, Greece (Prof S Androudi MD); College of Public 
Health (E A Faraon MD) and Department of Health Policy and 
Administration, College of Public Health (C T Antonio MD), University of 
the Philippines Manila, Manila, Philippines; Ministry of Health of Brazil, 
Brasília, Brazil (V E M Araújo PhD, P P V Oliveira MS, 
A M Soares Filho MPH); Birmingham City, University Department of 
Public Health and Therapies, Birmingham, UK (O Aremu PhD); School 
of Health and Social Studies, Dalarna University, Falun, Sweden 
(Prof J Ärnlöv PhD); University of Manitoba, Winnipeg, MB, Canada 
(A Artaman PhD); Nepal Health Research Council, Kathmandu, Nepal 
(K K Aryal MPH); University of Oslo, Oslo, Norway (K K Aryal MPH, 
A Htet); Department of Medical Emergency, School of Paramedical, Qom 
University of Medical Sciences, Qom, Iran (H Asayesh MS); South Asian 
Public Health Forum, Islamabad, Pakistan (R J Asghar MD); Wolaita Sodo 
University, Wolaita Sodo, Ethiopia (N Asseffa MPH); Centre for Clinical 
Global Health Education (S R Atre PhD), Johns Hopkins Bloomberg 
School of Public Health (A T A Khoja MD), Johns Hopkins University, 
Baltimore, MD, USA (B X Tran PhD); Dr D Y Patil Vidyapeeth Pune, 
Pune, India (S R Atre PhD); Keimyung University, Daegu, South Korea 
(M Atteraya PhD); National Institute of Public Health, Cuernavaca, 
Mexico (L Avila-Burgos PhD, S Barquera PhD, L Cahuana-Hurtado PhD, 
I R Campos-Nonato PhD, J C Campuzano PhD, H Gomez-Dantes MSc, 
F Mejia-Rodriguez MD, J C Montañez Hernandez MSc, 
D V Ortega-Altamirano PhD, C A Razo-García MSc, 
M Rios Blancas MPH, Prof J A Rivera PhD, Prof E E Servan-Mori MSc); 
Institut de Recherche Clinique du Bénin, Cotonou, Benin 
(E F G Avokpaho MPH); Laboratoire d’Etudes et de Recherche-Action en 
Santé (LERAS Afrique), Parakou, Benin (E F G Avokpaho MPH); Indian 
Institute of Public Health, Gandhinagar, India (A Awasthi PhD); Austin 
Clinical School of Nursing (M Rahman PhD), The Judith Lumley Centre 
for Mother, Infant and Family Health Research 
(B P Ayala Quintanilla PhD), La Trobe University, Melbourne, VIC, 
Australia (Prof D Edvardsson PhD); Peruvian National Institute of Health, 
Lima, Peru (B P Ayala Quintanilla PhD); Debre Markos University, Debre 
Markos, Ethiopia (A A Ayalew MS, Y A Belay MPH, D H Kassa MS, 
G M Kassa MS, G D Kibret MPH, C T Leshargie MPH, F Wagnew MS); 
Department of Epidemiology, Biostatiststics, and Occupational Health, 
McGill University, Montreal, QC, Canada (H Ayele PhD); Dilla University, 
Dilla, Ethiopia (H Ayele PhD); The University of Tokyo, Tokyo, Japan 
(R Ayer MS); Institute of Medical Research and Plant Medicinal Studies–
Cameroon, Yaounde, Cameroon (T B Ayuk MPH); University of South 
Africa, Pretoria, South Africa (T B Ayuk MPH); Burnet Institute, 
Melbourne, VIC, Australia (P Azzopardi PhD); Department of Paediatrics 
(P Azzopardi PhD, Prof G C Patton MD), Murdoch Childrens Research 
Institute (P Azzopardi, Prof G C Patton), Department of Medicine 
(A Meretoja PhD), and Institute of Health and Ageing 
(Prof C E I Szoeke PhD), Melbourne School of Population and Global 
Health (Prof A D Lopez PhD), University of Melbourne, Melbourne, VIC, 
Australia (M Rahman PhD, M T Mackay PhD, R G Weintraub MBBS, 
N M Prasad DO); Wardliparingga Aboriginal Research Unit, South 
Australian Health and Medical Research Institute, Adelaide, SA, Australia 
(P Azzopardi PhD); University of Malta Department of Health Services 
Management/Islands and Small States Institute, Msida, Malta 
(N Azzopardi-Muscat PhD); Department of Community Health and 
Primary Care (T K Babalola MS), Department of Psychiatry, College of 
Medicine, University of Lagos, Lagos, Nigeria (A T Olagunju MD); 
Invasive Fungi Research Center, Sari, Iran (Prof H Badali PhD); Centre of 
Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands 
(Prof H Badali PhD); Public Health Agency of Canada, Toronto, ON, 
Canada (A Badawi PhD, J J Lang PhD); Department of Hypertension, 
Medical University of Lodz, Lodz, Poland (Prof M Banach PhD); Institute 
of Epidemiology & Health (T Tillmann MSc) and The Farr Institute of 
Health Informatics Research, Institute of Health Informatics 
(A Banerjee DPhil, S Chung PhD), University College London, London, 
UK (C Birungi MS, M R Mathur PhD); Public Health Perspective Nepal, 
Pokhara, Nepal (A Banstola MPH); Hospital Dr Rafael A Calderón 
Guardia, CCSS, San José, Costa Rica (M A Barboza MD); Universidad de 
Costa Rica, San Pedro, Costa Rica (M A Barboza MD, 
Prof J Castillo Rivas MPH); School of Psychology, University of Auckland, 
Auckland, New Zealand (S L Barker-Collo PhD); Ariadne Labs 
(E K Macarayan PhD), Department of Global Health and Population, 
Harvard T H Chan School of Public Health (Prof T Bärnighausen MD, 
A B Feigl ScD, J A Salomon PhD), Harvard T H Chan School of Public 
Health (I R Campos-Nonato PhD), Harvard University, Boston, MA, USA; 
Africa Health Research Institute, Mtubatuba, South Africa 
(Prof T Bärnighausen); Institute of Public Health (Prof T Bärnighausen, 
S Mohammed PhD), Heidelberg University, Heidelberg, Germany 
(Prof S Listl PhD); Department of Industrial Engineering, School of 
Engineering (L H Barrero ScD), Pontificia Universidad Javeriana, Bogota, 
Colombia; Barcelona Institute for Global Health, Universitat de 
Barcelona, Barcelona, Spain (Prof Q Bassat MD); ICREA, Barcelona, 
Spain (Prof Q Bassat MD); Stanford University, Stanford, CA, USA 
(S Basu PhD); College of Medicine, Charles R Drew University of 
Medicine and Science, Los Angeles, CA, USA 
(Prof S Bazargan-Hejazi PhD); David Geffen School of Medicine, 
University of California at Los Angeles, Los Angeles, CA, USA 
(Prof S Bazargan-Hejazi); College of Public Health and Tropical Medicine, 
Jazan University, Jazan, Saudi Arabia (N Bedi MD); IRCCS–Istituto di 
Ricerche Farmacologiche Mario Negri, Milan, Italy (E Beghi MD, 
B Bikbov MD, M Cortinovis Biotech D, S Gallus DSc, G Giussani BiolD, 
N Perico MD, Prof G Remuzzi MD); Social Determinants of Health 
Research Center (M Behzadifar MS), Lorestan University of Medical 
Sciences, Khorramabad, Iran (M Behzadifar MS); Air Pollution Research 
Center (B Heibati PhD), Department of Community Medicine 
(A Tehrani-Banihashemi PhD, M Moradi-Lakeh MD), Preventive 
Medicine and Public Health Research Center (A Tehrani-Banihashemi, 
M Moradi-Lakeh), Gastrointestinal and Liver Disease Research 
Center (M Moradi-Lakeh), Health Management and Economics Research 
Center (M Behzadifar MS), and Department of Environmental Health 
Engineering, School of Public Health (F Momeniha MS), Iran University 
of Medical Sciences, Tehran, Tehran, Iran (K Ghasemi Falavarjani MD); 
Mizan Tepi University, Mizan Aman, Ethiopia (B Bekele PhD, 
H Y Hassen MPH); Dr Tewelde Legesse Health Sciences College, 
Mekelle, Ethiopia (S A Belay MPH); Yale University, New Haven, CT, USA 
(Prof M L Bell PhD, J J Huang MD); University of Alberta, Edmonton, 
AB, Canada (A K Bello PhD); Oxford Big Data Institute, Li Ka Shing 
Centre for Health Information and Discovery (Prof S I Hay DSc, 
T C D Lucas PhD), Nuffield Department of Medicine (T C D Lucas), 
Department of Zoology (P W Gething PhD), NIHR Musculoskeletal 
Biomedical Research Centre (Prof C Cooper FMedSci), and Nuffield 
Department of Population Health (D A Bennett PhD), University of 
Oxford, Oxford, UK (Prof V Jha DM, Prof C R Newton MD, 
K Rahimi DM); Center for Clinical and Epidemiological Research Center, 
Hospital Universitario (A C Goulart PhD), Internal Medicine Department 
(Prof I S Santos PhD), University of São Paulo, São Paulo, Brazil 
(I M Bensenor PhD, Prof P A Lotufo DrPH, M R T Palone MSc); 
Department of Psychiatry, University Medical Center Groningen 
(Prof H W Hoek MD), University Medical Center Groningen 
(D Berhe MS), University of Groningen, Groningen, Netherlands 
(Prof M J Postma PhD, J F M van Boven PhD); Division of Health and 
Social Care Research (Prof C D Wolfe MD), King’s College London, 
London, UK (E Bernabé PhD, M Molokhia PhD); Department of Global 
Articles
2264 www.thelancet.com   Vol 391   June 2, 2018
Health, Rollins School of Public Health (R S Bernstein MD), Emory 
University, Atlanta, GA, USA (Prof K Narayan MD, 
Prof M R Phillips MD); Department of Global Health, College of Public 
Health, University of South Florida, Tampa, FL, USA (R S Bernstein MD); 
Emergency Hospital of Bucharest, Bucharest, Romania 
(Prof M Beuran PhD, I Negoi PhD); School of Public Health 
(Prof J Thakur MD), Post Graduate Institute of Medical Education and 
Research, Chandigarh, India (A Bhalla MD, D P Lad DM); Medtronic 
Philanthropy, Minneapolis, MN, USA (P Bhatt MPH); Centre of 
Excellence in Women and Child Health (Z A Bhutta PhD), Department of 
Paediatrics and Child Health (J Das MBA), Aga Khan University, Karachi, 
Pakistan; Health Research Institute (R Ghadimi PhD), Infectious Diseases 
and Tropical Medicine Research Center, School of Medicine 
(A Rostami PhD), Social Determinants of Health Research Center, Health 
Research Institute (S Hosseini MD), Social Determinants of Health 
Research Center, Health Research Institute (A Bijani PhD), Babol 
University of Medical Sciences, Babol, Iran (M Faramarzi PhD, 
M Ghasemi-Kasman PhD, H Parsian PhD, M Zamani MD); St Paul’s 
Hospital Millennium Medical College, Addis Ababa, Ethiopia 
(H Bizuneh MPH, M T Jalu MPH); Jigjiga University, Jigjiga, Ethiopia 
(H Bizuneh MPH); University Hospital Heidelberg, Department of 
General Practice and Health Services Research, Heidelberg, Germany 
(K Bozorgmehr MD); European Observatory on Health Systems and 
Policies (E Nolte PhD), London School of Hygiene & Tropical Medicine, 
London, UK (O J Brady DPhil, Prof S Kinra PhD, Prof M McKee DSc, 
Prof R G White PhD); Faculty of Medicine, Institute of Epidemiology 
(A Brazinova MD), Comenius University, Bratislava, Slovakia; The Ohio 
State University, Columbus, OH, USA (Prof N J K Breitborde PhD, 
M Yotebieng PhD); German Cancer Research Center, Heidelberg, 
Germany (H Brenner MD); INDICASAT AIP, Panama, Panama 
(G Britton PhD); University of Leicester, Leicester, UK 
(Prof T S Brugha MD); Al Shifa Trust Eye Hospital, Rawalpindi, Pakistan 
(Z A Butt PhD); LKCMedicine, Nanyang Technological University, 
Singapore, Singapore (J Car PhD, L Tudor Car PhD); Department of 
Epidemiology and Biostatistics (F B Piel PhD), Department of Infectious 
Disease Epidemiology (T Fürst PhD), Department of Primary Care & 
Public Health (Prof A Majeed MD), WHO Collaborating Centre 
(D L Rawaf MD), Imperial College London, London, UK (J Car PhD, 
M Car PhD, K J Foreman, Prof S Rawaf MD, S Saxena MD, 
L Tudor Car PhD); Ministry of Health of the Republic of Croatia, Zagreb, 
Croatia (M Car PhD); Metropolitan Autonomous University, Mexico City, 
Mexico (R Cárdenas ScD); Department of Chemical Sciences 
(Prof E Fernandes PhD), Faculty of Pharmacy (Prof F Carvalho PhD), 
INEB–Instituto de Engenharia Biomédica (J das Neves PhD), UCIBIO@
REQUIMTE, Toxicology Group, Faculty of Pharmacy (J P Silva PhD), 
i3S–Instituto de Investigação e Inovação em Saúde (J das Neves PhD), 
University of Porto, Porto, Portugal; Colombian National Health 
Observatory (C A Castañeda-Orjuela MSc), Instituto Nacional de Salud, 
Bogota, Colombia; Epidemiology and Public Health Evaluation Group, 
Public Health Department (C A Castañeda-Orjuela MSc), Universidad 
Nacional de Colombia, Bogota, Colombia; Caja Costarricense de Seguro 
Social, San Jose, Costa Rica (Prof J Castillo Rivas MPH); Department of 
Medicine, University of Valencia, INCLIVA Health Research Institute and 
CIBERSAM, Valencia, Spain (F Catalá-López PhD, 
Prof R Tabarés-Seisdedos PhD); Clinical Epidemiology Program, Ottawa 
Hospital Research Institute, Ottawa, ON, Canada (F Catalá-López PhD); 
National Health Research Institutes, Zgunan Town, Taiwan 
(H Chang DrPH); National Yang-Ming University, Taipei, Taiwan 
(H Chang DrPH); School of Nursing, College of Medicine, National 
Taiwan University, Taipei, Taiwan (Prof J Chang PhD); International 
Institute for Population Sciences, Mumbai, India (A Chattopadhyay PhD, 
M Dubey MPhil, P Kumar MPhil, Prof U Ram PhD); Tata Memorial 
Hospital, Mumbai, India (Prof P Chaturvedi MD); Clinical Governance 
Unit, Gold Coast Health, Southport, QLD, Australia (P P Chiang PhD); 
University of Zambia, Lusaka, Zambia (V H Chisumpa MPhil, 
C C Mapoma PhD); University of Witwatersrand, Johannesburg, South 
Africa (V H Chisumpa MPhil); College of Health Sciences, Department of 
Health Policy and Management (Prof Y Khang MD), Seoul National 
University, Seoul, South Korea (J J Choi PhD); Seoul National University 
Medical Library, Seoul, South Korea (J J Choi PhD); Bispebjerg University 
Hospital, Copenhagen, Denmark (Prof H Christensen DMSCi); Christian 
Medical College, Vellore, India (Prof D J Christopher MD, 
Prof N Thomas PhD, Prof S Varughese DM); University of Salerno, 
Baronissi, Italy (Prof M Cirillo MD); Research Centre on Public Health 
(P A Cortesi PhD), University of Milano Bicocca, Monza, Italy 
(S Conti PhD, A Lafranconi MD, F Madotto PhD, 
Prof L G Mantovani DSc); MRC Lifecourse Epidemiology Unit, University 
of Southampton, Southampton, UK (Prof C Cooper FMedSci); Heart 
Institute, University of Sao Paulo, Sao Paulo, Brazil (A Costa Pereira PhD); 
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 
(E Cousin MS); University of California, San Diego, La Jolla, CA, USA 
(M H Criqui MD); Centre for International Health, Dunedin School of 
Medicine, University of Otago, Dunedin, New Zealand 
(Prof J A Crump MD); Flinders University, Adelaide, SA, Australia 
(A F Dadi MPH); Guy’s and St Thomas’ NHS Foundation Trust, London, 
UK (P I Dargan MBBS); Health Science Research Center, Addiction 
Institute (M Moosazadeh PhD), Molecular and Cell Biology Research 
Center, School of Medicine (M Fakhar PhD, Prof A Rafiei DVM), 
Toxoplasmosis Research Center (Prof A Daryani PhD), Mazandaran 
University of Medical Sciences, Sari, Iran (M Daryani MD, M Rezai MD); 
K G Medical University, Lucknow, India (S K Das MD); School of Public 
Health, Kazakh National Medical University, Almaty, Kazakhstan 
(K Davletov PhD); Monash University, Melbourne, VIC, Australia 
(Prof B de Courten PhD, R Ofori-Asenso MS); Monash Medical Center, 
Clayton, VIC, Australia (Prof B de Courten PhD); Griffith University, 
Brisbane, QLD, Australia (Prof D De Leo DSc, S K Tadakamadla PhD); 
Heidelberg Institute of Public Health, Heidelberg, Germany 
(Prof J De Neve MD); University of Colorado School of Medicine and the 
Colorado School of Public Health, Aurora, CO, USA (R P Dellavalle MD); 
College of Health Sciences & Referral Hospital (M T Shfare MS), Aksum 
University, Aksum, Ethiopia (G Demoz MS); Brighton and Sussex 
Medical School, Brighton, UK (K Deribe MPH); Mount Sinai Beth Israel, 
New York, NY, USA (Prof D C Des Jarlais PhD); Icahn School of Medicine 
at Mount Sinai, New York, NY, USA (Prof D C Des Jarlais PhD); 
Department of Community Medicine, Faculty of Medicine, University of 
Peradeniya, Peradeniya, Sri Lanka (S D Dharmaratne MD); Nepal Health 
Research Council, Government of Nepal, Kathmandu, Nepal 
(M Dhimal PhD); Undersecretary for Research & Technology 
(S Djalalinia PhD), Ministry of Health & Medical Education, Tehran, Iran 
(B Eshrati PhD, N Peykari PhD); University of Cape Coast, Cape Coast, 
Ghana (D T Doku PhD); University of Tampere, Tampere, Finland 
(D T Doku PhD); UNSW, Sydney, NSW, Australia (Prof K Dolan PhD); 
University of Rochester Medical Center, Rochester, NY, USA 
(E Dorsey MD); Universidade do Estado de Santa Catarina, Florianópolis, 
Brazil (Prof K P B dos Santos MA); RMIT University, Bundoora, VIC, 
Australia (Prof K E Doyle PhD); Sydney School of Public Health 
(T R Driscoll PhD), University of Sydney, Sydney, NSW, Australia 
(J Leigh PhD, M A Mohammed MS); Centre School of Public Health and 
Health Management (M M Santric Milicevic PhD), Institute of 
Microbiology and Immunology (E Dubljanin PhD), Institute of Social 
Medicine, Faculty of Medicine (M M Santric Milicevic), University of 
Belgrade, Belgrade, Serbia; Federal University of Rio Grande do Sul, Porto 
Alegre, Brazil (B B Duncan PhD, Prof M I Schmidt MD); University of 
North Carolina, Chapel Hill, NC, USA (B B Duncan PhD); Umea 
University, Umea, Sweden (Prof D Edvardsson PhD); University of 
Michigan, Ann Arbor, MI, USA (J R Ehrlich MD); Department of Global 
Health and Social Medicine (Z El-Khatib PhD), Program in Global 
Surgery and Social Change (B B Massenburg MD), Harvard Medical 
School, Kigali, Rwanda (Prof A Sheikh MD, M G Shrime MD); Arba 
Minch University, Arba Minch, Ethiopia (A Y Endries MPH, 
G Temam Shifa MPH); Arak University of Medical Sciences, Arak, Iran 
(B Eshrati PhD); Multiple Sclerosis Research Center, Tehran, Iran 
(S Eskandarieh PhD); Department of Health, Manila, Philippines 
(E A Faraon MD); Federal University of Sergipe, Aracaju, Brazil 
(Prof A Faro PhD); Doctor Evidence, Santa Monica, CA, USA 
(M S Fazeli MD, R Milam BS); National Institute for Stroke and Applied 
Neurosciences, Auckland University of Technology, Auckland, 
New Zealand (V L Feigin PhD); Institute Health, Faculty of Public Health, 
Department of Health, Behavior and Society (N Fentahun PhD), Jimma 
University, Jimma, Ethiopia (T T Gebrehiwot MPH, 
A T Gebremedhin MPH, A Workicho MPH); CBQF–Center for 
Biotechnology and Fine Chemistry–Associate Laboratory, Faculty of 
Articles
www.thelancet.com   Vol 391   June 2, 2018 2265
Biotechnology, Catholic University of Portugal, Porto, Portugal 
(J C Fernandes PhD); Heller Graduate School, Brandeis University, 
Waltham, MA, USA (D O Fijabi MBBS); Kaiser Permanente, Fontana, CA, 
USA (I Filip MD); School of Public Health, Bielefeld University, Bielefeld, 
Germany (F Fischer PhD); Fred Hutchinson Cancer Research Center, 
Seattle, WA, USA (C Fitzmaurice MD); Escola Nacional de Saúde Pública 
Sergio Arouca, Rio de Janeiro, Brazil (L S Flor MPH); Universidade 
Federal do Espírito Santo, Vitoria, Brazil (L S Flor MPH); Institute of 
Gerontology, Academy of Medical Science, Kyiv, Ukraine (N Foigt PhD); 
Department of Epidemiology and Public Health (T Fürst PhD), Swiss 
Tropical and Public Health Institute, Basel, Switzerland 
(C K Karema MSc); University of Basel, Basel, Switzerland (T Fürst PhD); 
National Center for Disease Control & Public Health, Tbilisi, Georgia 
(K Gambashidze MS, A Gamkrelidze PhD, K Kazanjan MS, 
M Kereselidze PhD, M Shakh-Nazarova MS, L Sturua PhD); Ludwig 
Maximilians University, Munich, Germany (A T Gebremedhin MPH); 
Division of Human Nutrition (J M Geleijnse PhD), Wageningen 
University, Wageningen, Netherlands; Department of Nutrition, Babol, 
Iran (R Ghadimi PhD); University Hospital of Dijon, Dijon, France 
(Prof M Giroud MD); Kersa Health and Demographic Surveillance 
System, Harar, Ethiopia (M Gishu MS); Jawaharlal Nehru University, 
New Delhi, India (S Goli PhD); University of Massachusetts Boston, 
Boston, MA, USA (Prof P N Gona PhD); Instituto de Investigaciones 
Cientificas y Servicios de Alta Tecnologia– INDICASAT-AIP, Ciudad del 
Saber, Panama (A Goodridge PhD); Department of Health and Social 
Affairs, Government of the Federated States of Micronesia, Palikir, 
Federated States of Micronesia (S V Gopalani MPH); Organisation for 
Economic Co-operation and Development, Paris, France 
(Y Goryakin PhD); Boston University School of Medicine, Boston, MA, 
USA (A Grada MD); University Hospital Policlinico “Vittorio Emanuele”, 
Catania, Italy (G Grosso PhD); NNEdPro Global Centre for Nutrition and 
Health, Cambridge, UK (G Grosso PhD); Departments of Microbiology 
and Epidemiology & Biostatistics, Saint James School of Medicine, 
The Quarter, Anguilla (Prof H C Gugnani PhD); West Virginia Bureau for 
Public Health, Charleston, WV, USA (R Gupta MD); Eternal Heart Care 
Centre and Research Institute, Jaipur, India (R Gupta PhD); Montefiore 
Medical Center, Bronx, NY, USA (T Gupta MD); Albert Einstein College of 
Medicine, Bronx, NY, USA (T Gupta, Prof H Hosgood PhD); Indian 
Institute of Technology Kanpur, Kanpur, India (Prof T Gupta DSc); 
Department of Anthropology (V Gupta PhD), University of Delhi, Delhi, 
India; Department of Public Health (S Polinder PhD), Erasmus MC, 
University Medical Center Rotterdam, Rotterdam, Netherlands 
(J A Haagsma PhD); Department of Clinical Neurological Sciences 
(L A Sposato MD), Western University, London, ON, Canada 
(Prof V Hachinski DSc, T O Olagunju MD); Kilte Awlaelo Health and 
Demographic Surveillance System, Mekelle, Ethiopia (G B Hailu MSc); 
Arabian Gulf University, Manama, Bahrain (Prof R R Hamadeh DPhil); 
Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates 
(S Hamidi DrPH); School of Medicine and Pharmacology 
(Prof G J Hankey MD), University of Western Australia, Perth, WA, 
Australia (A Sahebkar PhD); Harry Perkins Institute of Medical Research, 
Nedlands, WA, Australia (Prof G J Hankey MD); Western Australian 
Neuroscience Research Institute, Nedlands, WA, Australia 
(Prof G J Hankey MD); Eunice Gibson Polyclinic, Bridgetown, Barbados 
(H C Harewood MPH); Sree Chitra Tirunal Institute for Medical 
Sciences and Technology, Trivandrum, India (S Harikrishnan DM); 
Research and Development Unit (A Koyanagi MD), Parc Sanitari 
Sant Joan de Déu–CIBERSAM, Barcelona, Spain (J Haro MD); Child 
Neuropsychology (S J C Hearps PGDipBiostat), Murdoch Childrens 
Research Hospital, Parkville, VIC, Australia; Faculty of Health, 
Hormozgan University of Medical Sciences, Bandar Abbas, Iran 
(M Heidari PhD); School of Public Health (D Hendrie PhD), School of 
Public Health (T R Miller PhD), Curtin University, Perth, WA, Australia; 
Gorgas Memorial Institute for Studies of Health, Panama, Panama 
(Prof V H Herrera Ballesteros MS); University of Panama, Panama, 
Panama (Prof V H Herrera Ballesteros MS); Department of Statistics and 
Econometrics (Prof C Herteliu PhD), Bucharest University of Economic 
Studies, Bucharest, Romania (B V Ileanu PhD, Prof A Mirica PhD, 
A Pana MPH); Samara University, Samara, Ethiopia (M K Hiluf MPH, 
M L Liben MPH); Department of Epidemiology, Mailman School of 
Public Health (Prof H W Hoek MD), Columbia University, New York, NY, 
USA (Prof V Skirbekk PhD); Guilan Road Trauma Research Center, 
Guilan University of Medical Sciences, Rasht, Iran (E Homaie Rad PhD); 
Department of Pulmonology (N Horita MD), Yokohama City University 
Graduate School of Medicine, Yokohama, Japan; Public Health Division 
(D G Hoy PhD), The Pacific Community, Noumea, New Caledonia; 
Department of Epidemiology (Prof M Hsairi MD), Salah Azaiz Institute, 
Tunis, Tunisia; Department of Epidemiology and Health Statistics, School 
of Public Health (G Hu PhD), Central South University, Changsha, China; 
National Centre for Register-Based Research, Aarhus School of Business 
and Social Sciences (Prof J J McGrath PhD), Aarhus University, Aarhus, 
Denmark (K M Iburg PhD); Sriwijaya University, Palembang, Indonesia 
(Prof F Idris PhD); Social Security Administering Body for Health, 
Jakarta, Indonesia (Prof F Idris PhD); US Centers for Disease Control and 
Prevention, Pretoria, South Africa (Prof E U Igumbor PhD); School of 
Public Health, University of the Western Cape, Cape Town, Western Cape, 
South Africa (Prof E U Igumbor PhD); National Public Health Institute, 
Monrovia, Liberia (O S Ilesanmi MD); National Institute for Health 
Development, Tallinn, Estonia (K Innos PhD); Prevention of Metabolic 
Disorders Research Center, Research Institute for Endocrine Sciences, 
Tehran, Iran (S N Irvani MD); Ophthalmic Research Center 
(M Yaseri PhD), School of Public Health (N Jahanmehr PhD), Shahid 
Beheshti University of Medical Sciences, Tehran, Tehran, Iran 
(S N Irvani MD, A Khajavi MS); Surveillance and Health Services 
Research, American Cancer Society, Atlanta, GA, USA (F Islami PhD); 
MCH Division, USAID—Global Health Bureau, HIDN, Washington, DC, 
USA (T A Jacobs MD); Department of Global and Community Health 
(K H Jacobsen PhD), George Mason University, Fairfax, Virginia, USA; 
Jain hospital MSS, Kanpur, India (R Jain MD); National Centre For 
Disease Control Delhi, Delhi, India (S K Jain MD); Faculty of Medical 
Sciences, University of Kragujevac, Kragujevac, Serbia 
(Prof M M Jakovljevic PhD); University of Aberdeen, Aberdeen, UK 
(M Javanbakht PhD); Postgraduate Institute of Medicine, Colombo, 
Sri Lanka (A U Jayatilleke PhD); Institute of Violence and Injury 
Prevention, Colombo, Western, Sri Lanka (A U Jayatilleke PhD); Centre for 
Chronic Disease Control, New Delhi, India (P Jeemon PhD); Banaras 
Hindu University, Varanasi, India (R P Jha MSc); The George Institute for 
Global Health, New Delhi, India (Prof V Jha DM, O John MD, S Shariful 
Islam PhD); Institute of Health and Nutrition Sciences, Czestochowa 
University of Technology, Czestochowa, Poland (Prof J Józwiak PhD); 
Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-
Karls-University Heidelberg, Mannheim, Germany (Prof J B Jonas MD); 
National Institute of Epidemiology (V Joshua PhD), Indian Council of 
Medical Research, Chennai, India (M Sharma PhD); Institute of Family 
Medicine and Public Health, University of Tartu, Tartu, Estonia (M 
Jürisson MD); University College Cork, Cork, Ireland (Z Kabir PhD); 
London School of Economics and Political Science, London, UK 
(R Kadel MPH); SCB Medical College, Cuttack, India (Prof C Kar DM); 
European Observatory on Health Systems and Policies, London, UK 
(M Karanikolos MPH); Epidemiological and Statistical Methods Research 
Group, Helmholtz Centre for Infection Research, Braunschweig, 
Germany (A Karch MD); Hannover-Braunschweig Site, German Center 
for Infection Research, Braunschweig, Germany (A Karch); Quality and 
Equity Health Care, Kigali, Rwanda (C K Karema MSc); University of 
Washington Tacoma, Tacoma, WA, USA (S M Karimi PhD); Department 
of Anesthesiology & Pain Medicine, Seattle Children’s Hospital, Seattle, 
WA, USA (N J Kassebaum MD); MRC/CSO Social & Public Health 
Sciences Unit, University of Glasgow, Glasgow, UK (S V Katikireddi PhD); 
Oklahoma State University, Tulsa, OK, USA (A Kaul MD); School of 
Public Health, University of Tokyo, Tokyo, Japan (Prof N Kawakami MD); 
Institute of Tropical and Infectious Diseases, Nairobi, Kenya (P N Keiyoro 
PhD); School of Continuing and Distance Education, Nairobi, Kenya 
(P N Keiyoro PhD); UKZN Gastrointestinal Cancer Research Centre 
(Prof B Sartorius PhD), South African Medical Research Council, Cape 
Town, South Africa (A P Kengne PhD, Prof A E Schutte PhD); 
Department of Psychiatry (Prof D J Stein PhD), Faculty of Health 
Sciences, Hatter Institute for Cardiovascular Research in Africa 
(Prof K Sliwa PhD), University of Cape Town, Cape Town, Western Cape, 
South Africa (A P Kengne PhD, J N Noubiap MD); Ahvaz Jundishapur 
University of Medical Sciences, Ahvaz, Iran (M A Khafaie PhD); Health 
Services Academy, Islamabad, Pakistan (E A Khan MD); Department of 
Microbiology and Immunology, College of Medicine & Health Sciences 
Articles
2266 www.thelancet.com   Vol 391   June 2, 2018
(G Khan PhD), United Arab Emirates University, Al Ain, United Arab 
Emirates; The University of Newcastle, Australia, Newcastle, NSW, 
Australia (M N Khan MS); Jatiya Kabi Kazi Nazrul Islam University, 
Mymensingh, Bangladesh (M N Khan MS); University of Tennessee 
Health Science Center, Memphis, TN, USA (M Khan MD); Department of 
Health Services, Health Management Information System, Kathmandu, 
Nepal (M N Khanal MA); Institute of Health Policy and Management, 
Seoul National University Medical Center, Seoul, South Korea 
(Prof Y Khang MD); Department of Public Health and Department of 
Family Medicine, College of Medicine, Mohammed Ibn Saudi University, 
Riyadh, Saudi Arabia (A T A Khoja MD); Iranian Ministry of Health and 
Medical Education, Tehran, Iran (A Khosravi PhD); Department of 
Nutrition and Health Science, Ball State University, Muncie, IN, USA 
(J Khubchandani PhD); Kenya Revenue Authority, Nairobi, Kenya 
(D N Kiirithio MSc); Synotech Consultants, Nairobi, Kenya 
(D N Kiirithio MSc); Department of Health Sciences, Northeastern 
University, Boston, MA, USA (Prof D Kim DrPH); School of Medicine, 
Xiamen University Malaysia Campus, Sepang, Malaysia (Y Kim PhD); 
Simmons College, Boston, MA, USA (R W Kimokoti MD); Centre for 
Research and Action in Public Health, University of Canberra, Canberra, 
ACT, Australia (Y Kinfu PhD); Oslo University, Oslo, Norway 
(Prof A Kisa PhD); School of Population and Public Health, Faculty of 
Medicine (Prof N Sarrafzadegan MD), University of British Columbia, 
Vancouver, BC, Canada (Prof N Kissoon MD, J A Kopec PhD, S Murthy 
MD, F Pourmalek PhD); Global Healthcare Consulting, New Delhi, India 
(S Kochhar MD); Department of Preventive Cardiology, National Cerebral 
and Cardiovascular Center, Suita, Japan (Y Kokubo PhD); Center for 
Community Empowerment, Health Policy and Humanities, National 
Institute of Health Research & Development, Jakarta, Indonesia 
(S Kosen MD); Sher-i-Kashmir Institute of Medical Sciences, Srinagar, 
India (Prof P A Koul MD); Research Center of Neurology, Moscow, Russia 
(M Kravchenko PhD, Prof M A Piradov DSc); Panjab University, 
Chandigarh, India (K Krishan PhD); Department of Demography and 
Public Health Research Institute and Department of Social and Preventive 
Medicine, School of Public Health, University of Montreal, Montreal, QC, 
Canada (Prof B Kuate Defo PhD); State Institution “Public Health Center” 
of the Ministry of Health of Ukraine, Kyiv, Ukraine (I Kuzin MPH); 
Center for Translation Research and Implementation Science, National 
Heart, Lung, and Blood Institute (G A Mensah MD), Institute of Health 
Policy and Development Studies (Prof H Lam PhD), National Institutes of 
Health, Manila, Philippines; National Cancer Institute, Rockville, MD, 
USA (Q Lan PhD); Children’s Hospital of Eastern Ontario Research 
Institute, Ottawa, ON, Canada (J J Lang PhD); Help Me See, Inc, New 
York, NY, USA (V C Lansingh PhD); Instituo Mexicano de Oftalmologia, 
Queretaro, Mexico (V C Lansingh); School of Medicine Federal University 
of Minas Gerais, Belo Horizonte, Brazil (S Lansky PhD); Secretaria 
Municipal de Saúde, Belo Horizonte, Brazil (S Lansky PhD); Department 
of Medical Sciences (Prof A Larsson PhD), Uppsala University, Uppsala, 
Sweden; Managerial Epidemiology Research Center, Department of 
Public Health, School of Nursing and Midwifery (S Safiri PhD), Maragheh 
University of Medical Sciences, Maragheh, Iran (A Latifi PhD); ISGlobal, 
Hospital Clinic (Prof J V Lazarus PhD), University of Barcelona, 
Barcelona, Spain; CHIP, Rigshospitalet (Prof J V Lazarus), Department of 
Neurology, Rigshospitalet (T Truelsen DMSc), University of Copenhagen, 
Copenhagen, Denmark; College of Optometry (J L Leasher OD), Nova 
Southeastern University, Fort Lauderdale, Florida, USA; Hong Kong 
Polytechnic University, Hong Kong, China (P H Lee PhD); State 
University of New York, Albany, Rensselaer, NY, USA (R Leung PhD); 
Tuscany Regional Centre for Occupational Injuries and Diseases, 
Florence, Italy (M Levi PhD); San Francisco VA Medical Center, 
San Francisco, CA, USA (Y Li PhD); National Office for Maternal and 
Child Health Surveillance, West China Second University Hospital 
(Prof J Liang MD), Sichuan University, Chengdu, China; University of 
Malaya, Kuala Lumpur, Malaysia (L Lim MD); The Chinese University of 
Hong Kong, Shatin, China (L Lim MD); University of Haifa, Haifa, Israel 
(Prof S Linn MD); Radboud University Medical Center, Nijmegen, 
Netherlands (Prof S Listl PhD); National Center for Chronic and 
Noncommunicable Disease Control and Prevention (S Liu PhD, 
P Yin PhD, Prof M Zhou PhD), Chinese Center for Disease Control and 
Prevention, Beijing, China; All India Institute of Medical Sciences, 
New Delhi, India (R Lodha MD, Prof R Malhotra MS, N Naik DM, 
A Roy DM, R Sagar MD, Prof N Tandon PhD); Children’s Hospital of 
Philadelphia (S A Lorch MD), The Children’s Hospital of Philadelphia, 
University of Pennsylvania School of Medicine, Philadelphia, PA, USA; 
Institute of Nutrition (Prof S Lorkowski PhD), Friedrich Schiller 
University Jena, Jena, Germany; Competence Cluster for Nutrition and 
Cardiovascular Health (nutriCARD) Halle-Jena-Leipzig, Jena, Germany 
(Prof S Lorkowski PhD); Aintree University Hospital National Health 
Service Foundation Trust, Liverpool, UK (Prof R Lunevicius PhD); School 
of Medicine (Prof R Lunevicius PhD), University of Liverpool, Liverpool, 
UK; Farr Institute (Prof R A Lyons MD), Swansea University, Swansea, 
UK; Center for Research on Population and Health, Faculty of Health 
Sciences (Prof C M Obermeyer DSc), Department of Psychiatry 
(F Maalouf MD), American University of Beirut, Beirut, Lebanon; Royal 
Children’s Hospital Melbourne, Melbourne, VIC, Australia 
(M T Mackay PhD); Mansoura Faculty of Medicine, Mansoura, Egypt 
(H Magdy Abd El Razek MBBCH); Aswan University Hospital 
(M Magdy Abd El Razek MBBCH), Aswan Faculty of Medicine, Aswan, 
Egypt; Faculty of Health Sciences and Social Work, Department of Public 
Health (M Majdan PhD), Trnava University, Trnava, Slovakia; National 
Institute of Health Research, Tehran, Iran (Prof R Majdzadeh PhD); 
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil 
(Prof D C Malta PhD); Ethiopian Public Health Association, Addis Ababa, 
Ethiopia (T Manyazewal PhD); Hospital Universitario Doctor Peset, 
Valencia, Spain (J Martinez-Raga PhD, M Tortajada PhD); CEU Cardinal 
Herrera University, Moncada, Spain (J Martinez-Raga PhD); Hospital de 
Clinicas de Porto Alegre, Porto Alegre, Brazil (Prof S C O Martins PhD); 
Hospital Moinhos de Vento, Porto Alegre, Brazil (Prof S C O Martins 
PhD); Federal Institute of Education, Science and Technology of Ceará, 
Caucaia, Brazil (F R Martins-Melo PhD); Synlab Academy, Mannheim, 
Germany (Prof W März MD); Clinical Institute of Medical and Chemical 
Laboratory Diagnostics, (Prof W März MD), Medical University of Graz, 
Graz, Austria; George Institute for Global Health India, New Delhi, India 
(P K Maulik PhD); George Institute for Global Health, Oxford University, 
Oxford, UK (P K Maulik PhD); Department of Biology and Biological 
Engineering, Food and Nutrition Science (M Mazidi PhD), Chalmers 
University of Technology, Gothenburg, Sweden; University Hospitals 
Bristol NHS Foundation Trust, Bristol, UK (C McAlinden PhD); Public 
Health Wales, Swansea, UK (C McAlinden PhD); Queensland Centre for 
Mental Health Research (Prof J J McGrath PhD), The Park Centre for 
Mental Health, Wacol, QLD, Australia; Ipas Nepal, Kathmandu, Nepal 
(S Mehata PhD); National Institute of Cancer Prevention & Research, 
Noida, India (Prof R Mehrotra DPhil); University of California, 
San Francisco, San Francisco, California, USA (K M Mehta DSc); MGM 
Medical College, Navi Mumbai, India (V Mehta MBBS); Competence 
Cluster for Nutrition and Cardiovascular Health (nutriCARD) 
(T Meier PhD), Institut für Medizinische Epidemiologie, Biometrie und 
Informatik (I Shiue PhD), Martin-Luther-Universität Halle-Wittenberg, 
Saale, Germany; University of West Florida, Pensacola, FL, USA 
(P Memiah PhD); Saudi Ministry of Health, Riyadh, Saudi Arabia 
(Prof Z A Memish MD); College of Medicine (Prof Z A Memish MD), 
Alfaisal University, Riyadh, Saudi Arabia; United Nations Population 
Fund, Lima, Peru (W Mendoza MD); Comprehensive Cancer Center, 
Breast Surgery Unit (T J Meretoja PhD), Department of Neurology 
(A Meretoja PhD), Helsinki University Hospital, Helsinki, Finland; 
Finnish Institute of Occupational Health, Work Organizations, Work 
Disability Program, Department of Public Health, Faculty of Medicine 
(R Shiri PhD), University of Helsinki, Helsinki, Finland 
(T J Meretoja PhD); Pomeranian Medical University, Szczecin, Poland 
(Prof T Miazgowski PhD); Friedman School of Nutrition Science and 
Policy (R Micha PhD), Tufts University, Boston, Massachusetts, USA 
(P Shi PhD); Pacific Institute for Research & Evaluation, Calverton, MD, 
USA (T R Miller PhD); Sree Chitra Tirunal Institute for Medical Sciences 
and Technology, Trivandrum, Thiruvananthapuram, India (G Mini PhD, 
Prof P Sylaja DM); Amrita Institute of Medical Sciences, Kochi, India 
(G Mini PhD); Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan 
(Prof E M Mirrakhimov PhD); National Center of Cardiology and Internal 
Disease, Bishkek, Kyrgyzstan (Prof E M Mirrakhimov PhD); Brien Holden 
Vision Institute (Prof S Resnikoff MD), School of Optometry and Vision 
Science (Prof S Resnikoff MD), University of New South Wales, 
Kensington, NSW, Australia (Prof P B Mitchell MD, 
Prof P S Sachdev MD); Department of Ophthalmology, Medical Faculty 
Articles
www.thelancet.com   Vol 391   June 2, 2018 2267
Mannheim (S Panda-Jonas MD), Institute of Public Health 
(B Moazen MS), University of Heidelberg, Heidelberg, Germany; 
Salahaddin University, Erbil, Iraq (K A Mohammad PhD); Ishik 
University, Erbil, Iraq (K A Mohammad PhD); Hamedan University of 
Medical Sciences, Hamedan, Iran (R Mohammadibakhsh PhD); Jigjiga 
University, Jigjiga, Ethiopia (M A Mohammed MS); Health Systems and 
Policy Research Unit (S Mohammed PhD), Ahmadu Bello University, 
Zaria, Nigeria (M B Sufiyan MBA); Reproductive Health and ObGyn 
School of Medicine and Health Sciences (Prof G L D Mola DPH), 
University of Papua New Guinea, Boroko, Papua New Guinea; Institute 
for Maternal and Child Health, IRCCS “Burlo Garofolo”, Trieste, Italy 
(L Monasta DSc, L Ronfani PhD); Lancaster Medical School 
(P Moraga PhD), Lancaster University, Lancaster, UK; International 
Laboratory for Air Quality and Health (L Morawska PhD), Queensland 
University of Technology, Brisbane, QLD, Australia (Q G To MS); Gorgas 
Memorial Institute for Health Studies, Panama City, Panama 
(I Moreno Velasquez PhD); National Center for Child Health and 
Development, Setagaya, Japan (R Mori PhD, C Nagata PhD, 
R Tobe-Gai PhD); Competence Center Mortality-Follow-Up of the German 
National Cohort (A Werdecker PhD), Federal Institute for Population 
Research, Wiesbaden, Germany (Prof U O Mueller PhD, R Westerman 
PhD); ICMR-National Institute of Epidemiology, Chennai, India 
(M Murhekar MD); London School of Hygiene and Tropical Medicine, 
London, UK (Prof G V S Murthy MD); University of Jos, Jos, Nigeria 
(J Musa MD); Jos University Teaching Hospital, Jos, Nigeria (J Musa MD); 
School of Medical Sciences (K Musa MD), University of Science Malaysia, 
Kubang Kerian, Malaysia; Helping Hands Foundation, Multan, Pakistan 
(Prof G Mustafa MD); Nishtar Medical University, Multan, Pakistan 
(Prof G Mustafa MD); Institute of Epidemiology and Medical Biometry 
(Prof D Rothenbacher MD), Ulm University, Ulm, Germany 
(Prof G Nagel PhD); International Centre for Diarrhoeal Disease 
Research, Bangladesh (icddr,b), Dhaka, Bangladesh (A Naheed PhD, 
A R Sarker MS, S Zaman MPH); Research Center for Environmental 
Determinants of Health, School of Public Health (S Rezaei PhD), 
Kermanshah University of Medical Sciences, Kermanshah, Iran 
(F Najafi PhD, S Siabani PhD, M Soofi PhD); Azienda Ospedaliera Papa 
Giovanni XXIII, Bergamo, Italy (Prof L Naldi MD); Suraj Eye Institute, 
Nagpur, India (V Nangia MD); Department of Public Health, Faculty of 
Medicine and Biomedical Sciences, University of Yaoundé, Yaoundé, 
Cameroon (J N Nansseu MD); Department for the Control of Disease, 
Epidemics and Pandemics, Ministry of Public Health, Yaoundé, 
Cameroon (J N Nansseu MD); Hospital das Clínicas da Universidade 
Federal de Minas Gerais, Belo Horizonte, Brazil (Prof B R Nascimento 
PhD, Prof A L Ribeiro MD); Hospital Universitário Ciências Médicas, 
Belo Horizonte, Brazil (Prof B R Nascimento PhD); KEMRI-Wellcome 
Trust, Kilifi, Kenya (Prof C R Newton MD); University of Nairobi, Nairobi, 
Kenya (J W Ngunjiri PhD); Institute for Global Health Innovations, Duy 
Tan University, Da Nang, Vietnam (T H Nguyen MSc, V M Nong MSc); 
Department of Public Health, Semarang State University, Semarang City, 
Indonesia (D N A Ningrum MPH); Graduate Institute of Biomedical 
Informatics, Taipei Medical University, Taipei City, Taiwan 
(D N A Ningrum MPH); University of Bergen, Bergen, Norway 
(Prof O F Norheim PhD); Medical Diagnostic Centre, Yaounde, Cameroon 
(J N Noubiap MD); Rwanda Ministry of Health, Kigali, Rwanda 
(A Nyandwi MPH); Centre for Health Research (F A Ogbo MPH), 
Western Sydney University, Sydney, NSW, Australia 
(Prof A M N Renzaho PhD); Department of Preventive Medicine, School 
of Medicine, Kyung Hee University, Seoul, South Korea (Prof I Oh PhD); 
Human Sciences Research Council, South Africa and University of 
KwaZulu-Natal, Durban, South Africa (O Oladimeji MS); Department of 
Psychiatry, Lagos University Teaching Hospital, Lagos, Nigeria 
(A T Olagunju MD); Universidad Autonoma de Chile, Talca, Chile 
(Prof P R Olivares PhD); Center for Healthy Start Initiative, Lagos, Nigeria 
(B O Olusanya PhD, J O Olusanya MBA); Lira District Local Government, 
Lira Municipal Council, Uganda (J Opio MPH); Division of Epidemiology 
& Biostatistics, Graduate School of Public Health (Prof E Oren PhD), 
San Diego State University, San Diego, CA, USA; IIS-Fundacion Jimenez 
Diaz-UAM, Madrid, Spain (Prof A Ortiz PhD); Karabuk University, 
Karabuk, Turkey (R Ozdemir PhD); JSS Medical College, JSS University, 
Mysore, India (Prof M PA DNB); Christian Medical College Ludhiana, 
Ludhiana, India (J D Pandian DM); Department of Medical Humanities 
and Social Medicine, College of Medicine, Kosin University, Busan, South 
Korea (E Park PhD); White Plains Hospital, White Plains, NY, USA 
(T Patel MD); Krishan Institute of Medical Sciences, Deemed University, 
School of Dental Sciences, Karad, India (S T Patil MDS); National Health 
System Resource Center, Ministry of Health & Family Welfare, New Delhi, 
India (A Patle MPH); Clinical Research, Diabetes Research Society, 
Hyderabad, India (V R Paturi MD); DiabetOmics, Portland, OR, USA 
(V R Paturi MD); UK Department for International Development, 
Lalitpur, Nepal (D Paudel PhD); Instituto de Comunicação e Informação 
Científica e Tecnológica em Saúde da Fundação Oswaldo Cruz, Rio de 
Janeiro, Brazil (M d Pedroso PhD); REQUIMTE/LAQV, Laboratório de 
Farmacognosia, Departamento de Química, Faculdade de Farmácia, 
Universidade do Porto, Porto, Portugal (Prof D M Pereira PhD); Health 
Metrics Unit, University of Gothenburg, Gothenburg, Sweden 
(Prof M Petzold PhD); University of the Witwatersrand, Johannesburg, 
South Africa (Prof M Petzold PhD); Shanghai Jiao Tong University School 
of Medicine, Shanghai, China (Prof M R Phillips MD); Durban University 
of Technology, Durban, South Africa (J D Pillay PhD); University of 
Newcastle, Callaghan, NSW, Australia (Prof C D Pond PhD); University 
Medical Center Groningen, Groningen, Netherlands 
(Prof M J Postma PhD); Sanjay Gandhi Postgraduate Institute of Medical 
Sciences, Lucknow, India (S Prakash PhD); Charotar University of Science 
and Technology, Anand, India (Prof V Prakash MPT); Sanjay Gandhi Post 
Graduate Institute of Medical Sciences, Lucknow, India 
(Prof N Prasad MD); The Fred Hollows Foundation, Melbourne, VIC, 
Australia (N M Prasad); Non-communicable Diseases Research Center, 
Alborz University of Medical Sciences, Karaj, Iran (M Qorbani PhD); 
Commemorative Gorgas Institute for Health Studies, Panama, Panama 
(H K Quintana PhD); A T Still University, Kirksville, MO, USA 
(A Radfar MD); Contech International Health Consultants, Lahore, 
Pakistan (A Rafay MS, Prof S M Rana PhD); Contech School of Public 
Health, Lahore, Pakistan (A Rafay, Prof S M Rana); Research and 
Evaluation Division, BRAC, Dhaka, Bangladesh (M Rahman PhD); Sweidi 
Hospital, Riyadh, Saudi Arabia (S U Rahman FCPS); Society for Health 
and Demographic Surveillance, Suri, India (R Rai MPH); Nizam’s 
Institute of Medical Sciences, Hyderabad, India (Prof S Raju DM); 
Instituto Gonçalo Muniz, Fundação Oswaldo Cruz, Salvador, Brazil 
(Prof D Rasella PhD); North Hampshire Hospitals, Basingstroke, UK 
(D L Rawaf MD); University College London Hospitals, London, UK 
(D L Rawaf); Human Sciences Research Council, Cape Town, South 
Africa (P Reddy PhD); Loma Linda University Medical Center, Loma 
Linda, CA, USA (C Reis MD); Azienda Socio-Sanitaria Territoriale, Papa 
Giovanni XXIII, Bergamo, Italy (Prof G Remuzzi MD); Department of 
Biomedical and Clinical Sciences “L Sacco”, University of Milan, Milan, 
Italy (Prof G Remuzzi MD); Federal University of Uberlândia, Uberlandia, 
Brazil (L Roever MPH); Golestan Research Center of Gastroenterology 
and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran 
(G Roshandel PhD); BARC Hospital, HBNI University, Mumbai, India 
(N Roy MD); Muhimbili University of Health and Allied Sciences, Dar es 
Salaam, Tanzania (G M Ruhago PhD, B F Sunguya PhD); National 
Institute for Research in Environmental Health, Bhopal, India 
(Prof Y D Sabde MD); Prince of Wales Hospital, Randwick, NSW, 
Australia (Prof P S Sachdev MD); Mashhad University of Medical 
Sciences, Mashhad, Iran (A Sahebkar PhD); Fiocruz, Rio de Janeiro, 
Brazil (R d Saldanha MS); Faculty of Science, Ain Shams University, 
Cairo, Egypt (A M Samy PhD); Department of Public Health 
(M Sawhney PhD), J Edwards School of Medicine (J R Sanabria MD), 
Marshall University, Huntington, WV, USA; Case Western Reserve 
University, Cleveland, OH, USA (J R Sanabria MD); Sancheti Institute for 
Orthopaedics & Rehabilitation, Pune, India (P K Sancheti MS); 
IIS-Fundacion Jimenez Diaz, Madrid, Spain (M Sanchez-Niño PhD); 
Queensland Centre for Mental Health Research, Brisbane, QLD, Australia 
(D Santomauro, Prof H A Whiteford PhD); Isfahan Cardiovascular 
Research Institute, Isfahan, Iran (Prof N Sarrafzadegan MD); Public 
Health Medicine, School of Nursing and Public Health (Prof B Sartorius 
PhD), University of KwaZulu-Natal, Durban, South Africa; Centre of 
Advanced Study in Psychology, Utkal University, Bhubaneswar, India 
(M Satpathy PhD); Center for Disease Burden (Prof S Vollset DrPH), 
Norwegian Institute of Public Health, Oslo, Norway (M Savic PhD, 
Prof V Skirbekk PhD); Bayer Turkey, Istanbul, Turkey (M I Saylan PhD); 
Global Perspective Studies Unit (J Schmidhuber PhD), Food and 
Articles
2268 www.thelancet.com   Vol 391   June 2, 2018
Agriculture Organization, Rome, Italy; Federal University of Santa 
Catarina, Florianópolis, Brazil (I J C Schneider PhD, D A S Silva PhD); 
Hypertension in Africa Research Team, North-West University, 
Potchefstroom, South Africa (Prof A E Schutte PhD); Croatian National 
Cancer Registry, Croatian Institute of Public Health, Zagreb, Croatia 
(M Sekerija PhD); School of Public Health Dr Andrija Å tampar, 
University of Zagreb School of Medicine, Zagreb, Croatia (M Sekerija 
PhD); Department of Rehabilitation Medicine (A Shafieesabet MD), 
New York University Langone Medical Center, New York, NY, USA; 
Middle East Liver Disease Center, Tehran, Iran (H Sharafi PhD); Institute 
for Physical Activity and Nutrition (S Shariful Islam PhD), Deakin 
University, Burwood, VIC, Australia (Prof M A Stokes PhD); University 
School of Management and Entrepreneurship, Delhi Technological 
University, Delhi, India (R Sharma MA); Department of Pulmonary 
Medicine, Zhongshan Hospital, Fudan University, Shanghai, China 
(J She MD); National Institute of Infectious Diseases, Tokyo, Japan 
(M Shigematsu PhD); Tachikawa Hospital, Tokyo, Japan 
(Y Shinohara PhD); Alzheimer Scotland Dementia Research Centre 
(I Shiue PhD), University of Edinburgh, Edinburgh, UK 
(Prof A Sheikh MD, I N Soyiri PhD); Symbiosis Institute of Health 
Sciences, Symbiosis International University, Pune, India 
(Prof S R Shukla PhD); Diabetes Unit, KEM Hospital Research Centre, 
Pune, India (Prof S R Shukla); University of Technology Sydney, Sydney, 
NSW, Australia (S Siabani PhD); Reykjavik University, Reykjavik, Iceland 
(I D Sigfusdottir PhD); University of Pennsylvania, Philadelphia, PA, USA 
(D H Silberberg MD, J Weiss MA); Brasília University, Brasília, Brazil 
(D G A Silveira MD); Max Hospital, Ghaziabad, India 
(Prof N P Singh MD); Asthma Bhawan, Jaipur, India (V Singh MD); 
School of Preventive Oncology, Patna, India (D N Sinha PhD); WHO 
FCTC Global Knowledge Hub on Smokeless Tobacco, National Institute 
of Cancer Prevention, Noida, India (D N Sinha PhD); Ethiopian Medical 
Association, Addis Ababa, Ethiopia (A H Sinke MD); King Khalid 
University Hospital, Riyadh, Saudi Arabia (B H A Sobaih MD); Tunisian 
Center for Public Health, Les Berges du Lac, Tunisia (M Somai MD); 
Dartmouth College, Hanover, New Hampshire, USA (S Soneji PhD); 
Instituto de Investigación Hospital Universitario de la Princesa (IISP), 
Madrid, Spain (Prof J B Soriano MD); Universidad Autónoma de Madrid, 
Madrid, Spain (Prof J B Soriano); Department of Community Medicine 
(C T Sreeramareddy MD), International Medical University, Kuala 
Lumpur, Malaysia; Attikon University Hospital, Athens, Greece 
(V Stathopoulou PhD); University of East Anglia, Norwich, UK 
(Prof N Steel PhD); Public Health England, London, UK (Prof N Steel); 
South African Medical Research Council Unit on Anxiety & Stress 
Disorders, Cape Town, Western Cape, South Africa (Prof D J Stein PhD); 
Ministry of Health, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia 
(R A Suliankatchi MD); Departments of Criminology, Law & Society, 
Sociology, and Public Health, University of California, Irvine, Irvine, CA, 
USA (Prof B L Sykes PhD); Mizan-Tepi University, Mizan-Teferi, Ethiopia 
(A H Tadesse MPH); Instituto Superior de Ciências da Saúde Egas Moniz, 
Almada, Portugal (Prof N Taveira PhD); Faculty of Pharmacy, 
Universidade de Lisboa, Lisboa, Portugal (Prof N Taveira PhD); 
Department of Anesthesiology, University of Virginia, Charlottesville, VA, 
USA (A S Terkawi MD); Department of Anesthesiology, King Fahad 
Medical City, Riyadh, Saudi Arabia (A S Terkawi MD); Outcomes Research 
Consortium, Cleveland Clinic, Cleveland, OH, USA (A S Terkawi); 
University of Calgary, Calgary, AB, Canada (Prof M Tonelli MD); Institute 
of Public Health, Faculty of Health Sciences, Jagiellonian University 
Medical College, Kraków, Poland (R Topor-Madry PhD); Faculty of Health 
Sciences, Wroclaw Medical University, Wroclaw, Poland 
(R Topor-Madry PhD); Aristotle University of Thessaloniki, Thessaloniki, 
Greece (Prof F Topouzis PhD); School of Medicine), University of 
Valencia, Valencia, Spain (M Tortajada PhD; Hanoi Medical University, 
Hanoi, Vietnam (B X Tran PhD); Auckland Cancer Society Research 
Centre, University of Auckland, Auckland, New Zealand (K B Tran MD); 
University of Louisville School of Medicine, Louisville, KY, USA 
(A Tripathi PhD); National Institute for Research in Tuberculosis, 
Chennai, India (S P Tripathy MD); Parc Sanitari Sant Joan de Déu, 
Fundació Sant Joan de Déu, Universitat de Barcelona, CIBERSAM, 
Barcelona, Spain (S Tyrovolas PhD); Department of Veterans Affairs, 
Washington, DC, USA (U S Uchendu MD); Department of Internal 
Medicine (K N Ukwaja MD), Federal Teaching Hospital, Abakaliki, 
Nigeria; Gomal Centre of Biochemistry and Biotechnology, Gomal 
University, Dera Ismail Khan, Pakistan (Prof I Ullah PhD); Programmatic 
Management of Drug Resistant TB Unit, TB Culture Laboratory, Mufti 
Mehmood Memorial Teaching Hospital, Dera Ismail Khan, Pakistan 
(Prof I Ullah PhD); Warwick Medical School, University of Warwick, 
Coventry, UK (Prof P S Gill DM, O A Uthman PhD); University of 
Nigeria, Nsukka, Enugu Campus, Enugu, Nigeria (Prof B S C Uzochukwu 
MD); Sociedad Argentina de Medicina, Ciudad Autónoma de Buenos 
Aires, Argentina (Prof P R Valdez PhD); Hospital Vélez Sarsfield, Ciudad 
Autónoma de Buenos Aires, Argentina (Prof P R Valdez PhD); UKK 
Institute for Health Promotion Research, Tampere, Finland 
(Prof T Vasankari PhD); Raffles Neuroscience Centre, Raffles Hospital, 
Singapore, Singapore (N Venketasubramanian MBBS); University of 
Bologna, Bologna, Italy (Prof F S Violante MD); Federal Research Institute 
for Health Organization and Informatics, Moscow, Russia 
(S K Vladimirov PhD); National Research University Higher School of 
Economics, Moscow, Russia (Prof V V Vlassov MD); Foundation 
University, Islamabad, Pakistan (Y Waheed PhD); VA Medical Center, 
Washington, DC, USA (M T Wallin MD); Neurology Department, 
Georgetown University, Washington, DC, USA (M T Wallin); Natural 
History Museum, London, UK (J L Walson MD); Zhongshan Hospital, 
Fudan University, Shanghai, China (Y Wang MD); The First Affiliated 
Hospital of Xi’an Jiaotong University, Xi’an, China (Y Wang MD); 
University of São Paulo Medical School, São Paulo, São Paulo, Brazil 
(Y Wang PhD); The University of Adelaide, Adelaide, SA, Australia 
(M M Wassie MS); Department of Research, Cancer Registry of Norway, 
Institute of Population-Based Cancer Research, Oslo, Norway 
(E Weiderpass); Department of Community Medicine, Faculty of Health 
Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, 
Norway (E Weiderpass); Genetic Epidemiology Group, Folkhälsan 
Research Center, Helsinki, Finland (E Weiderpass); Royal Children’s 
Hospital, Melbourne, VIC, Australia (R G Weintraub MBBS); Murdoch 
Childrens Research Institute, Melbourne, VIC, Australia (R G Weintraub); 
German National Cohort Consortium, Heidelberg, Germany 
(R Westerman PhD); VitroLive Sp z o.o., Szczecin, Poland 
(J Widecka PhD); Center for Global Health, Department of Neurology, 
Klinikum rechts der Isar, Technical University of Munich (TUM), 
Munich, Germany (Prof A S Winkler DrMed); Centre for Global Health, 
Institute of Health and Society, University of Oslo, Oslo, Norway 
(Prof A S Winkler); South African Medical Research Council, Cochrane 
South Africa, Cape Town, South Africa (Prof C S Wiysonge PhD); National 
Institute for Health Research Comprehensive Biomedical Research 
Centre, Guy’s & St. Thomas’ NHS Foundation Trust and King’s College 
London, London, UK (Prof C D Wolfe MD); Ghent University, Ghent, 
Belgium (A Workicho MPH); NHS National Services Scotland, Glasgow, 
UK (G M A Wyper MS); University of Strathclyde, Glasgow, UK 
(G M A Wyper); St John’s Medical College and Research Institute, 
Bangalore, India (Prof D Xavier MD); Department of Neurology, Jinling 
Hospital, Nanjing University School of Medicine, Nanjing, China 
(Prof G Xu PhD); Global Health Research Center, Duke Kunshan 
University, Kunshan, China (Prof L L Yan PhD); Department of Preventive 
Medicine, Northwestern University, Chicago, IL, USA (Y Yano MD); 
Woldia University, Woldia, Ethiopia (N B Yimer MS); Social Work and 
Social Administration Department, The Hong Kong Jockey Club Centre 
for Suicide Research and Prevention, University of Hong Kong, Hong 
Kong, China (Prof P Yip PhD); University of South Australia, Mawson 
Lakes, SA, Australia (B D Yirsaw PhD); Department of Biostatistics, 
School of Public Health, Kyoto University, Kyoto, Japan 
(N Yonemoto MPH); NCD Research to Policy Unit, Aga Khan University, 
East Africa, Nairobi, Kenya (Prof G Yonga MD); Department of Preventive 
Medicine, College of Medicine, Korea University, Seoul, South Korea 
(S Yoon PhD); School of Public Health, University of Kinshasa, Kinshasa, 
Democratic Republic of the Congo (M Yotebieng PhD); Jackson State 
University, Jackson, MS, USA (Prof M Z Younis DrPH); Department of 
Epidemiology and Biostatistics, School of Public Health, Global Health 
Institute, Wuhan University, Wuhan, China (Prof C Yu PhD); Institute of 
Oncology Ljubljana, Epidemiology and Cancer Registry, Ljubljana, 
Slovenia (Prof V Zadnik PhD); University Hospital of Setif, Setif, Algeria 
(Prof Z Zaidi DSc); National Office of MCH Surveillance of China, 
Chengdu, China (Prof J Zhu MD); Red Cross War Memorial Children’s 
Hospital, Cape Town, South Africa (L J Zuhlke PhD).
Articles
www.thelancet.com   Vol 391   June 2, 2018 2269
Contributors
Nancy Fullman, Rafael Lozano, and Christopher J L Murray prepared the 
first draft of the manuscript. Jamal Yearwood ran the risk-standardisation 
analyses, constructed mortality-to-incidence ratios for cancers, and 
computed indices. Ryan M Barber created the original code and 
methodological approach for index construction. Julian Chalek and 
Erika Eldrenkamp generated figures and tables, and contributed to 
supplementary analyses. Chloe Shields provided project management 
and support. Nancy Fullman, Rafael Lozano, and Christopher J L Murray  
conceived this study and provided overall guidance. Nancy Fullman and 
Rafael Lozano finalised the manuscript on the basis of reviewer feedback. 
Please see the appendix for more detailed information about all authors’ 
contributions to this work and the GBD 2016 results included in this 
analysis.
Declaration of interests
Carl Abelardo T Antonio reports grants and personal fees from Johnson & 
Johnson (Philippines), Inc, outside the submitted work. Johan Ärnlöv 
reports personal fees from AstraZeneca, outside the submitted work. 
Oliver Jerome Brady reports personal fees from Sanofi Pasteur, and grants 
from Janssen, outside the submitted work. Mir Sohail Fazeli reports 
personal fees from Doctor Evidence LLC, outside the submitted work. 
Panniyammakal Jeemon reports and Clinical and public health 
intermediate fellowship from the Wellcome Trust and Department of 
Biotechnology, India Alliance (2015–20), outside the submitted work. 
Jacek Józwiak reports grants and personal fees from VALEANT, personal 
fees from ALAB Laboratoria, personal fees from AMGEN, non-financial 
support from MICROLIFE, non-financial support from SERVIER, outside 
the submitted work. Nicholas J Kassebaum reports personal fees and 
non-financial support from Vifor Pharmaceuticals, outside the submitted 
work. Srinivasa Vittal Katikireddi reports grants from National Health 
Service (NHS) Research Scotland (SCAF/15/02), grants from Medical 
Research Council (MRC; MC_UU_12017/13 & MC_UU_12017/15), and 
grants from Scottish Government Chief Scientist Office (SPHSU13 & 
SPHSU15), during the conduct of the study. Jeffrey Victor Lazarus reports 
grants and personal fees from AbbVie, grants and personal fees from 
Gilead Sciences, grants and personal fees from MSD, personal fees from 
CEPHEID, outside the submitted work. Stefan Lorkowski reports that he 
is a member of the Executive Board of the German Nutrition Society, 
outside of the submitted work. Ronan A Lyons is supported by the Farr 
Institute, outside of the submitted work, which is supported by a 
10-funder consortium: Arthritis Research UK, the British Heart 
Foundation, Cancer Research UK, the Economic and Social Research 
Council, the Engineering and Physical Sciences Research Council, the 
Medical Research Council, the National Institute of Health Research, the 
Health and Care Research Wales (Welsh Assembly Government), 
the Chief Scientist Office (Scottish Government Health Directorates), the 
Wellcome Trust, (MRC grant number MR/K006525/1). Winfried März 
reports grants and personal fees from Siemens Diagnostics, Aegerion 
Pharmaceuticals, AMGEN, AstraZeneca, Danone Research, Pfizer, BASF, 
Numares AG, and Berlin-Chemie, personal fees from Hoffmann 
LaRoche, MSD, Sanofi, and Synageva, grants from Abbott Diagnostics, 
and other from Synlab Holding Deutschland GmbH, outside the 
submitted work. Renata Micha reports support from National Institute of 
Health (NIH) grants during the conduct of the study, and research 
funding from Unilever and personal fees from the World Bank and 
Bunge, all outside the submitted work. Constance D Pond reports 
personal fees from Nutricia advisory board, outside the submitted work, 
and acted as an unpaid consultant to the Wicking Dementia Research and 
Education Centre in Tasmania for development of GP education on 
dementia (airfares and accommodation paid), and was paid as a dementia 
clinical lead and dementia pathways adviser for the Sydney North 
Primary, outside the submitted work. Maarten J Postma reports grants 
personal fees from various pharma companies, and holds 2% of stocks in 
Ingress Health while advising two pharmacoeconomics spin-off 
companies from the University of Groningen, outside the submitted 
work. Miloje Savic reports that from Feb 1, 2018, he is an employee of 
GSK Biologicals SA, Wavre, Belgium. Mark G Shrime reports grants from 
GE Foundation and from Damon Runyon Cancer Research Foundation, 
outside the submitted work. Jasvinder A Singh serves as the principal 
investigator for an investigator-initiated study funded by Horizon 
pharmaceuticals through a grant to DINORA, Inc, a 501c3 entity, and is 
on the steering committee of OMERACT, an international organisation 
that develops measures for clinical trials and receives arm’s-length 
funding from 36 pharmaceutical companies, outside of the submitted 
work. Jeffrey D Stanaway reports grants from Merck, outside the 
submitted work. Dan J Stein reports personal fees from Lundbeck, 
Biocodex, Servier, and SUN, outside the submitted work. Denis Xavier 
reports grants from Cadila Pharmaceuticals, Boehringer Ingelheim, 
Sanofi Aventis, Pfizer, Bristol Myers Squibb, and United Health, outside 
the submitted work. All other authors declare no competing interests.
Acknowledgments
Barbora de Courten is supported by a National Heart Foundation Future 
Leader Fellowship (100864). Ai Koyanagi’s work is supported by the 
Miguel Servet contract financed by the CP13/00150 and PI15/00862 
projects, integrated into the National R + D + I and funded by the ISCIII 
—General Branch Evaluation and Promotion of Health Research—and 
the European Regional Development Fund (ERDF-FEDER). Alberto Ortiz 
was supported by Spanish Government (Instituto de Salud Carlos III 
RETIC REDINREN RD16/0019 FEDER funds). Ashish Awasthi 
acknowledges funding support from Department of Science and 
Technology, Government of India through INSPIRE Faculty scheme 
Boris Bikbov has received funding from the European Union’s Horizon 
2020 research and innovation programme under 
Marie Sklodowska-Curie grant agreement No. 703226. Boris Bikbov 
acknowledges that work related to this paper has been done on the behalf 
of the GBD Genitourinary Disease Expert Group. Panniyammakal 
Jeemon acknowledges support from the clinical and public health 
intermediate fellowship from the Wellcome Trust and Department of 
Biotechnology, India Alliance (2015–20). Job F M van Boven was 
supported by the Department of Clinical Pharmacy & Pharmacology of 
the University Medical Center Groningen, University of Groningen, 
Netherlands. Olanrewaju Oladimeji is an African Research Fellow hosted 
by Human Sciences Research Council (HSRC), South Africa and he also 
has honorary affiliations with Walter Sisulu University (WSU), Eastern 
Cape, South Africa and School of Public Health, University of Namibia 
(UNAM), Namibia. He is indeed grateful for support from HSRC, WSU 
and UNAM. EUI is supported in part by the South African National 
Research Foundation (NRF UID: 86003). Ulrich Mueller acknowledges 
funding by the German National Cohort Study grant No 01ER1511/D, 
Gabrielle B Britton is supported by Secretaría Nacional de Ciencia, 
Tecnología e Innovación and Sistema Nacional de Investigación  de 
Panamá. Giuseppe Remuzzi acknowledges that the work related to this 
paper has been done on behalf of the GBD Genitourinary Disease Expert 
Group. Behzad Heibati would like to acknowledge Air pollution Research 
Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. 
Syed Aljunid acknowledges the National University of Malaysia for 
providing the approval to participate in this GBD Project. Azeem Majeed 
and Imperial College London are grateful for support from the Northwest 
London National Insititute of Health Research (NIHR) Collaboration for 
Leadership in Applied Health Research & Care. Tambe Ayuk 
acknowledges the Institute of Medical Research and Medicinal Plant 
Studies for office space provided. José das Neves was supported in his 
contribution to this work by a Fellowship from Fundação para a Ciência 
e a Tecnologia, Portugal (SFRH/BPD/92934/2013). João Fernandes 
gratefully acknowledges funding from FCT–Fundação para a Ciência 
e a Tecnologia (grant number UID/Multi/50016/2013). 
Jan-Walter De Neve was supported by the Alexander von Humboldt 
Foundation. Kebede Deribe is funded by a Wellcome Trust Intermediate 
Fellowship in Public Health and Tropical Medicine (201900). Kazem 
Rahimi was supported by grants from the Oxford Martin School, the 
NIHR Oxford BRC and the RCUK Global Challenges Research Fund. 
Laith J Abu-Raddad acknowledges the support of Qatar National Research 
Fund (NPRP 9-040-3-008) who provided the main funding for generating 
the data provided to the GBD-IHME effort. Liesl Zuhlke is funded by the 
national research foundation of South Africa and the Medical Research 
Council of South Africa. Monica Cortinovis acknowledges that work 
related to this paper has been done on the behalf of the GBD 
Genitourinary Disease Expert Group. Chuanhua Yu acknowleges support 
from the National Natural Science Foundation of China (grant number 
81773552 and grant number 81273179) Norberto Perico acknowledges that 
work related to this paper has been done on behalf of the GBD 
Genitourinary Disease Expert Group. Charles Shey Wiysonge’s work is 
Articles
2270 www.thelancet.com   Vol 391   June 2, 2018
supported by the South African Medical Research Council and the 
National Research Foundation of South Africa (grant numbers 106035 
and 108571). John J McGrath is supported by grant APP1056929 from the 
John Cade Fellowship from the National Health and Medical Research 
Council and the Danish National Research Foundation (Niels Bohr 
Professorship). Quique Bassat is an ICREA (Catalan Institution for 
Research and Advanced Studies) research professor at ISGlobal. 
Richard G White is funded by the UK MRC and the UK Department for 
International Development (DFID) under the MRC/DFID Concordat 
agreement that is also part of the EDCTP2 programme supported by the 
European Union (MR/P002404/1), the Bill & Melinda Gates Foundation 
(TB Modelling and Analysis Consortium: OPP1084276/OPP1135288, 
CORTIS: OPP1137034/OPP1151915, Vaccines: OPP1160830), and 
UNITAID (4214-LSHTM-Sept15; PO 8477-0-600). 
Rafael Tabarés-Seisdedos was supported in part by grant number 
PROMETEOII/2015/021 from Generalitat Valenciana and the national 
grant PI17/00719 from ISCIII-FEDER. Mihajlo Jakovljevic acknowleges 
contribution from the Serbian Ministry of Education Science and 
Technological Development of the Republic of Serbia (grant OI 175 014). 
Shariful Islam is funded by a Senior Fellowship from Institute for 
Physical Activity and Nutrition, Deakin University and received career 
transition grants from High Blood Pressure Research Council of 
Australia. Sonia Saxena is funded by various grants from the NIHR. 
Stefanos Tyrovolas was supported by the Foundation for Education and 
European Culture, the Sara Borrell postdoctoral program (reference 
number CD15/00019 from the Instituto de Salud Carlos III 
(ISCIII–Spain) and the Fondos Europeo de Desarrollo Regional. Stefanos 
was awarded with a 6 months visiting fellowship funding at IHME from 
M-AES (reference no. MV16/00035 from the Instituto de Salud Carlos 
III). S Vittal Katikreddi was funded by a NHS Research Scotland Senior 
Clinical Fellowship (SCAF/15/02), the MRC (MC_UU_12017/13 & MC_
UU_12017/15) and the Scottish Government Chief Scientist Office 
(SPHSU13 & SPHSU15). Traolach S Brugha has received funding from 
NHS Digital UK to collect data used in this study. The work of 
Hamid Badali was financially supported by Mazandaran University of 
Medical Sciences, Sari, Iran. The work of Stefan Lorkowski is funded by 
the German Federal Ministry of Education and Research (nutriCARD, 
Grant agreement number 01EA1411A). Mariam Molokhia’s research was 
supported by the National Institute for Health Research (NIHR) 
Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation 
Trust and King’s College London. The views expressed are those of the 
author(s) and not necessarily those of the NHS, the NIHR or the 
Department of Health. We also thank the countless individuals who have 
contributed to GBD 2016 in various capacities.
References
1 WHO. The World Health Report 2000—health systems: improving 
performance. Geneva: World Health Organization, 2000.
2 WHO. Everybody’s business: strengthening health systems to 
improve health outcomes: WHO’s framework for action. Geneva: 
World Health Organization, 2007.
3 WHO. Declaration of Alma-Ata. Almaty: World Health Organization, 
1978.
4 UN. Transforming our world: the 2030 Agenda for Sustainable 
Development. New York: United Nations, 2015.
5 WHO. The World Health Report 2010—health systems financing: 
the path to universal coverage. Geneva: World Health Organization, 
2010.
6 Nolte E, McKee M. Does health care save lives? Avoidable mortality 
revisited. London: The Nuffield Trust, 2004.
7 Nolte E, McKee M. Measuring the health of nations: analysis of 
mortality amenable to health care. BMJ 2003; 327: 1129.
8 Nolte E, McKee CM. Measuring the health of nations: updating an 
earlier analysis. Health Aff (Millwood) 2008; 27: 58–71.
9 Nolte E, McKee M. Variations in amenable mortality—trends in 
16 high-income nations. Health Policy 2011; 103: 47–52.
10 Mackenbach JP, Hoffmann R, Khoshaba B, et al. Using ‘amenable 
mortality’ as indicator of healthcare effectiveness in international 
comparisons: results of a validation study. 
J Epidemiol Community Health 2013; 67: 139–46.
11 Eurostat. Amenable and preventable deaths statistics. 2017. 
http://ec.europa.eu/eurostat/statistics-explained/index.php/
Amenable_and_preventable_deaths_statistics (accessed Jan 28, 2018).
12 Gay JG, Paris V, Devaux M, de Looper M. Mortality amenable to 
health care in 31 OECD countries. Paris: Organisation for Economic 
Co-operation and Development, 2011.
13 Radley DC, McCarthy D, Lippa JA, Hayes SL, Schoen C. Aiming 
higher: results from a scorecard on state health system performance, 
2014. Washington, DC: The Commonwealth Fund, 2014.
14 Hone T, Rasella D, Barreto M, Atun R, Majeed A, Millett C. Large 
reductions in amenable mortality associated with Brazil’s primary 
care expansion and strong health governance. Health Aff (Millwood) 
2017; 36: 149–58.
15 Mackenbach JP, Hu Y, Artnik B, et al. Trends in inequalities in 
mortality amenable to health care in 17 European countries. 
Health Aff (Millwood) 2017; 36: 1110–18.
16 Schmidt H, Gostin LO, Emanuel EJ. Public health, universal health 
coverage, and Sustainable Development Goals: can they coexist? 
Lancet 2015; 386: 928–30.
17 Weber A, Clerc M. Deaths amenable to health care: Converging 
trends in the EU? Health Policy 2017; 121: 644–52.
18 Gusmano MK, Rodwin VG, Wang C, Weisz D, Luo L, Hua F. 
Shanghai rising: health improvements as measured by avoidable 
mortality since 2000. Int J Health Policy Manag 2014; 4: 7–12.
19 Franco-Marina F, Lozano R, Villa B, Soliz P. La Mortalidad en 
México, 2000–2004: Muertes Evitables: magnitud, distribución y 
tendencias. México: Dirección General de Información en Salud, 
Secretaría de Salud, 2006.
20 Barber RM, Fullman N, Sorensen RJD, et al. Healthcare Access and 
Quality Index based on mortality from causes amenable to personal 
health care in 195 countries and territories, 1990–2015: a novel 
analysis from the Global Burden of Disease Study 2015. Lancet 2017; 
390: 231–66.
21 Kruk ME, Kelley E, Syed SB, Tarp F, Addison T, Akachi Y. 
Measuring quality of health-care services: what is known and where 
are the gaps? Bull World Health Organ 2017; 95: 389.
22 Sunkara V, Hébert JR. The colorectal cancer mortality-to-incidence 
ratio as an indicator of global cancer screening and care. Cancer 
2015; 121: 1563–69.
23 Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 
1990–2016: burden of diseases, injuries, and risk factors among US 
states. JAMA 2018; 319: 1444–72. 
24 Dandona L, Dandona R, Kumar GA, et al. Nations within a nation: 
variations in epidemiological transition across the states of India, 
1990–2016 in the Global Burden of Disease Study. Lancet 2017; 
390: 2437–60.
25 ICMR, PHFI, IHME. India: Health of the Nation’s States—
The India State-Level Disease Burden Initiative. New Dehli: Indian 
Council of Medical Research, Public Health Foundation of India, 
Institute for Health Metrics and Evaluation, 2017.
26 de Souza MdeFM, França EB, Cavalcante A. Burden of disease and 
health situation analysis: results of the Global Burden of Disease 
(GBD) Brazil network. Rev Bras Epidemiol 2017; 20: 1–3.
27 Nomura S, Sakamoto H, Glenn S, et al. Population health and 
regional variations of disease burden in Japan, 1990–2015: 
a systematic subnational analysis for the Global Burden of Disease 
Study 2015. Lancet 2017; 390: 1521–38.
28 Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, et al. 
Dissonant health transition in the states of Mexico, 1990–2013: 
a systematic analysis for the Global Burden of Disease Study 2013. 
Lancet 2016; 388: 2386–402.
29 Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes 
in China during 1990–2013: a systematic subnational analysis for the 
Global Burden of Disease Study 2013. Lancet 2016; 387: 251–72.
30 Newton JN, Briggs ADM, Murray CJL, et al. Changes in health in 
England, with analysis by English regions and areas of deprivation, 
1990–2013: a systematic analysis for the Global Burden of Disease 
Study 2013. Lancet 2015; 386: 2257–74.
31 Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, 
and national age-sex specific mortality for 264 causes of death, 
1980–2016: a systematic analysis for the Global Burden of Disease 
Study 2016. Lancet 2017; 390: 1151–210.
32 Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, 
and national comparative risk assessment of 84 behavioural, 
environmental and occupational, and metabolic risks or clusters of 
risks, 1990–2016: a systematic analysis for the Global Burden of 
Disease Study 2016. Lancet 2017; 390: 1345–422.
Articles
www.thelancet.com   Vol 391   June 2, 2018 2271
33 Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national 
incidence, prevalence, and years lived with disability for 328 diseases 
and injuries for 195 countries, 1990–2016: a systematic analysis for 
the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–59.
34 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and 
Transparent Health Estimates Reporting: the GATHER statement. 
Lancet 2016; 388: e19–23.
35 Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen MLG, 
Visser O, Verbeek ALM, Kiemeney LALM. The validity of the 
mortality to incidence ratio as a proxy for site-specific cancer 
survival. Eur J Public Health 2011; 21: 573–77.
36 Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, 
and national comparative risk assessment of 79 behavioural, 
environmental and occupational, and metabolic risks or clusters of 
risks, 1990–2015: a systematic analysis for the Global Burden of 
Disease Study 2015. Lancet 2016; 388: 1659–724.
37 Wang H, Abajobir AA, Abate KH, et al. Global, regional, and 
national under-5 mortality, adult mortality, age-specific mortality, 
and life expectancy, 1970–2016: a systematic analysis for the Global 
Burden of Disease Study 2016. Lancet 2017; 390: 1084–150.
38 Fullman N, Barber RM, Abajobir AA, et al. Measuring progress 
and projecting attainment on the basis of past trends of the 
health-related Sustainable Development Goals in 188 countries: 
an analysis from the Global Burden of Disease Study 2016. Lancet 
2017; 390: 1423–59.
39 Frenk J. The concept and measurement of accessibility. In: Health 
services research: an anthology. White KL, Frenk J, Ordonez C, 
Paganini JM, Starfield B, eds. Washington, DC: Pan American 
Health Organization, 1992.
40 Dieleman JL, Haakenstad A, Micah A, et al. Spending on health and 
HIV/AIDS: domestic health spending and development assistance 
in 188 countries, 1995–2015. Lancet 2018; 391: 1799–829.
41 Wang H, Naghavi M, Allen C, et al. Global, regional, and national 
life expectancy, all-cause mortality, and cause-specific mortality for 
249 causes of death, 1980–2015: a systematic analysis for the Global 
Burden of Disease Study 2015. Lancet 2016; 388: 1459–544.
42 Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for 
universal health coverage: achieving social protection for all in 
Mexico. Lancet 2012; 380: 1259–79.
43 Lozano R, Soliz P, Gakidou E, et al. Benchmarking of performance 
of Mexican states with effective coverage. Lancet 2006; 368: 1729–41.
44 Gutiérrez JP, García-Saisó S, Dolci GF, Ávila MH. Effective access 
to health care in Mexico. BMC Health Serv Res 2014; 14: 186.
45 Desai M, Nolte E, Karanikolos M, Khoshaba B, McKee M. 
Measuring NHS performance 1990–2009 using amenable mortality: 
interpret with care. J R Soc Med 2011; 104: 370–79.
46 Watkins J, Wulaningsih W, Zhou CD, et al. Effects of health and 
social care spending constraints on mortality in England: a time 
trend analysis. BMJ Open 2017; 7: e017722.
47 Rice T, Unruh LY, Rosenau P, Barnes AJ, Saltman RB, 
van Ginneken E. Challenges facing the United States of America 
in implementing universal coverage. Bull World Health Organ 
2014; 92: 894–902.
48 Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national 
disability-adjusted life-years (DALYs) for 333 diseases and injuries 
and healthy life expectancy (HALE) for 195 countries and territories, 
1990–2016: a systematic analysis for the Global Burden of Disease 
Study 2016. Lancet 2017; 390: 1260–344.
49 Dieleman J, Campbell M, Chapin A, et al. Evolution and patterns of 
global health financing 1995–2014: development assistance for 
health, and government, prepaid private, and out-of-pocket health 
spending in 184 countries. Lancet 2017; 389: 1981–2004.
50 Mackenbach JP, Karanikolos M, Lopez Bernal J, Mckee M. Why did 
life expectancy in Central and Eastern Europe suddenly improve in 
the 1990s? An analysis by cause of death. Scand J Public Health 2015; 
43: 796–801.
51 Shkolnikov VM, Andreev EM, McKee M, Leon DA. Components and 
possible determinants of decrease in Russian mortality in 2004–2010. 
Demogr Res 2013; 28: 917–50.
52 Cotlear D, Nagpal S, Smith OK, Tandon A, Cortez RA. 
Going universal: how 24 developing countries are implementing 
universal health coverage reforms from the bottom up. 
Washington, DC: The World Bank, 2015.
53 Yu H. Universal health insurance coverage for 1·3 billion people: 
What accounts for China’s success? Health Policy 2015; 119: 1145–52.
54 Atun R. Transforming Turkey’s health system—lessons for universal 
coverage. N Engl J Med 2015; 373: 1285–89.
55 Shakya HS, Adhikari S, Gurung G, et al. Strengthening national 
health systems for improving efficiency of health service delivery in 
Nepal. J Nepal Health Res Counc 2012; 10: 101–07.
56 Lim J, Chan MMH, Alsagoff FZ, Ha D. Innovations in 
non-communicable diseases management in ASEAN: a case 
series. Glob Health Action 2014; 7: 25110.
57 Fullman N, Lozano R. Towards a meaningful measure of universal 
health coverage for the next billion. Lancet Glob Health 2017; 
6: e122–23.
58 Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, 
de Bernis L. Evidence-based, cost-effective interventions: how many 
newborn babies can we save? Lancet 2005; 365: 977–88.
59 Beattie A, Yates R, Noble D. Accelerating progress toward universal 
health coverage for women and children in South Asia, East Asia, 
and the Pacific. New York: United Nations Children’s Fund, 2016.
60 Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss 
in palliative care and pain relief—an imperative of universal health 
coverage: the Lancet Commission report. Lancet 2017; 391: 1391–454.
61 Dieleman JL, Sadat N, Chang AY, et al. Trends in future health 
financing and coverage: future health spending and universal health 
coverage in 188 countries, 2016–40. Lancet 2018; 391: 1783–798.
62 Glassman A, Giedion U, Smith PC. What’s in what’s out? designing 
benefits for universal health coverage. Washington, DC: Center for 
Global Development, 2017.
63 Anselmi L, Lagarde M, Hanson K. Equity in the allocation of public 
sector financial resources in low- and middle-income countries: 
a systematic literature review. Health Policy Plan 2015; 30: 528–45.
64 Sadana R, Blas E, Budhwani S, Koller T, Paraje G. Healthy ageing: 
raising awareness of inequalities, determinants, and what could be 
done to improve health equity. Gerontologist 2016; 
56 (suppl 2): S178–93.
65 WHO. World report on ageing and health 2015. Geneva: World 
Health Organization, 2015.
66 Goodyear-Smith F, van Weel C. Account for primary health care 
when indexing access and quality. Lancet 2017; 390: 205–06.
67 Weiss DJ, Nelson A, Gibson HS, et al. A global map of travel time to 
cities to assess inequalities in accessibility in 2015. Nature 2018; 
553: 333–36.
